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Natural tolerance is the ability of the immune system to prevent any immune re-
sponse against body components and tissues. This capacity coexists with and
cannot be disentangled by the ability of the immune system to recognize and
fight against any kind of fast evolving pathogen that enters the body. The pro-
cess of natural tolerance is so robust and inconspicuous in healthy individuals
that it shows its actual immunological nature when it fails, in pathologic condi-
tions referred as autoimmune diseases. Autoimmunity consists in the disruption
of body tissues orchestrated by the immune system cells. Namely during au-
toimmunity, the immune system uses against its own tissues and organs the very
same destructive mechanisms otherwise used for fighting pathogens. It occurs
together with an uncontrolled clonal expansion of auto-reactive lymphocytes.
Natural tolerance is the result of developmental processes that take place,
first, in the thymus and in the bone marrow, and continue in the periphery. As a
result, activation and proliferation of the auto-reactive lymphocytes, that have es-
caped the negative selection, is controlled by specific Regulatory T cells (Tregs).
It is nowadays clear in the field that tolerance relies on Tregs, a subset of
CD4 T cells enriched in auto-reactivity which selectively express the transcription
factor Foxp3. It is also widely established that, in particular, tolerance emerges as
the result of the interactions and the dynamics that maintain Tregs population in
balance with the population of auto-reactive CD4 T effector cells (Teffs) that they
suppress. The interactions among Tregs and Teffs are mediated by the antigen
presenting cells (APCs) that present auto-antigens as peptides complexed with
MHC class II on their surface. These interactions, through which Tregs feed
on the very same population they suppress, are strongly non-linear and density
dependent.
It is also known that Foxp3 expression is necessary for Tregs development
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and regulatory function, as much as individuals whose CD4 T cell cannot ex-
press functional Foxp3 protein suffer from multi-organ and lethal autoimmune
diseases. In the past years several observations in vivo of Foxp3 dynamics have
been gathered. In healthy individuals Foxp3 expression in Tregs is stable over
several rounds of cells divisions, persisting for several months. In some ”patho-
logic” experimental conditions, such as lymphodeficiency or under inflammation,
loss of Foxp3 expression in Tregs and the accumulation of cells that used to ex-
press Foxp3 (exFoxp3) is observed over time. Moreover, cells that lose Foxp3
expression can become pathogenic, having the ability to infiltrate tissues and
expressing inflammatory cytokines.
In the past, robustness of tolerance, has been partially attributed to the ro-
bustness of Tregs. The experimental observations about Foxp3 dynamics in vivo,
in which Tregs lose their identity, push to probe other possible scenarios.
The present work aims at investigating theoretically and quantitatively the
mechanisms that make tolerance robust. Robustness of tolerance in physiologic
condition is achieved at two complementary levels: on the one hand, at a cellular
level, Foxp3 expression in Tregs is stably maintained, and on the other hand,
at a multicellular level, Tregs population is maintained in balance with the Teff
population they suppress. For this reason our approaches also followed two
complementary levels.
At a population level, we asked whether Tregs could be maintained as a stable
population, even in case Foxp3 expression is determined by the inputs the cells
receive from the other immune cells population, in a density-dependent way. We
built upon the previous developed cross regulation model, which describes the
temporal evolution and interaction between Teffs and Tregs mediated by APCs.
We introduced the loss of Foxp3 expression and their consequent conversion into
Teffs, in Tregs that lack the pro-Foxp3 stimuli. We found parameter regimes in
which, as long as the Foxp3 loss rate is slow enough, not only Tregs population
can be stably maintained, but also their robustness in response to perturbation
is increased as compared to a scenario of purely committed Tregs. Differently
from the original model, in which, in response to a perturbation, homeostasis is
restored through oscillation, when Foxp3 loss is allowed, homeostatic restora-
tion happens much more smoothly. Avoiding oscillations could be a key point for
tolerance robustness, being that both over-shootings and strong declines in ei-
14
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ther Teff and Treg population densities may cause the system to collapse toward
autoimmunity.
At a cellular level, we asked whether the stability of Foxp3 expression, ob-
served in physiologic condition, can be due to the context, rather than to a pro-
grammed developmental process. To this aim, we investigated how the assump-
tion of context-dependent Foxp3 loss, introduced in the population dynamics
model, could be explained at a cellular level, in CD4 T cells. We developed a
stochastic model for Foxp3 expression in CD4 T cells which allowed us to inves-
tigate the characteristic time scale of Foxp3 loss in vivo, and the commitment
and plasticity of Tregs. The model accounted for heterogeneity in Tregs: it con-
siders committed Tregs, that in no case can lose Foxp3 expression, and plastic
Tregs, whose Foxp3 expression depends on the context. We used this model
to fit in vivo data on temporal evolution of Foxp3+ cell frequency in cohorts of
cells that were either Foxp3+ or Foxp3- at a given time, in different experimental
conditions. We found that experimental data are compatible with Tregs being a
homogeneous pool of CD4 T cells, in which Foxp3 expression is either stable
or labile depending on the context, in particular depending on Teffs number and
proportion. This result means that the data are compatible with Foxp3 expres-
sion dynamics in CD4 T cells being dependent on immune populations densities.
We were also able to quantify the average time a Treg is able to maintain Foxp3
expression, in the periphery and in absence of pro-Foxp3 stimuli, to be of four
weeks.
We went further, asking which cellular mechanisms could explain the found
slow Foxp3 loss rate. To do that, we extended the previous model for Foxp3
expression in CD4 T cells, introducing the epigenetic dynamics along with the
transcriptional/translation dynamics, already present. We tried to put forward the
idea that slow epigenetic dynamics, dependent on the transcriptional state of the
cell, together with a fast and context-dependent transcriptional/translational dy-
namics could explain both stability and lability of Foxp3 expression. Data fitting
suggests that this could be the case. The model predicts that in physiologic con-
dition, where Tregs are stable, the vast majority of them has an active state of
chromatin in the Foxp3 locus. It also predicts that the slow dynamics of Foxp3
loss, observed in lymphopenia, would be mainly explained by the epigenetic re-
modeling dynamics of the Foxp3 locus.
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In conclusion, our work indicates that robustness of tolerance can be ex-
plained as a result of non-linear and density-dependent dynamics among Teffs
and Tregs, mediated by APCs. These interactions happen in a context in which
Tregs identity, exemplified by stable Foxp3 expression, is not committed, at least
for a conspicuous part of Tregs. On the contrary, Tregs identity largely depends
on the interactions Tregs make with the other two populations, therefore ulti-
mately depends on the population densities themselves. Furthermore, the slow
dynamics observed in the loss of Foxp3 expression in Tregs that do not receive
enough pro-Foxp3 stimulation from the context can be attributable to epigenetic
mechanisms. Epigenetic mechanisms here involved are consequences of the
transcriptional state of the cell, without being necessarily and directly determined
by inputs the cell receives. Finally, these epigenetic mechanisms take also place
in physiologic conditions. However, they are counterbalanced by fast and context-
dependent Foxp3 up-regulation which results in the apparent stability of Foxp3
expression which is rather a dynamical process.
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Resumo
A tolerância natural refere-se à capacidade do sistema imunológico de evitar a
resposta destrutiva contra os tecidos e orgãos corporais. A tolerância é indis-
sociável da capacidade do sistema de reconhecer e responder contra todo e
qualquer tipo de patogénio. Em indivı́duos saudáveis, o processo de tolerância
natural é tão robusto e inconspı́cuo que só se revela quando falha em situações
patológicas chamadas doenças autoimunes. A autoimunidade patológica cor-
responde à ruptura da fisiologia e destruição dos tecidos corporais orquestrada
pelas células do sistema imunológico, através dos mecanismos destrutivos us-
ados para combater patógenios. A autoimunidade ocorre concomitantemente
com a expansão clonal descontrolada de linfócitos autoreativos.
A tolerância natural é o resultado de processos de desenvolvimento que
ocorrem, em primeiro lugar, no timo e na medula óssea e que prosseguem na
periferia. Estes processos asseguram que a ativação e proliferação dos linfócitos
autoreativos, que escaparam à seleção negativa, sejam controlados especifi-
camente por células T reguladoras (Tregs). As Tregs são um subconjunto de
células T CD4 predominantemente autoreactivas que expressam seletivamente
o fator de transcrição Foxp3. A tolerância surge como resultado das interações
e da dinâmica que mantém a população de Tregs em equilı́brio com a população
de células efetoras T CD4 autoreativas (Teffs), que as primeiras inibem. As in-
tera cões entre Tregs e Teffs dependem de células apresentadoras de antigénios
(APCs), que apresentam à sua superfı́cie antı́genos sob a forma de péptidos
complexados com as moléculas de MHC de classe II. Essas interações, nas
quais as Tregs são estimuladas pelas células Teffs que suprimem dão origem
a dinâmicas fortemente não lineares dependentes das densidades das várias
popula cões celulares intervenientes.
A expressão de Foxp3 é necessária para o desenvolvimento e a função reg-
17
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uladora das Tregs, sendo que os indivı́duos cuja células T CD4 não podem ex-
pressar a protéina Foxp3 funcional sofrem de doenças autoimunes letais que
afetam múltiplos orgãos . Em indivı́duos saudáveis, a expressão de Foxp3
em Tregs é estável ao longo de várias divisões celulares, persistindo durante
vários meses. Em algumas condições experimentais ?patológicas?, como a lin-
fodeficiência ou a inflamação, observa-se a perda de expressão do Foxp3 em
Tregs e a acumulação, ao longo do tempo, de células que anteriormente expres-
savam este factor de transcrição (exFoxp3) . Além disso, as células que perdem
a expressão de Foxp3 podem tornar-se patogénicas, tendo a capacidade de se
infiltrar nos tecidos e expressar citocinas inflamatórias.
No passado, a robustez da tolerância natural foi parcialmente atribuı́da à
robustez da identidade das Tregs. Contudo, as observações experimentais da
dinâmica de perda de expressão de Foxp3 in vivo sugerem a necessidade de
investigar de cenários alternativos. O presente trabalho tem como objetivo in-
vestigar, teórica e quantitativamente, os mecanismos que tornam a tolerância
robusta. A robustez da tolerância em condições fisiológicas é alcanccada em
dois nı́veis complementares: por um lado, a nı́vel celular, a expressão de Foxp3
em Tregs é mantida de forma estável; e, pelo outro, ao nı́vel multicelular, as
populações de Tregs e Teffs mantêm-se em equilı́brio dinâmico. Por essa razão,
abordamos estes dois nı́veis.
Ao nı́vel da dinâmica populacional, perguntamos se as Tregs podem ser man-
tidas como uma população estável, mesmo quando a expressão de Foxp3 seja
determinada pelos sinais que as células recebem das outras células imunes,
sinais esses que são dependentes da densidade celular. Desenvolvemos o
modelo de regulaição cruzada proposto anteriormente, introduzindo a perda da
expressão de Foxp3 em Tregs que não recebendo estı́mulos extracelulares pro-
motores da expressão de Foxp3 se convertem em Teffs. Encontramos regimes
de parâmetros nos quais, desde que a taxa de perda do Foxp3 seja suficien-
temente lenta, se observa a manutenção estável da população de Tregs. Mais
ainda, o estado em que as Tregs predominam torna-se mais robusto em resposta
á perturbação quando as Tregs podem transformar-se em Teffs em comparação
com um cenário em que as Tregs mantêm a sua identidade. No modelo original,
em resposta a uma perturbação, a homeostasia é restaurada após oscilações
da densidade das c’elulas. No entanto, quando a perda de Foxp3 é permitida no
18
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modelo, a restauraccão do equilı́brio ocorre suavemente sem oscilações. Evitar
oscilações pode ser um ponto chave para a robustez da tolerância, sendo que
tanto o crescimento excessivo quanto o forte declı́nio das densidades popula-
cionais de Teff e Treg podem causar o colapso do sistema ou a sua evolução
para o estado de autoimunidade.
Ao nı́vel celular, perguntamo-nos se a estabilidade da expressão de Foxp3
observada em condições fisiológicas poderia ser causada pelo contexto em vez
de o resultado de processo de desenvolvimento programado. Com esse obje-
tivo, investigamos como a hipótese de perda de Foxp3 dependente do contexto,
introduzida no modelo de dinâmica populacional, poderia ser explicada ao nı́vel
celular. Desenvolvemos portanto um modelo estocástico da expressão de Foxp3
nas células T CD4, o que nos permitiu investigar a escala de tempo caracterı́stica
da perda de Foxp3 in vivo, bem como a determinação e a plasticidade das Tregs.
Tendo em conta a heterogeneidade das Tregs, o modelo considera Tregs irrever-
sivelmente determinadas, que em nenhum caso podem perder a expressão de
Foxp3, e Tregs plásticas, cuja expressão de Foxp3 é dependente do contexto.
Esse modelo permitiu ajustar dos dados in vivo relativos à evolução temporal da
frequência das células Foxp3+ nas coortes de células Foxp3+ ou Foxp3- num de-
terminado momento, em diferentes condições experimentais. Descobrimos que
os dados experimentais são compaı́veis com a hipótese de que as Tregs seriam
um conjunto homogêneo de células T CD4 nas quais a expressão do Foxp3 é
estável ou l ábil, dependendo do contexto, em particular dependendo do número
e da proporção de Teffs. Este resultado implica que os dados são compaı́veis
com uma dinâmica de expressão Foxp3 nas células T CD4 dependente das den-
sidades das populações de células imunes. Foi também possı́vel quantificar em
quatro semanas o tempo médio em que uma Treg consegue manter a expressão
de Foxp3 na periferia e na ausência de esı́mulos pró-Foxp3.
Interrogamo-nos ainda sobre os mecanismos celulares que poderiam justi-
ficar a lenta taxa de perda de Foxp3 pela Tregs. Assim, estendemos o mod-
elo anterior para a expressão de Foxp3 introduzindo a dinâmica epigenética.
Tentamos avan car o conceito de que uma dinâmica epigenética lenta (depen-
dente do estado de transcrição da célula) juntamente com a dinâmica rápida da
transcrição e tradução dependente do contexto poderia explicar a estabilidade e
a volatilidade da expressão de Foxp3. O ajustamento dos dados confirmou essa
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possibilidade. O modelo prevê que, em condições fisiológicas onde os Tregs
são estáveis, a grande maioria destes possui um estado de cromatina activo no
locus Foxp3. O modelo também indica que a dinâmica lenta da perda de Foxp3,
observada na linfopenia, poderá ser explicada principalmente pela dinâmica de
remodelação epigenética do locus Foxp3.
Em conclusão, o nosso trabalho indica que a robustez da tolerância pode
ser explicada como o resultado da dinâmica não linear das densidades de
populações de Teffs, Tregs e APCs. As interações entre estas células ocor-
rem num contexto em que a identidade das Tregs, exemplificada pela expressão
estável de Foxp3, não está determinada, pelo menos para uma parte conspı́cua
de Tregs. Pelo contrário, a identidade das Tregs depende em grande parte das
interações que estas fazem com as células das outras duas populações, de-
pendendo portanto, em última análise, da densidade da sua própria população.
Além disso, a lenta dinâmica observada na perda da expressão Foxp3 em Tregs
que não recebem suficientes estı́mulos pró-Foxp3 pode ser atribuı́da a mecan-
ismos epigenéticos. Os mecanismos epigenéticos envolvidos são determinados
pelo estado de transcrição da célula, sem serem necessaria e diretamente deter-
minados pelos estı́mulos que a célula recebe. Finalmente, esses mecanismos
epigenéticos também ocorrem em condições fisiológicas. No entanto, eles são
contrabalançados pela regulação rápida da transcrição do Foxp3, dependente
do contexto, o que resulta numa aparente estabilidade da expressão de Foxp3,
que é no entanto o resultado de um processo dinâmico.
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Zé for his precious feedbacks, for our discussions and for finding the time and
the energies to review my manuscript, even under a pandemic. Salvatore and
Sandro who, in a hard moment, took the time to review a much older and unripe
manuscript. Prof. Francesco Sciortino who, in the right moment, reminded me
that the smallness of an advancement in the knowledge does not nullify its wor-
thiness. Manuela Cordeiro and Ana Aranda for taking care of us Ph.D.. students
in an extraordinary way.
I thank Nando, Rachele, Rita, Serena, and Valeria for being at my side, re-
gardless of physical distances, no matter what. And Macarena, for our journey in
search of barycenters in the dance.
The greatest lesson of these people over these years finds its synthesis in
the words of the students of the school of Barbiana, written back in 1967: ”I have
learned that other people’s problems are like mine. Overcoming them together
is good politics. Overcoming them alone is avarice. I was not at all vaccinated
against avarice”. So I was, in many respects, when I started this Ph.D. journey.
For this reason, any weakness of this work is the result of avarice that, from time
to time, has appeared in the shape of shame, fear, feeling of inadequacy, com-
petition. On the contrary, each strength of this work comes from collaboration,
dialogue, openness, and the ability to be good students and good teachers.
22
LIST OF TABLES
This thesis is dedicated to three silhouettes on a lawn, which have been
close to mine own silhouette for ages and will keep on: the one of Alberto, Enza,
and Simone. To each one in equal amount.
This work was supported by Fundação para a Ciência e a Tecnologia through






1.1 Tolerance is robust
The adaptive immune system has evolved in a way that makes it able to mount
immune responses against any kind of fast evolving pathogens, such as viruses
and bacteria. At the same time, evolution has ensured the adaptive immune
system to be tolerant to body components, body tissues and non-harmful third
parties, such as commensals and food.
Although along the history of immunology it has not always been clear, these
two abilities of the immune system, not only are intertwined, but they constitute
two sides of the very same coin and one cannot be understood without the other.
Individuals are naturally tolerant, this status generally persisting during their
entire life. Moreover, the developmental processes that lead to natural tolerance
are so robust that it took long until natural tolerance started to be perceived as
an immunological process and therefore was integrated into an immunological
perspective. In 1900 the immunologist Erlich used the term horror autotoxicus
to describe what he thought was the body’s innate aversion to immunological
self-destruction [Ehrlich and Morgenroth, 1899, Ehrlich, 1902]. At that time an-
tibodies were the accepted hallmark of immunity, despite it was not yet known
which cells produced them. It was clear that several vertebrates are able to pro-
duce a large variety of antibodies which could recognize, in principle, any protein.
Yet, there was no clear idea on how the immune system could then distinguish
between ”non-self” and ”self”, targeting the former while sparing the latter.
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Natural tolerance can be clearly recognized as an immunological process
when it fails, during autoimmune disease.
Autoimmunity occurs as a consequence of massive clonal expansion of auto-
reactive lymphocytes, namely when the immune system redeploys against its
own tissues and organs the very same destructive mechanisms, otherwise used
for fighting pathogens. As a result, entire organs are infiltrated with auto-reactive
immune cells. They can be literally liquified by auto-reactive cytotoxic T cells
and with the help of autoantibody-producers B cells. Although CD8 T cells and
B cells are the one responsible for immune pathology, we know that their clonal
expansion cannot occur without the necessary trigger of auto-reactive CD4 T
cells, which actually orchestrate the immune response.
The reason why immunity and tolerance are deeply connected resides in the
peculiar characteristics of the adaptive immune system, which makes it able to
cope with evolving pathogens. In particular, it resides in the vast repertoire of
antigen receptors that are generated and that lymphocytes express in their sur-
face. Through this large variety of antigen receptors, lymphocytes have the po-
tential to recognize any possible antigen that enters the body and is presented as
peptides complexed with MHC class II on the surface of antigen presenting cells
(APCs). The generation of this vast repertoire is achieved in lymphocyte precur-
sors, by random recombination of the gene segments that code for the receptor
chains, such as the variable (V), the joining (J) and, in some cases, the diversity
(D) gene segment. This process is called V(D)J recombination. Most lympho-
cytes have a unique antigen receptor, able to recognize and react to specific
antigen presented. Also, lymphocytes can undergo clonal expansion, if activated
through receptor engagement.
The drawback of the potentiality to recognize any kind of antigen, is that lym-
phocytes that recognize body antigens are inevitably generated. These auto-
reactive lymphocytes can cause autoimmunity, unless their clonal expansion is
prevented in the periphery.
For this reason the key mechanism to build and maintain natural tolerance,
preventing pathologic autoimmunity, boils down to prevent the clonal expansion
of auto-reactive lymphocytes in the periphery. The mechanisms through which
this goal is achieved by the immune system have been a hotly debated topic
during the history of immunology.
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1.2 Clonal selection and natural tolerance by deletion of
immature lymphocytes
The original clonal selection theory [Burnet et al., 1957], introduced in 1957 by
Burnet, first claimed that each lymphocyte bears a single type of receptor, with
a unique specificity, that would undergo clonal expansion upon receptor engage-
ment and subsequent activation. In his theory, Burnet justified the prevention of
auto-rective lymphocyte clones with their deletion, that would take place during
embryonic development. However, we know that generation of lymphocytes is a
lifelong process in mammals.
Two years later, Lendeberg proposed that the deletion of potentially auto-
reactive lymphocytes would take place during lymphopoiesis, in the bone mar-
row and in the thymus [Lederberg, 1959]. Indeed immature lymphocytes that
express auto-reactive receptor are deleted either in the bone marrow or in the
thymus [Renno and Acha-Orbea, 1996, Kisielow et al., 1988]. This process is of-
ten referred as negative selection and central tolerance. In particular, in T cells
negative selection a key role is played by the transcription factor autoimmune
regulator (Aire), thanks to which tissue specific antigens are expressed in the
thymus [Taniguchi and Anderson, 2011].
1.3 Natural tolerance by deletion of circulating lympho-
cytes
Negative selection that takes place in thymus and in the bone marrow cannot
account for tolerance to peripheral antigens that are not expressed in either of
the two lymphopoietic organs. In 1987 Langman and Cohn proposed a solution to
this puzzle, introducing a second version of the so called ”two signal model”. This
model predicts deletion of auto-reactive lymphocytes circulating in the periphery.
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1.4 Regulation among lymphocytes: meet the Regula-
tory T cells
Neither central nor peripheral deletion of immature auto-reactive lymphocytes
can, by themselves, explain natural tolerance. Indeed, the presence of sig-
nificant number of mature auto-reactive lymphocytes circulating in the periph-
ery in healthy animals is experimentally well documented [Ramsdell et al., 1989,
Heath et al., 1992]. This suggests that their presence, per se, is not sufficient to
break tolerance. Nevertheless, several experimental evidences have shown that
auto-reactive circulating lymphocytes can undergo massive clonal expansion and
cause autoimmune pathology, unless they are controlled by specific Regulatory
T cells (Tregs). Tregs are a subset of CD4+ T cells, nowadays recognised as the
one selectively expressing the transcription factor forkhead box protein 3 (Foxp3)
and high level of the interleukine 2 (IL-2) receptor ↵-chain (CD25).
Let us recapitulate the experiments that led to the notion that natural tolerance
emerges as a result of the interactions among lymphocyte populations.
Mice that have been thymectomized in perinatal period, and within a small
time window, develop multi-organ autoimmune disease in adulthood. How-
ever, autoimmunity does not occur in case the thymectomy is performed later
[Nishizuka and Sakakura, 1969, Sakaguchi et al., 1982]. This suggested the ex-
istence of a special wave of production of Tregs in the thymus early after birth,
as proposed by Modigliani [Modigliani et al., 1996].
Beside this special period, Tregs are known to be produced in the
thymus throughout the entire life [Seddon and Mason, 1999, Itoh et al., 1999,
Jordan et al., 2001, Fontenot et al., 2005], although to a lesser extend, mainly
due to thymic involution [Boehm and Swann, 2013]. One possible interpre-
tation is that thymectomy performed during that perinatal window, results
in a strong imbalance in the bulk of the Tregs that colonize the periphery
[Dujardin et al., 2004]. The imbalance is later amplified by the cells popula-
tion dynamics that takes place in the periphery, as suggested by Carneiro
[Carneiro et al., 1995, Carneiro et al., 2007].
Autoimmune pathologies that develop in adulthood mice upon thymectomy in
perinatal period, can be prevented by adoptive transfer of CD4+ Tregs, sorted
from healthy adult mice [Suri-Payer et al., 1998]. However, transfer of CD4+ T
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cells, that lack a proper amount of Tregs, is not able to prevent the development
of autoimmunity in the recipient.
Many interesting experimental observations have been performed in lym-
phodeficient mice, which lack adaptive immunity. Adoptive transfers into empty
mice of small numbers of CD4+ T cells that are poor in Tregs, result in large
lymphoproliferative pathology, whether the pool of cells are sorted as CD25-
[Sakaguchi et al., 1995], CD45Rbhigh [Morrissey et al., 1993, Powrie et al., 1993]
or Foxp3- [Wan and Flavell, 2005]. However, massive clonal expansion and au-
toimmunity are prevented in case mice are reconstituted with CD4+ T cells pop-
ulation, either enriched in Tregs or in proper mixture of Tregs and non-Tregs
[Annacker et al., 2000, Annacker et al., 2001, Almeida et al., 2002].
Tregs sorted from donor that lacks specific tissue, fail to prevent autoimmune
response against that specific tissue in the host [Seddon and Mason, 1999]. This
finding highlights the antigen specificity, or at least tissue specificity, of Tregs.
Also it indicates that persistence of Tregs as population requires sustained stim-
ulation by peripheral antigens.
Furthermore, it was observed that break of tolerance can be triggered by
perturbations that cause disequilibrium between Tregs and their target T cells
population. These perturbations encompass either direct perturbations of T cells
proportions, perturbations of other leukocytes, or perturbations of the innate im-
mune system, such as the one occurring upon massive local inflammation that
follow immunization with adjuvants [Panoutsakopoulou and Cantor, 2001]. Inter-
estingly enough, when tolerance is broken, reverting the situation seems to be a
very difficult task, even more difficult than breaking tolerance.
Concerning the possibility of inducing tolerance to specific antigens, decades
of experiments in grafts have shown that, although successful grafts can be
performed during embryonic development, in most of the cases tissues are re-
jected as soon as immunocompetence develops. Billingham, Medawar and Brent
showed that hematopoietic tissue constitutes an exception. In their seminal ex-
periment, performed in 1953, they managed to induce chimerism and homo-
graft acceptance in mice, by transferring spleen cells into intrauterine fetuses
[Billingham et al., 1953]. Later, it was shown that also thymic epithelial cells are
able to induce tolerance in the host to themselves and to other tissues from the
same donor [Modigliani et al., 1995, Ohki et al., 1987].
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1.5 The cross regulation model of cell populations dy-
namics: an integrated framework for tolerance and
immunity
All the observations recalled in the previous section indicate that the robustness
of tolerance in adults is the result of density-dependent interactions that Tregs
make with other T cells and APCs populations, as put forward by the cross
regulation model (CRM) developed by León and Carneiro [León et al., 2001,
León et al., 2003, León et al., 2004b, León et al., 2004a, Carneiro et al., 2005,
Carneiro et al., 2007].
The CRM describes the temporal evolution of Treg and Teff population den-
sities whose interactions are mediated by the APC populations. APC-mediated
interactions happen through multicellular conjugates that Tregs, Teffs and APCs
of the same specificity form and brake over time, in a density-dependent way.
Through these interactions, Tregs control the proliferation of the Teffs that react
to the same set of antigens. According to the model, tolerance emerges as a
result of the population dynamics occurring in the periphery, mediated by APCs.
Antigen presentation is fundamental in the sense that it determines, in a ro-
bust way, the configuration of equilibrium reached by the populations of Tregs
and Teffs recognizing that specific antigen. In particular the population dynamics
in the periphery shapes the CD4+ T cell peripheral repertoire into two subsets
[Carneiro et al., 2007]. The first subset is constituted by a more diverse set of
clones, which are barely auto-reactive and whose clonal expansion is limited by
the APCs availability. These clones react to antigens that are rarely presented in
the periphery and, most likely, are the ones responsible for mounting immune re-
sponses against pathogens. The second subset of clones is constituted by a less
diverse set of clones of auto-reactive Teffs and Tregs that react to the same anti-
gen(s) and regulate each other’s growth. These clones are supported by a larger
density of APCs, if compared with the previous case. Bi-stability characterizes
the latter set of clones in the sense that there are two possible configurations of
equilibrium for them. In healthy individuals Tregs and Teffs of the same clone co-
exist, with Tregs regulating the Teffs. Nevertheless, in case a strong perturbation
leads the system far from the healthy equilibrium, the population dynamics can
amplify the perturbation and the system can eventually collapse into the other
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configuration of equilibrium, characterized by no Tregs.
Perturbations of the system can occur early in development or later in life.
Nevertheless, considering that a perturbation early in development would affect
the seed of Tregs that colonize the periphery, it appears much clear the funda-
mental role of thymus in early stages of development. In fact the thymus ensures
an appropriate seeding of clones in the periphery.
The bi-stability of the second subset of clones, which guarantee natural tol-
erance and can potential cause autoimmunity, can be explained as a result of
the competition of Teffs and Tregs for APCs. In fact the CRM assumes that
APCs are limited in density and the interactions among T cells and APCs de-
termine T cells activation. Activated T cells can proliferate, provided growth
factors (mainly IL-2) are available. Given that activated Teffs produce IL-2
[Almeida et al., 2006, Malek, 2008], it is enough a critical APCs density for Teffs
to sustain their own proliferation. On the other hand, because Tregs do not pro-
duce IL-2, their maintenance as a population requires a higher density of APCs.
In fact, higher density of APCs can sustain enough activated Teffs, which are
source of IL-2, while preventing Teffs to outcompete Tregs in the competion for
APCs.
Therefore the APCs-mediated population dynamics defined by the cross reg-
ulation model explains the self versus non-self discrimination operated by the
adaptive immune system and the partitioning of T cells repertoire, based on their
degree of auto-reactivity. It provides an explanation for the observation that auto-
reactive T cells leaving the thymus, are accompanied by Tregs that control them.
Finally it explains the high auto-reactivity of Tregs [Kim et al., 2007]. In summary,
the CRM clarifies in which sense immunity and tolerance are two faces of the
very same coin.
1.6 Tolerance robustness as a result of non-linear
density-dependent populations dynamics
As already mentioned, the CRM interprets natural tolerance as a result of the
non-linear and density-dependent interactions among Tregs and Teffs, mediated
by APCs. Along with the importance of the APCs discussed in the previous sec-
tion, the relative density of Tregs and Teffs plays a fundamental role in the popula-
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tion dynamics. The interactions among T cells and APCs need proximity and the
CRM approximates proximity by multicellular conjugates formed among APCs
and T cells. In particular, the model assumes that Tregs can inhibit Teffs when
they form multicellular conjugates together with them and APCs. As a result the
relative densities of the three populations determines which kind of conjugates
are more likely to be formed. In turn, the type of conjugates formed influences the
kind of interactions that are more likely to take place and which can either induce
or inhibit cell proliferation. Interactions determine both the population dynamics
and the populations densities of equilibrium.
The density dependent-interactions among the three cell populations, at the
end of the day, shape robustly the repertoire ensuring auto-reactive T cells to
be controlled by Tregs of similar specificity. Density dependency is therefore
responsible for a robust self versus non-self discrimination.
If we consider a given couple of Treg and Teff populations that react to the
same set of antigens, presented by a given population of APCs, we can refer
to these populations as a niche. Within each niche, the density-dependent in-
teractions are responsible for the robustness of the configuration of equilibrium.
In this context, robustness of the healthy equilibrium refers to the perturbations
the niche can cope with without Tregs being outnumbered, which would result in
autoimmunity.
Moreover, density dependent interactions explain tolerance robustness in
terms of the ability the system has in coping with increasing auto-antigens pre-
sentation, without breaking tolerance. This ability persists as as long as the
increase happens slowly. An increase in the density of APCs presenting auto-
antigens can occur when individuals are under immunological challenge and tis-
sues are destroyed as a consequence. In this case it is fundamental that tol-
erance is maintained, preventing the immune system to redirect toward body
components the immune response mounted against pathogens.
The cross regulation model, that provides an integrated framework for ex-
plaining immunity, tolerance and its robustness. However assumes that Tregs
and Teffs identity is defined, during their interaction. Along the years, several
experimental observations has been gathered suggesting that this assumption
might be relaxed. Let us dig into some fundamental knowledge about Tregs and
their lineage-specifying transcription factors Foxp3.
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1.7 Origin of Tregs and Foxp3 expression
Tregs are a subset of CD4 T cells which selectively express the transcription fac-
tor Foxp3 (forkhead domain DNA-binding transcription factor box protein 3). For
long time, before Foxp3 gene was discovered to be essential for Tregs develop-
ment and function, in 2003, regulatory T cells used to be identified based on high
level of expression of the high affinity IL-2 receptor ↵-chain (CD25) in their sur-
face. In 1995, Sakaguchi et al. first described thymically derived cell type, char-
acterized by the expression of CD4 and CD25, able to prevent and rescue multi-
organ autoimmunity and lethal systemic inflammation [Sakaguchi et al., 1995,
Asano et al., 1996]. Because CD4 and CD25 are not cell-specific surface mark-
ers, the discovery of the transcription factor Foxp3 as unique marker for Tregs, at
least in mice, constituted a turning point in the study of Tregs. In both humans
and mice, Foxp3 is essential for Tregs development and suppressive function
[Hori, 2003, Fontenot et al., 2003, Khattri et al., 2003, Tran et al., 2007]. How-
ever, in humans also recently activated Teffs express Foxp3 [Tran et al., 2007].
The fact that Foxp3 expression is necessary for regulatory function is proven by
the evidence that individuals whose CD4 T cells cannot express Foxp3 die due to
multi-organ autoimmunity early in development. Mutations or lack of Foxp3 lead
to the scurfy phenotype in mice and to immuno-dysregulation, polyendocrinopa-
thy, enteropathy, X-linked syndrome (IPEX) in humans, characterized by break
of tolerance and by the development of a spectrum of autoimmune diseases
[Bennett et al., 2001, Brunkow et al., 2001]. This is actually the way in which
Foxp3 gene was first discover, when it was realized that a mutation in the gene,
resulting in a truncated Foxp3 protein, was the cause of the scurfy phenotype
[Brunkow et al., 2001].
Tregs are enriched in self-reactivity [Kim et al., 2007] and constitute around
10 to 15% of the total CD4 T cells in the peripheral lymphoid compartment, in
mice in physiologic condition. Most of Foxp3 transcription is initiated in CD4
single positive thymocytes, as suggested by the genetic lineage tracing of Foxp3+
T [Zhou et al., 2009]. This stage of thymocytes maturation has been linked to
negative selection occurring in the thymus. For this reason, this finding supports
the claim that Tregs develop during negative selection, concurrently with the auto-
reactive Foxp3-CD4+ T cells that escape negative selection [Jordan et al., 2001,
Sprent and Kishimoto, 2002].
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Tregs are essential for ensuring natural tolerance and preventing autoim-
munity, by controlling the activation and proliferation of auto-reactive lym-
phocytes [Sakaguchi et al., 1995, Sakaguchi et al., 2001, Sakaguchi, 2004].
Accumulating evidences have shown that Tregs have the potential to
suppress many kind of immune response. During immune response
against pathogens, Tregs modulate the immune response preventing
associated immune pathology [Cahill et al., 1997, Belkaid et al., 2002,
Hori et al., 2002, Suvas et al., 2004]. Also, they prevent rejection of trans-
plants [Taylor et al., 2001, Kingsley et al., 2002, Graca et al., 2002] and
modulate the immune response against tumors [Onizuka et al., 1999,
Ohue and Nishikawa, 2019]. Tregs ensure tolerance to commensal bac-
teria [Nagano et al., 2012, Nutsch and Hsieh, 2012] and promote maternal
tolerance to the fetus during pregnancy [Aluvihare et al., 2004].
Several mechanisms of suppression perpetuated by Tregs have been iden-
tified. Tregs can directly inhibit other immune cells either by secreting anti-
inflammatory cytokines, or by expressing co-inhibitory molecules such as cyto-
toxic T lymphocytes antigen 4 (CTLA4) and lymphocyte activation gene 3 protein
(LAG3). Also, they are able to indirectly inhibit other lymphocytes, by modulating
the activity of APCs.
It was believed that Tregs constitute a distinct lineage of cells simultane-
ously committed to Foxp3 expression and regulatory activity [Sakaguchi, 2005,
Sakaguchi et al., 2008]: in this view, tolerance robustness was reduced to the pu-
tative robustness of Foxp3 differentiation program. This idea was progressively
undermined. Experimental evidences have shown that Foxp3 differentiation pro-
gram is plastic and unstable and, among Tregs, different populations of cells have
been named.
Thymic Tregs (tTreg) differentiate from thymic precursors, during the sin-
gle positive (SP) CD4+ CD8- stage, when thymic selection takes place and
upon a strong signal related to their TCR specificity [Fontenot et al., 2005].
These cells exit the thymus already expressing Foxp3 and with the ability
of preventing lymphocytes proliferation. Tregs differentiation happens also
in the periphery: in this case Foxp3 expression and regulatory function
is induced in mature peripheral naive CD4 T cells, as a consequence of
exposure to antigens in the periphery [Curotto de Lafaille and Lafaille, 2009,
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Bilate and Lafaille, 2012]. These cells are called peripheral Tregs (pTregs).
pTregs have been claimed to be important in maintaining tolerance, particu-
lar to self-antigens not expressed in thymus and to help tumor cells to es-
cape from immune surveillance [Yamaguchi and Sakaguchi, 2006]. For both
thymic and perypheral Tregs the differentiation program has been proposed to
take place in two steps [Burchill et al., 2008, Schallenberg et al., 2010]. The
first step is the up-regulation of CD25, the ↵-chain of the high-affinity trimeric
IL-2 receptor, induced through TCR signaling. Up-regulation of CD25 makes
Foxp3-CD25+ thymocytes more receptive to IL-2 stimulation, which induces the
Foxp3 up-regulation (second step). The full extent of differences and similar-
ities between tTreg and pTregs populations is yet to be defined. Helio and
neuropilin-1 have been used as markers to distinguish tTreg (Helios+ Nrp1+)
and pTreg (Helios- Nrp1-) [Yadav et al., 2012, Weiss et al., 2012]. It has been
shown that Foxp3 differentiation program is unstable in both tTreg and pTreg
[Duarte et al., 2009, Zhou et al., 2009]. Under inflammation [Zhou et al., 2009,
Yurchenko et al., 2012, Mellor and Munn, 2011] and in lymphodeficient condi-
tions [Duarte et al., 2009, Komatsu et al., 2009] Tregs can lose Foxp3 expression
and be reprogrammed to conventional T cells, mostly self-reactive. However, un-
der physiologic conditions, Tregs show stable phenotype [Rubtsov et al., 2010].
Stable expression of Foxp3 is required for Tregs to maintain suppressive
function [Williams and Rudensky, 2007]. Many molecular mechanisms that un-
derpin Foxp3 expression are known. Foxp3 gene has three conserved non-
coding sequence (CNS) regions, that serve as enhancer regions, and a con-
served region defined as promoter which is up-stream the transcriptional start
site (TSS). These regions are bound by several transcription factors down-
stream the TCR, the IL-2 and the TGF-  signalling pathways, influencing the
induction, consolidation and tuning of Foxp3 transcription. Foxp3 expres-
sion requires continuous TCR signalling which causes downstream NFAT (Nu-
clear factor of activated T cells) to bind to the Foxp3 promoter and to the
CNS1 [Tone et al., 2008]. NF-kB (nuclear factor kappa-light-chain-enhancer
of activated B cells) regulates Foxp3 expression downstream of TCR stimu-
lation, by binding to CNS3, which leads to open the Foxp3 promoter region
[Ruan et al., 2009, Zheng et al., 2010, Long et al., 2009]. NF-kB also binds to
the Foxp3 promoter and to the CNS2 [Long et al., 2009, Zheng et al., 2010].
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Downstream the TCR signalling pathway, also the activator protein 1(AP1) binds
to the Foxp3 promoter [Mantel et al., 2006], the cyclic AMP response element-
binding protein (CREB) binds to the CNS2 [Kim and Leonard, 2007] and the
Nr4a proteins bind to the promoter [Sekiya et al., 2013]. The binding of a
RUNX1-CBF  complex (runt-related transcription factor 1, core-binding factor
subunit   complex) to CNS2 is fundamental for the maintenance of Foxp3 ex-
pression in Tregs [Kitoh et al., 2009a] and allow for Foxp3 binding to CNS2
[Zheng et al., 2010]. IL-2 stimulation triggers downstream Jack-STAT5 (Janus
Kinase-signal transducer activator of transcription 5) signalling, with consequent
binding of the STAT5 dimers to the promoter and CNS2, which activate Foxp3
transcription [Yao et al., 2007, Villarino et al., 2007]. Extra-thymic Tregs develop-
ment relies, along with TCR engagement and IL-2 stimulation, on TGF-  induced
smad2/3 (small mothers against decapentaplegic) signalling, through the binding
to CNS1 [McKarns and Schwartz, 2005].
Based on the molecular knowledge, models of the gene regulatory network
(GRN) underlying the CD4 T cells differentiation program, in response to hetero-
geneous environments, have been proposed. Gene regulatory network models
focus on single cells and represent, through logic rules, the collections of regu-
lators that interact with each other and other substances inside a cell, to govern
gene expression levels. These models investigate how gene expressions are af-
fected from external environmental inputs. In particular, the model developed in
[Naldi et al., 2010, Abou-Jaoudé et al., 2015], in which gene regulatory network
together with signaling pathways drive the CD4 T cell differentiation program,
found the canonical CD4 T cells phenotypes, including Tregs, as stable states of
the state transition graph. Remarkably, for what concerns the stability of the cell
subtypes with respect to environmental changes, in this model Tregs appear to be
context-dependent and more plastic than the other CD4 T cell subpopulations.
Along these canonical populations, and coexisting with them, other transiently
hybrid phenotypes have been found, which express combined features of the
canonical ones, including Foxp3 expression, in a context-dependent way.
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1.8 Epigenetic control of Foxp3 expression
As already mentioned, three conserved non coding regions, other than a pro-
moter, have been identified within the Foxp3 locus. These regions have
been shown to play important role in ensuring stability to Foxp3 expression
[Zheng et al., 2010, Schlenner et al., 2012].
Tregs have been shown to display full demethylation of a conserved CpG-
rich region within the first intron of the Foxp3 locus (the CNS2), as well
as histone acetylations modifications [Floess et al., 2007, Polansky et al., 2008,
Huehn et al., 2009].
The demethylation of the CNS2 facilitates the recruitment of sev-
eral transcription factors to the CNS2 itself. Among the ones de-
scribed, there are RUNX1-CBF  complex, CREB/ATF and Ets-1 that bind
to the CNS2; STAT5 that binds to Foxp3 promoter and to the CNS2
and Foxp3 itself [Kitoh et al., 2009b, Kitagawa et al., 2013, Sekiya et al., 2016,
Kim and Leonard, 2007, Polansky et al., 2010]. Particularly, Foxp3 binding to
CNS2 appears to happen after and being dependent on CNS2 demethylation.
Foxp3 binding to CNS2 also depends on RUNX1-CBF  [Zheng et al., 2010], with
whom it forms large complexes [Ono et al., 2007]. In this sense the demethy-
lation of the Foxp3 locus has been proposed to provide epigenetic memory
of Foxp3 expression, because it maintains the Foxp3 locus accessible to the
transcription factors that then trans-activate Foxp3 transcription. The com-
plete demethylation of this region, called the Tregs-specific demethylated region
(TSDR), has been claim to be the key mechanism through which stable Foxp3
expression is achieved in CD4 T cells [Floess et al., 2007, Huehn et al., 2009,
Polansky et al., 2008, Zheng et al., 2010] and methylation status of the TCDR
has been used for the identification of stable Tregs [Toker et al., 2013].
Demethylation at the TSDR is not required for initiation of Foxp3 expres-
sion, but it is needed for its long-term maintenance [Polansky et al., 2008,
Huehn et al., 2009, Zheng et al., 2010] and happens when Foxp3 expression is
already sustained [Bending et al., 2018]. Furthermore TSDRs are fully demethy-
lated in stable Tregs, while they are fully methylated both in conventional
CD4 T cells and in in vitro induced Tregs [Huehn et al., 2009]. Forced TSDR
demethylation confers stability to Foxp3 expression in in vitro-induced Tregs
[Polansky et al., 2008]. Finally, ex-Foxp3 CD4+ T cells, generated in lymphopenic
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conditions, show a partially demethylated TSDR [Miyao et al., 2012]. Interest-
ingly, among them some are able to reacquire Foxp3 expression upon activation
and become fully demethylated at the TSDR. Others remain Foxp3- and exhibit
fully methylated TSDR upon activation [Miyao et al., 2012].
CpG-reach regions that are preferentially demethylated in Tregs have been
found in other genomic regions, outside the Foxp3 locus. These regions are also
called TSDRs, they have been found to be distributed in genes that belong to the
Treg signature genes and they are important for Treg differentiation and function.
These genes include Ctla4, Il2ra, Ikzf4 and Tnfrsf18 [Ohkura et al., 2012].
1.9 Foxp3 dynamics in vivo
As already mentioned, in lymphodeficient condition and under inflammation,
Foxp3+ cells have been observed to lose Foxp3 expression [Duarte et al., 2009,
Komatsu et al., 2009]. When these cells were transferred into lymphodeficient
host, a fraction of them became pathogenic, producing inflammatory cytokines
and infiltrating tissues [Duarte et al., 2009]. However, 10% of them reacquired
Foxp3 expression within 4 weeks [Komatsu et al., 2009].
In the attempt to investigate whether Foxp3 loss could be observed in lym-
phoreplete conditions, two laboratories have generated two different transgenic
mouse models to perform fate mapping studies. Zhou et al. generated the
Foxp3GFP-Cre ⇥ ROSA26YFP transgenic mouse by crossing the mice express-
ing the GFP-Cre fusion protein under the control of the Foxp3 promoter on a
bacterial artificial chromosome (BAC), with the reporter mice which express the
YFP, under the control of the ROSA26 promoter, after the excision of the loxP-
flanked cassette [Zhou et al., 2009]. Some years later, Miyao et al. generated
the Foxp3GFP-Cre ⇥ ROSA26RFP transgenic mouse, in which differently from the
previous one, the GFP-Cre is expressed under the control of the endogenous
Foxp3 locus [Miyao et al., 2012]. In both mice, cells that express Foxp3 are per-
manently labelled with YFP or RFP, respectively. These mice allow for assessing
the frequency of cells that have expressed Foxp3 at one point and then have
down-regulated it: cells that up-regulate Foxp3 become first GFP+, then GFP+
YFP+ or GFP+ RFP+, while exFoxp3 cells are GFP- YFP+ (or GFP- RFP+). In
both cases 10 to 20 % of CD4 T cells were found to be exFoxp3.
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When exTregs recovered from lymphoreplete condition were transferred into
lymphodeficient host, a portion of them became pathogenic. Also, in case these
exTregs belonged to a diabetogenic TCR transgenic mouse, they managed to
transfer diabetes into lymphodeficient host [Zhou et al., 2009]. Yet, when ex-
Tregs were transferred into lymphodeficient host, 10% of them reacquired Foxp3
expression within 4 weeks [Komatsu et al., 2009].
Nevertheless, in case the genetic fate-mapping was performed in an inducible
way in adult mice, less than 5% of Tregs lost Foxp3 expression during 5 months
[Rubtsov et al., 2010]. In fact Rubtsov et al. generated the Foxp3GFP-Cre-ERT2 ⇥
ROSA26YFP transgenic mouse. In this mouse when the GFP-Cre-ERT2 is ex-
pressed, it stays in the cytosol. Only upon treatment with tamoxifen it enters the
nucleus, allowing for excision of the loxP-flanked cassette.
1.10 Outline of the thesis
The aim of this thesis is to investigate theoretically and quantitatively the mech-
anisms that ensure tolerance robustness. In physiologic condition tolerance is
maintained thanks to processes that involve two complementary levels: on the
one hand, at a cellular level, Foxp3 expression in Tregs is stably maintained along
time; on the other hand, at a multicellular level, Tregs population is maintained in
balance with the Teffs population they suppress. For this reason our approach
also followed two complementary levels.
The thesis investigates the possibility that Tregs can be maintained as a sta-
ble population, even in case Foxp3 expression depends on the input the cells
receive from the other immune cells populations, in a density-dependent way.
Also, the work questions whether the stability of Foxp3 expression, observed in
physiologic condition, can be due to the context, rather than to a programmed de-
velopmental process. Using experimental data available from literature, we stud-
ied whether data support the possibility that Tregs identity is context-dependent,
rather that committed.
Beside the present general introduction and a general discussion, the thesis
is organized in three chapters. Each one follows the structure of a paper.
In Chapter 2, a new model of Treg and Teff population dynamics, mediated by
APCs, is developed, as an extension of the cross regulation model. This model
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accounts for loss of Foxp3 expression in Tregs, in case they lack sufficient pro-
Foxp3 stimuli. According to the model, Tregs that lose Foxp3 expression convert
into Teffs. Stability and bifurcation analysis is performed. In this chapter is shown
that there are parameter regimes in which, for slow rate of Foxp3 loss, not only
Tregs population can be stably maintained, but also their robustness in response
to perturbation is increased, if compared to to the original cross regulation model.
Chapter 3, moving from the theoretical result of the chapter 2, focuses on
the cellular level. It investigates how the assumption of context dependent Foxp3
loss can be realized at a cellular level in CD4 T cells. In particular, it focuses
on the time scale at which the Foxp3 loss would occur. A stochastic model for
Foxp3 expression in CD4 T cells is developed, in which gene expression can be
reversible and context-dependent, as well as committed. Two potential popula-
tions of Tregs are considered: committed Tregs, that in no case can lose Foxp3
expression, and plastic Tregs, whose Foxp3 expression depends on the context.
By tuning the model parameters, the model accounts for the possibility that either
one of the two populations exists or that they coexist, in any proportion. A meta-
analysis is performed, by fitting the model to experimental data on in vivo Foxp3
expression, in different experimental contexts. The analysis founds that experi-
mental data are compatible with Tregs being a homogeneous pool of CD4 T cells,
in which Foxp3 expression is either stable or labile depending on the context, in
particular depending on Teffs number and proportion. The rate of loss of Foxp3
expression in peripheral Tregs in absence of pro-Foxp3 stimuli is quantified.
Chapter 4 studies whether the slow loss of Foxp3 expression in Tregs can be
the consequence of epigenetic dynamics. An extended version of the stochastic
model of Foxp3 expression, introduced in Chapter 3, is developed, that also ac-
counts for epigenetic dynamics. A meta-analysis is performed, to check whether
both stability and lability of Foxp3 expression can be explained as a combination
of fast and context-dependent transcription/translation dynamics together with a
slow and context-independent epigenetic dynamics. Data fitting suggests that
indeed this could be the case.
The final discussion tries to put together the results of the three chapters, in
a critical way, highlighting point of force of the thesis, as well as weakness and
pitfalls.
In all the models presented in this work we tried to avoid complexity as much
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as possible, trying to capture the essential features of the mechanisms that, case
by case, we were investigating.
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Tolerance is compatible with
context-dependent Foxp3
expression in Tregs. Theoretical
insight from T cells population
dynamics.
Statement: All the work included in this chapter is my own, carried out under the
supervision of Jorge Carneiro and Jocelyne Demengeot.
Abstract
Immunological tolerance toward body components and tissues is a robust prop-
erty of the adaptive immune system. It relies on the development and mainte-
nance of populations of functional Regulatory T cells (Tregs), able to prevent the
clonal expansion of auto-reactive CD4 T Effector cells (Teffs). If not controlled by
specific Tregs, auto-reactive Teffs that circulate in the periphery undergo activa-
tion and clonal expansion, causing autoimmunity.
In healthy individuals, persistence of Tregs is ensured by density-dependent
interactions that Tregs make with Antigen Presenting cells (APCs) and Teffs that
they control. Depending on the initial conditions of the T cell populations, the
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same interactions can also result in Tregs extinction, giving rise to autoimmunity.
This claim was proposed in the past by the cross regulation model for APCs-
mediated CD4 T cells interactions and validated using in vivo and in vitro exper-
imental data. According to this view, tolerance and autoimmunity represent two
alternative stable states for the immune system.
Tregs are characterised as a subset of CD4 T cells enriched in auto-reactivity
which selectively express the transcription factor Foxp3, whose stable expression
is necessary for their regulatory function. In the last years, an increasing number
of experiments have shown loss of Foxp3 expression in CD4 T cells, in conditions
such as lymphopenia and under inflammation. The lability of Foxp3 expression
in vivo poses the problem of how Tregs can be maintained as a functional popu-
lation and, more generally, how tolerance is robustly maintained.
Here we extended the cross regulation model accounting for context-
dependent Foxp3 loss and subsequent conversion of Treg into Teff. We show
that tolerance is maintained provided that Foxp3 loss is sufficiently slow. Fur-
thermore, introduction of Foxp3 lability determines a qualitative change in the
tolerance stable state. As a result, robustness of tolerance in response to pertur-
bation is increased. We also show that thymic output results in enhanced toler-
ance robustness, whereas thymic involution causes a decrease in the amplitude
of the perturbations the system can cope with, without breaking tolerance.
2.1 Introduction
The presence of auto-reactive lymphocytes in the periphery, that have es-
caped thymic negative selection, is well documented [Ramsdell et al., 1989,
Heath et al., 1992]. These cells, can undergo clonal expansion and
cause autoimmunity, if they are not controlled by specific/cognate regula-
tory T cells, as experimental evidences have shown [Sakaguchi et al., 1995,
Annacker et al., 2000, Annacker et al., 2001, Almeida et al., 2002].
Several experiments of adoptive transfers have been performed in the past
years, in which immunodeficient mice were reconstituted with CD4 Teffs and/or
CD4 Tregs, sorted from immunocompetent mice. The aim of these experiments
was to check for development of immunopathology in the host over time and to
quantify the number of equilibrium of T cells reached in the host animal. Im-
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munodeficient mice that were transferred with Teffs cells alone, developed sys-
temic immunopatology that led to death, caused by uncontrolled proliferation of
Teffs which infiltrate tissues [Sakaguchi et al., 1995, Annacker et al., 2001]. On
the contrary, when Tregs were transferred alone, they did not cause death nor
autoimmunity. Co-transfer of Tregs together with Teffs, depending on their re-
spective proportions, resulted in either of the two scenario. Particularly, in mice
in which tolerance was not broken upon co-transfer, the total proliferation of T
cells was controlled: the equilibrium reached in the host was characterized by
a smaller number of T cells, compared with the case of Teffs transferred alone.
Moreover, the number of Tregs at equilibrium increased with the one of activated
Teffs in the host [Almeida et al., 2002, Annacker et al., 2001].
Indeed Tregs damp down the activation and clonal expansion of auto-reactive
T cells. These experiments have also shown that Tregs maintenance and prolif-
eration depends on Teffs, in the sense that Tregs feed on the populations of Teffs
they suppress.
In healthy individuals mechanism are operating to ensure the stable and ro-
bust maintenance of specific Tregs population, able to control the activation and
proliferation of auto-reactive Teffs in the periphery, without affecting the capacity
of the immune system to fight against pathogens.
Carneiro and León [León et al., 2000, Carneiro et al., 2007], in previous the-
oretical research, have been able to recapitulate, through mathematical model-
ing, these fundamental properties of both immunity and tolerance. The cross
regulation model (CRM) interprets both immunity and tolerance, as the result of
non-linear and density-dependent population dynamics, occurring among Teffs,
Tregs and mediated by APCs of similar specificity. The model has been vali-
dated using both in vivo and in vitro experimental data and is able to explain
the immune response against tumors, together with tumor control or expansion
[Carneiro et al., 2007, Leon et al., 2007].
For what concerns the duality tolerance-autoimmunity, observed in the adop-
tive transfer experiments just mentioned, the CRM explains it in terms of bi-
stability occurring in the system in which populations of auto-reactive Teffs (the
ones that can cause autoimmunity) and Tregs of similar specificity interact, me-
diated by APCs presenting auto-antigens.
The cross regulation model supports parameter regimes in which the system
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is characterised by two stable equilibria. One referred as tolerance state, in which
Tregs and Teffs populations coexist, with Tregs controlling proliferation of cognate
Teffs, and the autoimmune state, in which Tregs are extinct and auto-reactive
Teffs proliferation is not controlled. Moreover, in the case of autommune state,
Teffs proliferation is determined by APCs availability.
It is well known that Tregs selectively express the TF Foxp3, which
is necessary for Tregs development and regulatory function [Hori, 2003,
Fontenot et al., 2003, Khattri et al., 2003]: individuals that lack Foxp3 expression
in CD4 T cells, develop severe and multi-organs immuno-pathology and die early
after birth. For long time the robust maintenance of Tregs in healthy individuals
was attributed to the robust expression of Foxp3 in Tregs. In fact, in physiologic
conditions, Foxp3 expression is stably maintained for months and across several
rounds of cell division [Rubtsov et al., 2010].
Nevertheless, in the last years it has been shown that, in dif-
ferent conditions in vivo, such as in lymphodeficient condition
[Komatsu et al., 2009, Duarte et al., 2009] and under inflammation
[Zhou et al., 2009, Yurchenko et al., 2012, Mellor and Munn, 2011], Foxp3+
cells can lose Foxp3 expression. Also, upon loss of Foxp3 expression, these
cells become pathogenic, infiltrating tissues and expressing inflammatory
cytokines [Duarte et al., 2009]. The lability of Foxp3 expression in vivo poses
therefore the problem of how it is possible to maintain Tregs as population.
More in general, Foxp3 labilty poses the question of how can natural tolerance
mediated by Foxp3+ regulatory T cells be robust, if Foxp3 gene expression has
been shown to be context-dependent and potentially labile.
This question has not been addressed so far and constitute a reason for the-
oretical study. The Cross regulation model, as it stands, does not address the
possibility of Foxp3 loss. Here, based on the Cross Regulation model, we ex-
tended the model accounting for context-dependent lability of Foxp3. Introducing
the possibility for Foxp3+ cells that lack the environmental stimuli for Foxp3 main-
tenance, to convert into Teff, we then used the model to address the following
issues. Does the system still display bi-stability? Or does the it collapse to the
autoimmune state? Can tolerance be maintained, can it be robust, even if Foxp3
expression is labile?
We show that our model maintains the essential features of the cross regu-
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lation model, and that as long as the rate at which Tregs lose Foxp3 expression,
in absence of pro-Foxp3 stimuli, is slow enough, the system displays bi-stability.
Finally we show that there is an interval of values for the Foxp3 loss rate that
correspond to enhanced robustness of Tregs, with respect to their ability to cope
with perturbation, without breaking tolerance.
2.2 The model
The model is an extension of the cross regulation model, which has been
extensively described and analyzed in [León et al., 2000, León et al., 2001,
León et al., 2003, León et al., 2004, Carneiro et al., 2005, Carneiro et al., 2007].
In this section we recapitulate the principles and assumptions of the original
model, adding also the novel assumption of Foxp3 expression loss in unstim-
ulated Tregs.
2.2.1 General biological principles and model assumptions
The model adopts two general biological principles of cell population dynamics,
valid in any multicellular organism. The first one states that any cell lineage
needs recurrent interactions with other cells in order to persist as a population. In
absence of interactions cells die for apoptosis. Furthermore, the turnover of the
cells in any lineage is mediated by interactions among cells. These interactions
are either direct, such as contact inhibition, or indirect, such as competition for
limited survival factors and growth factors, be they provided by molecules (such
as cytokines) or by engagement with other cells (such as TCR engagement with
MHC-peptide complex displayed by APCs).
The model describes the dynamics of peripheral CD4 Teffs and Tregs and
their interaction, mediated by APCs. It assumes that APCs display MHC-peptide
complexes that can be recognized by the T cell receptors on the lymphocytes
surface. Furthermore, Teffs, depending on their specificity, meaning on the set
of antigens they recognize, can either induce autoimmunity or mount immune
response against pathogens. Finally, Tregs suppress Teffs with similar specificity
preventing their proliferation and clonal expansions.
The model is based on the following assumptions:
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- Many TCRs recognize the same peptide and many peptides are recognized
by the same TCR [Sewell, 2012]. Therefore, APCs in the body can be
considered as heterogeneous populations, each one presenting a given set
of peptides. Each APC population is considered homogeneous in terms of
recognition and conjugation with T cell populations (hereafter referred as
cognate populations);
- Similarly, Tregs and Teffs are classified as different populations according
to their clonal specificity and, in particular, according to their ability to rec-
ognize and interact with the same APCs population. We will therefore refer
to triplet of Tregs, Teffs and APCs populations able to interact among them-
selves (hereafter referred as cognate populations);
- Each APCs population is in stationary state: we are considering physio-
logical condition (no immunological challenge) in which, despite of their
turnover, APCs are expected to be constant;
- Teffs and Tregs are assumed to be exported in the periphery as such, by
the thymus, with functional TCR;
- Resting T cells slowly die for apoptosis;
- T cells activation, which is responsible for their proliferation, needs inter-
action with APCs that present cognate antigen. T cells activation also de-
pends on the interactions that Teffs and Tregs make with each other;
- Interactions are indirect, such as competition for limited cognate APCs, and
direct, given the molecular processes that require proximity among T cells
and APCs. The model assumes the simplest form of this interaction that
ensures a certain degree of specificity: T cells and APCs interact by forming
multicellular conjugates;
- Teffs proliferation is promoted by productive interactions with cognate
APCs, while is inhibited in case the interaction occurs together with cog-
nate Tregs;
- Tregs proliferation is promoted by productive interactions with cognate
APCs together with Teffs;
- Absence of productive interactions for Tregs, promotes loss of Foxp3 ex-
pression in Tregs and subsequent conversion into Teffs.
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Figure 2.1: Main rules of the model. Reaction diagram indicating events and
reactions underlying APCs mediated Tregs and Teffs dynamics.
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2.2.2 Mathematical formulation of the model
The system is constituted by a set of ordinary differential equation, describing the
time evolution of the densities of Tregs (R) and Teffs (E), mediated by a single
cognate population of APCs, at fixed density A. Equations are the following, both































are the density of activated Tregs and




are the respective proliferation rates. Activated Tregs are the ones in conjugate
together with at least a Teff, while activated Teffs are the one in conjugate without




represent the respective death rates. Finally
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u
indicates the density of un-activated Tregs (being either free or in conjugate
without any Teff) and c
R








are functions of R and E and are computed in
two steps. The first one consists in the calculation of the density of Tregs and
Teffs in conjugates. The second step consists in computing their distribution in
multicellular conjugates, together with cognate APCs. We start from the assump-
tion that the time scale at which any T cell conjugates and de-conjugates from
an available site on APC (conjugation and non-productive de-conjugation in Fig-
ure 2.1, which happen at rates c and d ) is much faster than the time scale at
which populations densities change (productive de-conjugation, in the same fig-
ure). Under this assumption we can, therefore, consider the density C of T cells
in conjugates to be at equilibrium (quasi-steady-state approximation). This equi-
librium density depends on the total densities of T cells, on the total density of
APCs sites and on the constant of equilibrium, in the following way:
C =
1 +K(S + T ) 
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where T = R + E is the total density of T cells and S is the total density of
APC conjugation sites given by S = nA, with n being the number of sites per
APC and A the total density of APCs. Finally K is the constant of equilibrium for
conjugates, given by the ratio between the conjugation rate and the sum of the
two de-conjugation rates (productive and not productive ones).













We can define the probabilities that a site is occupied by either a Treg (%) or a






























2.3.1 Regulation can take place even in presence of context-
dependent Foxp3 lability.
We analyzed the steady states of the system and their dependency on key model
parameters. Particularly, we focused on the total density S of APCs sites and on
the rate c
R
at which un-stimulated Tregs lose Foxp3 expression.
We found that the model recapitulates a crucial feature of the original cross
regulation model. In particular, for sufficiently large values of the density S of
APCs sites (S > S⇤), the system displays bi-stability. In other words the system is
characterized by two stable equilibria: the autoimmune equilibrium, in which Teff
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Figure 2.2: Bi-stability of the system is preserved for adequately large den-





) for unstimulated Tregs. A: Bifurcation diagram showing the
density of Teff cells of equilibrium (E) as a function of the density of available
APCs sites (S) and of the rate of Foxp3 loss by unstimulated Tregs (c
R
). The
red surface corresponds to the stable autoimmune equilibrium of the system,
characterized by the absence of Tregs, the green surface corresponds the the
stable healthy equilibrium, characterized by the coexistence of Tregs and Teff,
the former regulating the latter. Finally grey surface corresponds to the unstable
equilibrium. Curves on the surface are draw for c
r
= 0.002 and S = 2. Values of








= 0.02, c = 1, d = 1.B and C:
2D sections of the bifurcation diagram. B: density of Teff cells of equilibrium (E)
as a function of the density of available APCs sites (S), for c
R
= 0.002. Vertical
dashed line, in correspondence to S = 0.6, indicates the saddle-node bifurcation.
C: density of Teff cells of equilibrium (E) as a function of the rate of Foxp3 loss
by unstimulated Tregs (c
R
), for S = 2. Vertical lines indicates, respectively, the










two cognate populations coexist, Teffs being under the control of Tregs (Figure
2.2 A and B).
Bi-stability implies that any of the two equilibria can be reached by the system
depending on whether the initial condition lies in each of the respective equilib-
rium basin of attraction (see green and red regions in Figure 2.3). The basin
of attraction of the tolerance equilibrium highlights all the perturbations in both
population densities that the system can cope with, without breaking tolerance.
We found that bi-stability is lost for limited APC availability. In other words,
in case of rare antigen presentation, the unique stable equilibrium is the autoim-
mune one, which is characterized by the presence of Teffs alone.
In summary, if Tregs are committed to Foxp3 expression (c
R
= 0) bi-stability
is ensured as long as the total density S of APCs sites is big enough, as shown
by the original cross regulation model. Nevertheless, in case Tregs lose Foxp3
expression in a context-dependent way, there is an entire range of values for the





, for which bi-stability is still preserved (Figure 2.2




), the system no
longer displays bi-stability and it admits only the autoimmune equilibrium (see
Figure 2.2 C, and Figure 2.3 bottom).
2.3.2 Foxp3 lability can result in increased Tregs population robust-
ness
We found that within the range of values of c
R
that allow for bi-stability, the stable
equilibrium of tolerance changes its characteristics. In absence of Foxp3 loss
(c
R
= 0) and for small values of the parameter c
R
, the tolerance equilibrium is
a stable focus, while for higher values of c
R
the equilibrium becomes a stable
node. The difference between a stable focus and a stable node mainly concerns
the response of the system to the same perturbation of the equilibrium. In other
words, if we consider a perturbation of the equilibrium that leaves the system
within the basin of attraction of the equilibrium, the return to the equilibrium either
follows oscillations (in case of stable focus) or happens much smoothly (in case of
stable node). This result can be appreciated in Figure 2.4. Looking at the phase
plane of the system, the trajectories within the basin of attraction of the tolerance
equilibrium (dashed curves within the green area) present over-shootings and
dangerous decreases in Teffs population for c
R
















































Phase plane of the system for different values of the Foxp3 loss rate c
R
. Se-
lected values for c
R
, are the same highlighted in figure 2.2 B, with arrows and
small letters. Red lines represent the null-clines of the density E of Teffs, green
lines represent the null-clines of the density R of Tregs. Equilibria of the sys-
tem, found in correspondence of the intersections of null-clines, are depicted by
dots. In each graph, red dot represents the stable autoimmune equilibrium, red
area the corresponding basin of attraction; green dot represents the stable tol-
erance equilibrium, green area the corresponding basin of attraction. Grey dot









= 0.02, S = 2, c = 1, d = 1.
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2.3.3 Thymic output favours tolerance
We next explored the consequences of constant thymic influx in the system, in
presence of context-dependent Foxp3 expression. To do that we added a con-






































=   and s
E
=   k. The parameter k allows for differential thymic influx,
between Tregs and Teffs population. In particular, values of k bigger than 1,
imply a higher input in the periphery from the thymus of Teff cells, in compared
with Tregs.
We then studied the phase plane of the system, for different values of the
source parameter   and in correspondence to the previously studied value of the
Foxp3 rate loss (c
R
= 0.002), which ensures bi-stability to the system and robust-
ness of tolerance. We found that the introduction of the thymic source, even if the
contribution of Teffs exceeds the one of Tregs (k = 1.2), change the autoimmune
equilibrium. In the presence of thymic output, in fact, the autoimmune equilibrium
is characterized by the presence of Tregs, which nevertheless, remain outnum-
bered by cognate Teffs and are not able to control their proliferation. The change
in the autoimmune state is caused by the change in shape of the null-cline of
Tregs, whose intersection with the Teffs null-cline determines the steady state of
the system (as shown in figure 2.5).
As the thymic output increases, the basin of attraction of the tolerance state,
increases as well. Also, for the critical value  ⇤ = 0.07 of the thymic source,
a saddle-node bifurcation occurs in which the autoimmune steady state disap-
pears. In this case, and for higher values of thymic output, the only stable equi-
librium for the system, remains the tolerance one, in which proliferation of auto-
reactive Teffs is controlled by cognate Tregs.
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Figure 2.4: Robustness of tolerance is enhanced for slow rate c
R
of Foxp3
loss. Up: Phase plane, basins of attraction and trajectories of the system, in case
of committed Tregs (c
R
= 0, on the left) and for slow Foxp3 loss rate (c
R
= 0.002,
on the right). As in Figure 2.3 red line represents the E null-cline, red dot the
autoimmune equilibrium, red area its basin of attraction; green line represents the
R null-cline, green dot the tolerance equilibrium where Teffs are under the control
of Tregs, green area its basin of attraction. In dashed grey are represented some
trajectories: oscillations can be observed in the tolerance basin of attraction in
case c
R
= 0, where the equilibrium is a focus, for slow rate of loss the trajectories
within do not oscillate and goes much smoothly toward the equilibrium, which is
a node. Bottom: time course of the system in response to the same perturbation
from the tolerance equilibrium, in case of committed Tregs (c
R
= 0, on the left)
and for slow Foxp3 loss rate (c
R
= 0.002, on the right).
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Figure 2.5: Thymic output inhances tolerance. Phase plane of the system,
in case of slow Foxp3 rate loss, for increasing values of the constant thymic
source  . Red lines represent the null-clines of the density E of Teffs, green
lines represent the null-clines of the density R of Tregs. Equilibria of the system,
found in correspondence of the intersections of null-clines, are depicted by dots.
In each graph, red dot represents the stable autoimmune equilibrium, red area
the corresponding basin of attraction; green dot represents the stable tolerance
equilibrium, green area the corresponding basin of attraction. Grey dot depicts
the un-stable saddle-node equilibrium. Note that in presence of thymic output,
in the autoimmune stable equilibrium Tregs are not completely extinct .Values of








= 0.02, S = 2, c =
1, d = 1, c
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Figure 2.6: Thymic output enhances tolerance. Bifurcation diagram of the sys-
tem showing the density of Teff cells of equilibrium (E) for increasing values of the
constant thymic source  . Red line corresponds to the stable autoimmune equi-
librium of the system, in which Tregs are outnumbered; green line corresponds
to stable tolerance equilibrium, in which Tregs control Teffs proliferation; grey
dashed line corresponds to the unstable saddle-node equilibrium. For   = 0.07
a saddle-node bifurcation occurs, in which the autoimmune and the unstable
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In this chapter we investigated the theoretical effect of context-dependent
Foxp3 expression in Tregs on Tregs population maintenance. To do this, we
extended the previous developed cross regulation model [León et al., 2001,
Carneiro et al., 2007], introducing the possibility of Foxp3 expression loss. In
particular, because Foxp3 expression maintenance in Tregs needs continuous
TCR and IL-2 stimulation [Levine et al., 2014], we introduced the rule that Tregs
that lack either TCR stimulation or IL-2, would lose Foxp3 expression according
to the rate c
R
.
2.4.1 Enhanced tolerance robustness
We found the existence of parameter regimes in which, as long as the Foxp3
loss rate is slow enough, some fundamental characteristics of the original cross
regulation model (reviewed in chapter 1) are maintained.
In this parameter regimes, the bi-stability of the system is maintained: the
system supports two stable states, the tolerance steady-state in which Tregs and
Teffs populations coexist with the farmer controlling the latter, and the autoim-
mune steady state, in which Tregs population are outnumbered and only Teff
persist. This result implies that, even in presence of context-dependent Foxp3
loss, tolerance can be maintained.
Also, the existence of bi-stability depends on APCs population density. In
particular bi-stability of the system is ensured as long as antigen presentation is
not rare. On the contrary, for rare antigen presentation, meaning for low density
of APCs, only the cognate Teffs population is sustained. In other words, our
analysis suggests that even in presence of context-dependent Foxp3 loss, the
system supports the self versus non-self discrimination.
Moreover, we found that, for an entire interval of the rate c
R
of Foxp3 loss, the
equilibrium of coexistence becomes a stable node, while for no loss (as in the
original CRM) or extremely slow loss rate, the same equilibrium is a stable focus.
This means that, differently from the original model, in which after a perturbations
homeostasis is restored through oscillation, when Foxp3 loss rate belongs to the
said interval, homeostatic restoration happens much more smoothly.
Avoiding oscillation after a perturbation from the healthy steady state of co-
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existence could be fundamental for tolerance robustness. In fact, both over-
shootings and decreases in either population densities can cause the system to
collapse toward the autoimmune steady state, especially in presence of stochas-
ticity. Indeed during the oscillations, a stochasticity can cause the trajectory to
jump the the autoimmune basin of attraction. Alternatively, stochasticity together
with oscillations in trajectories, can cause the extinction of any of the two popu-
lations.
In case stochasticity causes any of the two populations to get extinct, the
expected outcome is the consequent collapse of the system toward the autoim-
munity steady state. If Tregs collapse first, the system reaches the autoim-
mune equilibrium, characterised by the presence of auto-reactive Teffs alone,
sustained by the cognate APCs. Nevertheless, in case Teffs collapse first,
the remaining Tregs are destined to die out, without the necessary growth fac-
tor produced by the cognate Teffs. The result is the entire collapse of a the
given niche of auto-reactive Teffs and Tregs. The consequence of said extinc-
tion is, most likely, autoimmunity. In fact, as we discussed in chapter 1, the
immune system has evolved in a way that auto-reactive Teffs clones, which
have escaped negative selection in the thymus, are ”coupled” with Tregs of
similar specificity. In the periphery, the population dynamics then determines
the two populations to reach the coexistence equilibrium, thank to the APCs
presenting their cognate antigen. We also mentioned that Tregs are mainly
produced in the thymus early in development, during a time window charac-
terised by a special wave of Tregs production, which then declines over time
[Nishizuka and Sakakura, 1969, Sakaguchi et al., 1982, Modigliani et al., 1996].
Nevertheless, lymphopoiesis continues throughout the entire life of individuals.
For this reason, in case a niche of auto-reactive Tregs and Teffs gets extinct after
the perinatal period, it is still likely that other clones of similar specificity, meaning
auto-reactive, will be produced by the thymus. This clones, in the periphery, will
find APCs able to activate them. Nevertheless, in adulthood, given the decreased
lymphocytes thymic productions, the auto-reactive Teffs most likely will not find,
in the periphery, counterpart Tregs able to control them. Which will lead to their
clonal expansion and subsequent autoimmunity.
On the one hand, in absence of continuous thymic output, the amount of cog-
nate auto-reactive Tregs and Teffs that are in the periphery, determines which
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of the two states is achieved, either the tolerant or the autoimmune. On the
other hand, the presence of thymic output, increases the extension of the basin
of attraction of the tolerance state, at the cost of the basin of attraction of the
autoimmune state, which instead decreases. With increased thymic influx, the
autoimmune state converts into an equilibrium in which, despite not being pre-
dominant, Tregs coexist with Teffs. Finally for even higher thymic influx, and even
if the thymus exports more Teffs than Tregs, the autoimmune steady-state com-
pletely disappears. In other words, while in case of huge thymic influx, as the
one expected in perinatal period, auto-reactive lymphocytes populations that exit
the thymus are likely to evolve toward the tolerant state, when the thymic output
declines, it is more likely, although not guaranteed, that they will evolve toward
auto-immunity.
2.4.2 Slow dynamics to be investigated
In case of lability of Foxp3 expression, we found that bi-stability is maintained
as long as the context-dependent loss of expression is a slow process. The
requirement for a critical slow Foxp3 loss rate, c
R
, to ensure tolerance, is a non
trivial theoretical result. In fact, we do not know the characteristic time of of
Foxp3 loss in vivo. Estimating such characteristic time and exploring the possible
mechanisms through which the aforesaid slowness can be achieved need further
study and they will be argument of the next two chapters.
2.5 Methods
The null-clines and the equilibria of the system of odes (figures 2.3, reflPhase-
PlanesTimeCourse) were numerically computed and plotted using Mathemat-
ica [Wolfram Research, Inc., ]. In case of the system including the thymic
output (Figure 2.5), null-clines and equilibria were computed using XPPAUT
[Ermentrout, 2007], exported into a text file, then imported and plotted using
Mathematica. Trajectories, were computed and plotted using the ode solver of
Mathematica. 3D and 2D bifurcation diagrams of the system (figure 2.2), were
numerically computed and plotted using R. 2D bifurcation diagrams were also
computed and analyzed using XPPAUT, the exported into text files, to be finally
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imported and plotted in R. Bifurcation diagram in figure 2.6 was numerically com-
puted and plotted using R.
2.6 Supplemental Materials
The functions that describe the densities of activated Teffs and Tregs (see equa-
tions 2.6 and 2.7) have been originally described in [León et al., 2001]. They
are ad hoc functions that are able to capture the non-linear interactions between
Tregs and Teffs in multicellular conjugates. These equations allow the model
with two conjugation sites per APC to display bi-stability and reproduce the same
qualitative behavior in the bifurcation diagrams observed in models twith higher
number of conjugation sites per APCs.
As an example, in figure 2.7 is shown the bifurcation diagram, describing the
density of Teffs (E) as a function of the density of the available APCs sites (S).
Figure 2.7 refers to the model with three conjugation sites per APCs. In this
case, under the assumption that the total density S of available sites is much
higher than the number of sites that form a multicellular conjugate (S   3), the
multinomial distribution can be used to approximate the density of activated Teffs











Comparison between figures 2.7 and 2.2B shows the same qualitative be-
havior. The saddle-node bifurcation and the consequent establishment of the
tolerance equilibrium, occurs for smaller density of available APCs sites, if com-












Figure 2.7: Bifurcation diagram of the model with three conjugation sites
per APC. Bifurcation diagrams of the system showing the density of Teff cells
of equilibrium (E) as a function of the density of available APCs sites (S) for
the model with three conjugation sites. Red line corresponds to the stable au-
toimmune equilibrium of the system, in which Tregs are outnumbered; green line
corresponds to stable tolerance equilibrium, in which Tregs control Teffs prolifer-
ation; grey dashed line corresponds to the unstable saddle-node equilibrium. A
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expression dynamics in murine
CD4 T cells
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Abstract
Regulatory T cells are essential for immune tolerance to body tissues. They se-
lectively express Foxp3, a transcription factor necessary for their development
and function. Experiments performed to address Foxp3 dynamics in mice, track-
ing its expression in cell cohorts in different experimental conditions, show that
Foxp3 expression can be either stably maintained over several months (in lym-
phoreplete condition) or can be lost within few weeks (in different lymphodeficient
conditions). So far, it has not been possible to reconcile all these observations.
Here we seek a unifying explanation for Foxp3 expression across the experi-
ments. We developed a stochastic model for Foxp3 expression in CD4 T cells. In
this model, Foxp3 expression can be fully reversible or irreversible, depending on
parameter settings. We fitted the model to the available data sets in the literature,
describing the temporal evolution of Foxp3+ cell frequency in cohorts of cells that
were either Foxp3+ or Foxp3- at a given time. In this way, we identified the most
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consistent and parsimonious model parameter sets.
We found that the experimental data could not be coherently reproduced with-
out postulating the existence of a large subpopulation of CD4 T cells(not less
than 80%)that in no case can up-regulate Foxp3. From meta-analysis we also
conclude that there is neither need to call for commitment to Foxp3 expression
to explain Foxp3 stability, nor for heterogeneity within Foxp3 expressing cells to
explain Foxp3 lability. Finally, Foxp3 stability positively correlates with absolute
number and frequency of Foxp3- cells in the host. We conclude that the experi-
mental data are compatible with Tregs being a homogeneous pool of CD4 T cells,
in which Foxp3 expression is stable or labile depending on the context.
3.1 Introduction
Regulatory T cells (Tregs) are essential for immune tolerance to body tissue by
damping down the activation and clonal expansion of auto-reactive CD4 effec-
tor T cells. Tregs constitute a subpopulation of CD4 T cells, enriched in self-
reactivity [Kim et al., 2007], and they selectively express the transcription factor
Foxp3. Foxp3 expression is necessary for Tregs development and for their reg-
ulatory function [Fontenot et al., 2003, Hori, 2003]. Any mutation that leads to
Foxp3 loss of function is enough for individuals, both mice and humans, to suffer
multi-organ auto-immunity and die early after birth.
In the last years several experiments have been performed in different labo-
ratories to address Foxp3 dynamics and stability in vivo in mice. These experi-
ments follow in vivo cohorts of either CD4+Foxp3+ or CD4+Foxp3- T cells, under
different experimental conditions, to asses the frequency of cells that, respec-
tively, maintain or acquire Foxp3 expression over time. According to these obser-
vations, Foxp3 expression can be either stably maintained over several months,
in lymphoreplete condition, or can be lost within few weeks, in lymphodeficient
condition.
Experiments that follow cohort of Foxp3+cells in lymphoreplete condition are
performed by using the inducible Cre-Lox system in mice that have a fully de-
veloped immune system. In these mice, upon tamoxifen administration, Foxp3+
cells are labeled genetically and permanently, as well as their daughter cells.
In this case, none of the labeled cells lose Foxp3 expression after four months
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[Rubtsov et al., 2010]. Also, when CD4+Foxp3+ Tregs are purified from a lym-
phoreplete mouse and adoptively transferred into a wild type mouse, 8% of them
lose the expression within 4 weeks and this frequency is maintained for the fol-
lowing two months [Komatsu et al., 2009].
Experiments that follow cohort of Foxp3+ cells in lymphodeficient condi-
tion are performed upon adoptive cells transfer: Foxp3+ cells are purified from
a lymphoreplete mouse and transferred into a lymphodeficient Rag2-/- host
[Duarte et al., 2009, Komatsu et al., 2009]. In this case, half of the followed cells
lose Foxp3 expression within four weeks, and become pathogenic upon a second
transfer into a lymphodeficient host. Also, in the attempt to understand the cause
of lability of Foxp3 expression in lymphodeficient conditions, adoptive transfer
experiments into lymphodeficient hosts (either Rag2-/- or TCR -/- ) have been
complemented by either sustained administration of IL-2 i.v. [Duarte et al., 2009]
or by co-transferring, together with CD4+Foxp3+ Tregs cells, also CD4+Foxp3- T
cells, in different proportions [Duarte et al., 2009, Komatsu et al., 2009]. In both
cases the frequency of cells maintaining Foxp3 expression over time increases in
a dose dependent way. Remarkably, depending on the dose of transferred Foxp3-
T cells, even the frequency of Foxp3+ cells that maintain Foxp3 expression char-
acteristic of the lymphoreplete condition could be rescued [Komatsu et al., 2009].
Finally, experiments that follow cohorts of Foxp3- cells are performed upon
adoptive transfer in lymphodeficient host, either Rag2-/-, TCR -/- or CD3✏-/- .
Total peripheral cells are purified from a lymphoreplete mouse in physiologic
condition and transferred, either alone or together with Foxp3+cells, into lym-
phodeficient host mice. In these cases, almost none of the followed cells ac-
quire Foxp3 expression in the periphery within four weeks. No significant ac-
quisition of Foxp3 expression in the periphery is observed, no matter whether
Foxp3- cells are transferred alone or whether they are co-transferred, together
with Foxp3+cells, even in the proportion that keeps Foxp3 maintenance as good
as in the lymphoreplete condition [Duarte et al., 2009, Komatsu et al., 2009,
Paiva et al., 2013]. However, higher frequency of acquisition of Foxp3 expression
in the periphery (10%) is observed in case the cohort of Foxp3- cells is consti-
tuted by the so called exTregs [Komatsu et al., 2009]. ExTregs are CD4+Foxp3-
cells that once have been sorted from physiologic condition as Foxp3+ and then
have lost Foxp3 expression within four weeks upon a first adoptive transfer into
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lymphodeficient condition. Also, when peripheral Foxp3- cells are enriched in re-
cent thymic emigrants, then within four weeks around 6% of cells acquire Foxp3
expression in the periphery [Paiva et al., 2013].
Taken together these experiments place the issue of context-dependency
for what concerns the stability of Foxp3 expression, at least for a subset
of Foxp3+ CD4 T cells. Yet, a coherent interpretation that reconciles all
the observations is still lacking. Over the past years there have been sev-
eral claims, often inconsistent within each other. Tregs have been claimed
to constitute a distinguished lineage, in which Foxp3 expression is stable
across many rounds of cell divisions in vitro and in vivo, in several condi-
tions [Sakaguchi, 2004, Rubtsov et al., 2010]. Foxp3 expression has been oth-
erwise claimed to be context-dependent [Duarte et al., 2009, Zhou et al., 2009,
Bailey-Bucktrout and Bluestone, 2011]; also, Foxp3+ cells have been claimed to
be heterogeneous for what concerns their ability to stably express the gene:
it has been proposed that within CD4 T cells sorted as Foxp3+, the majority
are committed to the Treg lineage, while a minor population just transiently ex-
press the Foxp3 gene [Komatsu et al., 2009]. Finally, within the ”heterogeneity
model”, it has been proposed that the committed state of Tregs is achieved by
DNA demethylation of the Foxp3 locus, irrespective of ongoing Foxp3 expression
[Miyao et al., 2012]. Basic questions remain still open. What controls lability of
Foxp3 expression in the environment of a mouse? Are Foxp3+ cells heteroge-
neous regarding their capacity to stably maintain Foxp3 expression and are they
all susceptible to Foxp3 expression loss? Finally, are all CD4 T cells inducible to
become Tregs in vivo, upon appropriate stimuli?
Here we address these questions through a quantitative approach. We devel-
oped a model for Foxp3 expression in CD4 T cells that accounts for both Foxp3
commitment and stochastic and context-dependent reversible Foxp3 expression.
Indeed, depending on model parameters, the gene expression can be fully re-
versible or irreversible. We used this model to perform a meta analysis on avail-
able experimental data on Foxp3 dynamics, aiming at identifying the conditions
for persistence of cellular Foxp3 expression.
By fitting the model to experimental data, we found that the model can co-
herently reproduce them all, as far as the ratio between Foxp3 transcriptional
activation and repression rates is tuned across the experiments.
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Meta analysis suggests that a large subpopulation of CD4 T cells, ranging
from 85 to 90% of CD4 T cells, in no case can be induced to up-regulate Foxp3
expression in vivo, not even transiently. From the meta-analysis we also conclude
that there is no need to call neither for commitment to Foxp3 expression nor for
heterogeneity within Foxp3 expressing cells to explain the stability and lability of
Foxp3. In fact, the data can be explained under the assumption that up to 28%
within Foxp3+ CD4 T cells in lymphoreplete conditions are committed to Foxp3
expression. Nevertheless, our analysis suggests that the most likely scenario
is that less than 7% within Tregs are indeed committed to Foxp3 expression.
Remarkably the ensemble of data is compatible with Tregs being a homogeneous
pool of CD4 T cells, in which Foxp3 expression is stable or labile depending on
the context.
Particularly, stability of Foxp3 expression correlates with high number and
high frequency of CD4+Foxp3- T cells in the host.
3.2 Results
3.2.1 A stochastic model able to describe Foxp3 dynamics in CD4
T cell cohorts.
We developed a stochastic model for Foxp3 expression in a CD4 T cell in which
Foxp3 expression can be reversible or irreversible, depending on model param-
eters. According to the model, any CD4 T cell can be found in one out of four
mutually exclusive states, indicated as Z0, Z1, Z2 and Z3 and depicted in Fig-
ure 3.1. A cell that is either in state Z0 or in state Z1 is negative for Foxp3
expression: Foxp3 is not transcribed/translated and/or the protein has been al-
ready degraded. A cell is in either state Z2 or Z3 if the Foxp3 gene is transcribed,
translated and the protein is expressed.
In order to account for possible commitment to Foxp3 expression, the model
assumes that the entire pool of CD4 T cells can be divided into up to three dis-
tinguished compartments.
A first compartment is constituted by the cells in state Z3 and represents
the fraction ↵ of the total pool of CD4 T cells. These cells are Foxp3+ and are
committed to Foxp3 expression.
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Figure 3.1: Stochastic model of Foxp3 expression in a CD4 T cells, able to
describe Foxp3 dynamics in CD4 T cell cohorts. Cartoon of the stochastic
model. According to the model any CD4 T cell can be found in any of the four
mutually exclusive states, here represented by a circle. A cell in state Z0 or Z1 is
negative for Foxp3 protein; a cell in state Z2 or Z3 is expressing Foxp3. Moreover,
state Z0 is characteristic of a CD4 T cell that in no case can express Foxp3, state
Z3 is characteristic of a cells that is committed to Foxp3 expression, therefore in
no case can lose it. Stochastic transitions between states can happen to any cell
that is in either state Z1 or Z2, according to constant rates. Respectively  + is
the rate of Foxp3 up-regulation (transition from state Z1 to state Z2), while vice-
versa    is the rate of Foxp3 gene repression and protein degradation. Rates
are assumed to depend on the context in which the cell is embedded. The model
assumes that, within the entire pool of CD4 T cells, a fraction ↵ is found in state
Z3(Foxp3 committed cells), a fraction   is found in one state out of Z1 or Z2, the
remaining 1   ↵     being in state Z0(cells that cannot express Foxp3). Rates
 + and    as well as fractions ↵ and   are model parameters, whose possible
values need to be determined, based on experimental evidences.
A second compartment represents the fraction   of CD4 T cells and it is con-
stituted by the cells which are either in state Z1 or Z2. Therefore the cells in such
compartment can be either expressing the gene (if in state Z2) or not (if in state
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Z1). Also, depending on the inputs received from the environment and translated
in terms of model parameters, the cells in the second compartment are assumed
to be able to acquire and/or lose Foxp3 expression over time, in the periphery.
A transition from a Z1 to Z2 represents Foxp3 gene transcription and translation,
until the cell becomes positive for the Foxp3 protein. Conversely, the transition
from Z2 to Z1 takes into account the inhibition of transcription and translation as
well as the degradation of both the RNA and the protein, until the cell is negative
for the Foxp3 protein. The cells in such second compartment are modeled by
a continuous time Markov chain model. Transitions happen stochastically with
average context-dependent constant rates,  + for Foxp3 up-regulation and   
for Foxp3 down-regulation. Each constant rate is the expected value of a specific
exponential distribution and its value can be tuned as will.
The remaining 1  (↵+ ) portion of CD4 T cells is constituted by CD4 T cells
that are in state Z0. These cells are Foxp3- T cells that do not express Foxp3,
regardless of the context.
Based on these assumptions, the model is able to describe the frequency
over time of Foxp3+ cells within a cohort of sorted Foxp3+ cells from lymphore-
plete condition. Such frequency, which in other words represents the frequency
of cells that maintain Foxp3 expression over time, is indicated by m(t) and can











# =  + +    (3.2)
represents the decay rate of Foxp3 expression within the Foxp3+ cells that belong





Finally, the variable eq in equation 3.1 is the frequency of Foxp3+ cells at equi-
librium in lymphoreplete condition, restricted to the second compartment of CD4
T cells, the one that are assumed to be able to up- and down-regulate Foxp3
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expression, depending on the context. Reasonings for the definition of # and %
are explained in more details in material and methods section 3.4.1, where the
solutions are fully derived.
Let us stress the fact that, due to the relations among  +,  , %, #, which
imply:
 + = % #,    = (1  %)#, (3.4)
the solution 3.1, it is not just a simple exponential decay. To understand this
statement, it can be helpful to look at three extreme cases. In case either  + ⌧
   or  + '   , the expression for m(t) is a single exponential decay, with rate of
decay equal to ✓. Nevertheless, in case  +     , the decay disappears and the
solution becomes a plateau. In particular:
% ' 1  +      m(t) ' 1 (3.5)















The model describes also the frequency over time of Foxp3+ cells within a co-
hort of sorted Foxp3- cells from lymphoreplete condition. Because it represents
the frequency of Foxp3- cells that acquire Foxp3 expression in the periphery, we






1  (↵+ eq ) . (3.8)
Finally, the model can represent the frequency aex(t) of cells that acquire
Foxp3 expression in the periphery within a cohort of Foxp3- cells entirely consti-
tuted by cells that belong to the second compartment. In other words, if we as-
sume that there is a subset of CD4+Foxp3- T cells that in no case can up-regulate
Foxp3 expression, when computing the frequency aex(t), we are restricting our
attention to the subset of Foxp3- that are able, in principle and depending on the
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inputs received by the environments, to up-regulate Foxp3 in the periphery. This
frequency can be expressed as following:
aex(t) = %  e #t%. (3.9)
More detailed description of the solutions can be found in material and method
section 3.4.1.
For each of these frequencies m(t), a(t), aex(t) of Foxp3+ within specific co-






1  (↵+ eq ) aex1 = %. (3.10)
In summary, using a stochastic model for Foxp3 expression in CD4 T cell, we
were able to describe the frequency of Foxp3+ CD4 T cells over time, within
specific cohort of CD4 T cells. The possible cohorts were constituted by either
the total Foxp3+ CD4 T cells, or the total Foxp3- CD4 T cells or the subset of
Foxp3- CD4 T cells able to up-regulate the gene, if opportunely stimulated.
3.2.2 Experiments assessing Foxp3 expression dynamics in the pe-
riphery can be reconciled under a single stochastic frame-
work.
We used the stochastic model for Foxp3 expression, described in the previous
section, to quantitatively reproduce the experimental data collected from litera-
ture, that address Foxp3 dynamics in mice.
The experiments used in our analysis are extensively described in material
and methods section 3.4.2. These experiments track the frequency of Foxp3+
cells within cell cohorts of either Foxp3+ or Foxp3- CD4 T cells, in ten differ-
ent experimental conditions. In this way the frequency of cells that maintain or
acquire Foxp3 expression over time, is assessed. The different experimental
settings comprise, first, the case in which Foxp3 expression is followed in co-
horts of Foxp3+ cells in lymphoreplete mice. Also, Foxp3 expression is assessed
in cohorts of CD4 T cells sorted from lymphoreplete mice and then adoptively
transferred, either alone or together with complementary populations, into lym-
phodeficient mice that otherwise would lack these populations of lymphocytes.
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Experimental results are presented in Figure 3.2, in dots. The frequency of cells
that either maintain (in blue) or acquire (in yellow) Foxp3 expression over time

































































































10 (0:1) neverTregs into CD3ϵ-/-
ρ10 =0.999
Figure 3.2: Model predictions reproducing the experimental data on Foxp3
in vivo dynamics. Frequency of Foxp3+ cells within cohort of cells followed in
vivo over time, in different experimental conditions. Dots represent experimental
data (experiments are described in details in materials and methods section),
lines are the model predictions from one representative parameter set out of the
equally good sets found. Solid lines are the temporal solutions of the stochas-
tic model, dashed lines represent the predicted value of equilibrium. In blue,
the experimental data in which maintenance of Foxp3 expression over time, is
assessed, in yellow, the experimental data in which acquisition of Foxp3 expres-
sion assessed over time. In each experiment is reported the value of the rate i⇢
obtained through the fitting. Other parameter values are ↵ = 0,  = 0.15.
We should stress the fact that most of the experimental data included in the
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analysis are constituted by only two time points, with few exceptions. However,
the experiment in [Duarte et al., 2009], here labeled as 7, in which Foxp3+ cells
are sorted from the Foxp3-GFP reporter lymphoreplete mouse and transferred
into lymphodeficient Rag2-/- host mouse, provides us with kinetics of the fre-
quency of cells that lose Foxp3 expression over time. This experiment is the
most informative for inferring the rate of decay of Foxp3 expression.
In order to understand the reasoning behind the meta-analysis we performed,
it can be useful to recall that Foxp3 expression in CD4 T cells is known to
depend on continuous T cell receptor stimulation [Levine et al., 2014] by cog-
nate antigen presenting cells, as well as continuous IL-2 stimulation, mainly
produced by activated T effector cells [Malek, 2003, Malek, 2008]. Also, TGF-
  stimulation, produced by several lineages of leukocytes, including Tregs, has
been shown to play a role in up-regulation of Foxp3 expression, at least in vitro
[Chen et al., 2003, Davidson et al., 2007, Yao et al., 2007]. Therefore, because
of the different compositions of the host immune cells populations across the
experiments analyzed, it is reasonable to assume that the average source and
availability of IL-2 and TGF-  might vary across experiments and be peculiar of
any given experimental condition. On the other hand, the composition of anti-
gen presenting cells population can be considered the same across the different
hosts. When we mention the average source and availability of IL-2 and TGF- 
we are referring to the one computed both across the space of interaction among
the cells and over the time window of each experimental observation. Therefore,
in our analysis we categorize the different hosts as different environments. Each
environment is characterized by peculiar average properties that provide an av-
erage amount of pro-Foxp3 inputs to any circulating CD4 T cells, which can be
translated in terms of model parameter values.
To asses these parameter values, we fitted the solutions in equations
3.1, 3.8, 3.9 to the ensemble of experimental data, by minimizing the sum of
the square of the residuals (details in Materials and method section 3.4.3). We
assumed the transcription/translation activation and repression rates to depend




   i = 1, ..., 10 (3.11)
where the index i refers to the i-th experiment. Looking for the most consistence
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and parsimonious parameter sets, able to quantitatively reproduce all the exper-
imental data, we distinguished the model parameters as experimental-context-
dependent and independent. Parameters that are independent from the specific






   i = 1, ..., 10 (3.13)
In fact, ↵ and   represent the fraction of CD4 T cells that are committed to Foxp3
expression and the ones that can lose and acquire Foxp3 expression over time,
respectively. These fractions are characteristics of the followed cell cohort which,
in all the experiment analyzed, belong to mice in physiologic condition. Also, the
model parameter # can be considered unique across the experiment given that,
as mentioned before, there is only one experimental setting (experiment 7) that
provides us with information about the kinetics of Foxp3.










i = 1, ..., 10 (3.14)
The parameter i% represents the frequency of equilibrium of the Foxp3+ cells
within the second compartment of CD4 T cells. Note that the experiment labelled
as 1, assesses the frequency of CD4 T cells that maintain Foxp3 expression
over time in lymphoreplete condition [Rubtsov et al., 2010]. In other words, the
variable eq, appearing in equations 3.1, 3.8, corresponds to 1⇢.
We found that the model is able to reproduce all the experimental data, by
tuning the ratios i%, i = 1, ..., 10, between activation and repression rate of tran-
scription across experiments, as shown in Figure 3.2, and for optimum values of
↵,   and #, that are kept constant across the experiments.
We found an ensemble of 2483 parameter sets that, based on the sum of
the square of residuals, explain equally well the experimental data. The distri-
bution, across these possible sets of parameters, of the Foxp3 down-regulation
rate associated with the experiment 7, 7  , is characterized by a median value
of one event for month. We found the same median value for the up-regulation
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rate of Foxp3 in lymphoreplete condition, 1 +. On the contrary, the median rate
of Foxp3 expression loss in lymphoreplete condition, 1  , was found close to
zero meaning that, in lymphoreplete condition, CD4 T cells never lose Foxp3 ex-
pression. Similarly, for the case in which Foxp3+ T cells are transferred alone in
lymphodeficient condition, we found the rate of Foxp3 up-regulation, 7 +, was
almost zero. Cumulative distributions are shown in Figure 3.3.




















































Figure 3.3: Cumulative distribution of Foxp3 activation and repression rates
in lymphoreplete and lymphodeficient conditions. (Top) Cumulative distribu-
tion functions (CDF) of 1 + and 1  , Foxp3 activation and repression rates
in experiment 1, across the optimal parameter set found. (Bottom) Cumulative
distributions of 7 + and 7  .
3.2.3 There is no need to assume commitment to Foxp3 expres-
sion.
We found that, in order to coherently reproduce the experimental data on Foxp3
dynamics in cohorts of CD4 T cells, there is no need to call for commitment to
Foxp3 expression, not even for a specific subset of CD4 T cells. Infact values of
the model parameter ↵, indicating the fraction of CD4 T cells committed to Foxp3
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expression in lymphoreplete condition, compatible with the experimental data,
ranged from 0 to 4.2%. Also the third quartile was found to be just 1% of the total
CD4 T cells pool. This percentage corresponds to 13% of Foxp3 committed cells
within Foxp3+ sorted from a lymphoreplete mouse, as shown in Figure 3.4.
In summary, although experimental data are compatible with the assumption
that up to 28% of Foxp3+cells being committed to Foxp3 expression, our meta-
analysis of the experimental data showed that the most likely scenarios is that
very few cells are indeed committed (less than 13% of Foxp3+ in lymphoreplete
condition).





























Figure 3.4: Up to 4.2% of CD4 T cells can be committed to Foxp3 expres-
sion, although data are most likely compatible with no commitment at all.
Cumulative distribution function of the model parameter indicating the frequency
of Foxp3 committed cells in physiologic condition, compatible with experimental
data. Left: CDF of ↵, the frequency committed cells within the entire pool of CD4
T cells. Right: CDF of ↵/(↵ + 1⇢ +  ), the frequency of committed cells within
Foxp3+ cells.
3.2.4 A large sub-population of CD4 T cells in no case is induced to
up-regulate Foxp3 expression in vivo.
We also found that, in order for the model to fit the experimental data of Foxp3
dynamics in vivo, it was necessary to relax the assumption that any CD4 T cells
is able, under opportune conditions, to up-regulate Foxp3 gene in the periphery.
On the contrary, in order to coherently explain all the experimental data, both in
lymphodereplete and lymphodeficient, it was necessary to assume the existence
of cells that in no case can express the gene. These cells represent the 1  
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↵     fraction of CD4 T cells. Our analysis suggested that these cells, which
are CD4 T cells in state Z0 according to our model, represent at least 84.5%
of the entire CD4 T cells pool. Compatible frequencies for these cells ranged,
according to our analysis, from 84.5% up to 89.8%, with median value of 85.2%.
In Figure 3.5 is shown the cumulative distribution of the frequency that could
explain the experimental data.
3.2.5 Foxp3 stability positively correlates with Teff and Treg in the
host.
Finally, we searched for correlations between the model parameter i⇢, and ob-
servables that change across the experiments. Parameter i⇢ was defined in
equation 3.14 as the ratio between Foxp3 activation and repression rates. We
defined it as a context-dependent parameter and we showed it is able to explain
the experimental data. We found that high Foxp3 stability positively correlates
with high number and high frequency of CD4+Foxp3- T cells in the animal host
in which Foxp3 dynamics is followed, at time zero of experiments. In fact, if we
restrict our analysis to the experiments in which stability of Foxp3 expression is
addressed (experiments with labels from 1 to 7), the Spearman’s rank correla-
tion coefficient between the values of ⇢ and the absolute number of Foxp3- cells
is equal to 0.9. Also, the Spearman’s rank correlation coefficient between the
values of ⇢ and the frequency of Foxp3- cells in the host at time zero of the ex-













Figure 3.5: A large subpopulation of CD4 T cells in no case can be induce
to express Foxp3. Cumulative distribution function of the frequency 1   ↵    
of CD4 T cells that, compatibly with the ensemble of experimental data, cannot
express Foxp3 in physiologic condition.
95
3. FOXP3 CELLULAR EXPRESSION
periment is 0.94. We could not find a strong positive correlation between ⇢ and
the absolute number of Foxp3+ cells, although it is positive and equal to 0.21.
Figure 3.6 (top) shows the values of i⇢ across experiments in which stability
of Foxp3 is assessed: the value of the ratio ⇢ decreases monotonously as the
label of the experiment increases. Figure 3.6 (bottom) shows the ranks of the
model parameter ⇢ according to increasing values as a function of the ranks
of a given experimental observables. Ranks increase according to the value of
the parameter they refer to. The considered observables are the following: the
frequency of Foxp3- cells at time zero (left), the absolute number of Foxp3- cells
at time zero (center), the absolute number of Foxp3+ cells at time zero (right) are
shown. An increasing monotonous trend indicates a positive correlation with ⇢.
Activated CD4+Foxp3- T cells are known to be the main in vivo producers of the T-
cell growth factor IL-2 [Malek, 2008] (CD8+ T cells and dendritic cells are also IL-
2 producers [Malek, 2008] however, given the experimental settings considered
in our analysis, neither of the two cell populations are expected to vary across
the experiments). For this reason while computing the correlation between ⇢
and either the frequency or the number of Foxp3 - cells, we did not include the
experiment labeled as 5, in which sustained IL-2 administration complements the
cells transfer.
In summary, we found that stability of Foxp3 expression strongly correlates
with the context, particularly with high number and frequency of CD4+Foxp3-
cells in the host. Also number of Foxp3+ cells in the host positively correlates
with Foxp3 stability.
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ϱ % Foxp3- # Foxp3-
Value Rank Value Rank Value Rank
1 0.99 6 0.88 5 30 000 000 5.5
2 0.94 5 0.90 6 1 000 000 4
3 0.89 4 0.87 4 30 000 000 5.5
4 0.85 3 0.5 3 175 000 3
6 0.40 2 0.09 2 25 000 2
7 0.26 1 0 1 0 1
Label
ϱ # Foxp3+
Value Rank Value Rank
1 0.99 7 4 500 000 6
2 0.94 6 100 000 1
3 0.89 5 4 900 000 7
4 0.85 4 175 000 2.5
5 0.72 3 250 000 4.5
6 0.40 2 250 000 4.5
7 0.26 1 175 000 2.5
Figure 3.6: Foxp3 stability positively correlates with Teff and Tregs in the
host. (Top) Values and ranks of the model parameter ⇢ and of the observables
across the experiments in which stability of Foxp3 is assessed. Observables
considered are frequency and absolute number of Foxp3- (left) or Foxp3+ (right)
CD4 T cells at time zero across experiments, indicated by corresponding labels.
Higher ranks correspond to higher values of the parameter. (Bottom) Ranks of
the model parameter ⇢ versus ranks of experimental observables (frequency and
absolute number of Foxp3- or Foxp3+) across experiments.
3.3 Discussion
In this chapter we looked for a coherent interpretation of Foxp3 expression dy-
namics in CD4 T cells in vivo in mice. In particular, we aimed at address the
conditions for persistence of Foxp3 expression in CD4 T cells. For this, we tried
to understand whether commitment to Foxp3 expression is a necessary assump-
tion in order to explain stable Foxp3 expression and, if not, what, beside commit-
ment, controls stability and lability of Foxp3 expression in the environment of a
mouse. Also, we asked whether we could draw conclusions about the hetero-
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geneity of Foxp3+ cells, regarding their ability to maintain stable Foxp3 expres-
sion. Similarly, we investigated whether any conclusion could be drawn about the
heterogeneity of Foxp3- CD4 T cells, regarding their ability to up-regulate Foxp3,
under appropriate stimulation.
We addressed these questions by developing a stochastic model for Foxp3
expression in CD4 T cells, in which Foxp3 expression can be fully reversible,
irreversible or heterogeneous, depending on model parameters. We then used
this model to perform a meta-analysis on available experimental data, which track
the frequency of Foxp3 expressing cells over time in CD4 T cell cohort in vivo,
addressing Foxp3 stability and dynamics in different experimental conditions.
3.3.1 A single framework for different experimental contexts.
We showed that all the experimental data could be quantitatively reproduced
under a single framework. Data used for the analysis included the experiments
in lymphoreplete condition, where Foxp3 expression is stably maintained over
months, the ones in lymphodeficient conditions, where Foxp3 expression can be
lost within few weeks, and also compelled several intermediate cases.
3.3.2 Heterogeneity of CD4 Foxp3- T cells.
Meta-analysis showed that in order for all the experiments to be coherently re-
produced, it is necessary to assume heterogeneity within Foxp3- cells that can
be sampled from mice in physiologic condition. In particular, analysis suggested
that the majority of CD4 T cells, spanning from 84.5 to 89.8% of them, in no case
happen to be induced to express Foxp3 in vivo.
The presence of a large subpopulation of CD4 T cells that, in lymphore-
plete condition, are prevented to up-regulate Foxp3 can be biologically explained
in different ways. The first explanation can be in terms of T cell receptors
(TCR) repertoire of CD4 T cells. Foxp3 expression, in fact, has been shown
to require continuous TCR engagements together with IL-2 stimulation to be
maintained [Levine et al., 2014]. Also in vitro Foxp3 induction in CD4 naive T
cells has been shown to rely on TCR stimulation, together with IL-2 and TGF-
  [Chen et al., 2003, Davidson et al., 2007, Yao et al., 2007]. It has also been
shown that, despite of the negative selection toward self-reactive lymphocytes
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that takes place in the thymus during lymphocytes development, Tregs have a
TCR repertoire skewed toward self-reactivity [Kim et al., 2007]. It is therefore
reasonable to assume that, because of their repertoire, not all the CD4 T cells
can get in the periphery enough TCR engagement together with the necessary
cytokines stimulations, for Foxp3 to be stably expressed, while only a small frac-
tion of them (not more then 20%), get the amount of needed stimulation.
Other explanations, which are not in conflict with the previous one, can be
given either in terms of differentiation state of the cells or in terms of maturation.
Indeed, the majority of CD4 T cells, due to their differentiation program, have a
gene expression profile that inhibits Foxp3 expression; also, recent thymic emi-
grant CD4 T cells, that have been shown to be the preferential precursor of Tregs
that differentiate in the periphery, have also been shown to lose, over time, the
potential to up-regulate Foxp3 [Paiva et al., 2013].
3.3.3 Homogeneous Tregs population.
On the other hand, there is no need to call for heterogeneity within Foxp3+ cells.
Indeed the ensemble of experimental data is compatible with Tregs being a ho-
mogeneous pool of CD4 T cells in which Foxp3 expression is stable or labile de-
pending on the context. Particularly, Foxp3 stability strongly positively correlates
with frequency and absolute number of Foxp3- CD4 T cells in the host. Weak
positive correlation was also found with the absolute number of Foxp3+ cells, in
accordance with the notion that neither maintenance of Foxp3 expression nor
re-acquisition of Foxp3 by exTregs depend on TGF-  [Komatsu et al., 2009].
Although not necessary for explaining the experimental data, the existence of
Foxp3+ cells that are committed to Foxp3 expression cannot be excluded. In fact,
data also supported the possibility that up to 28% of Foxp3+ cells are committed
to Foxp3 expression, while the remaining ones express the gene as far as the
context provides the opportune stimuli. Yet the frequency of cells committed
to Foxp3 expression, represents a minority of Foxp3+ cells. These results are
summarized in Figure 3.7, left.
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3.3.4 A coherent view of Foxp3 dynamics in different contexts.
The analysis provided us with a new key to reading coherently the experiments
we analyzed, which is summarized in Figure 3.7, right. We analyzed the distri-
bution of ↵ +   (the frequency of CD4 T cells that either are or can be Foxp3+)
together with the distribution of 1⇢ (the frequency of equilibrium, in lymphore-
plete condition, of Foxp3+ cells within the compartment of cells that, based on
the context, are able to up- or down- regulate the gene).
Based on this analysis, we concluded that in lymphoreplete condition all the
cells that can up-regulate Foxp3, end up expressing the gene. When Foxp3+
cells are followed over time, whether in lymphoreplete condition (experiment 1)
or after being transferred into lymphodeficient host (experiment 7), the followed
cohort is the same. This cohort is sampled from the compartments highlighted
in Figure 3.7, right, through the vertical green line. What changes is then the
context in which the cohort is followed over time and which provides more or
less amount of pro-Foxp3 inputs, mainly depending on frequency and number
of cognate Foxp3- CD4 T cells. Indeed, as the number of Foxp3- cells in the
host, or its ratio with respect to Foxp3+ cells, decrease, the same happens to the
frequency of Foxp3+ cells that maintain Foxp3 expression over time, as shown in
Figure 3.7, top right.
From the same analysis it follows that within any cohort of total peripheral
Foxp3- CD4+ T cells, sorted from lymphoreplete conditions, (sampled from the
compartments highlighted with vertical dark gray line in Figure 3.7, right) a neg-
ligible proportion of them (around 0.3%) belongs to the compartment of cell able
to up-regulate the gene (vertical light gray line). For this reason, we observe poor
acquisition of Foxp3 expression within this cohort of cells, no matter the context
in which cells are followed. As an example, it should be noted that even in the
context that ensures a degree of stability to Foxp3+ cells that is comparable to
the physiologic case (experiment 2, showed in Figure 3.2), nevertheless the ac-
quisition of Foxp3 expression by total peripheral Foxp3-CD4+ T cells is the same
as in lymphodeficient condition (experiment 9). In the same line, we have also
noted that the value of 9⇢ was poorly informative in the sense that could freely
span from 0 to 1, without changing the quality of the fitting (see Materials and
methods section). This result means that, no matter how much the environment
provides pro-Foxp3 inputs to total peripheral Foxp3-CD4+ T cells (and therefore
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no matter how big the correspondent ratio ⇢ is), the frequency of cells able to
express the gene is so small that the up-regulation will be negligible.
This is not the case for the experiment 8, which assesses the frequency of
Foxp3 induction in cohort of exTreg. In this case, the cell cohort is constituted by
cells whose Foxp3 expression is influenced by the context (compartment high-
lighted with vertical light grey line in Figure 3.7, right). We observe indeed Foxp3
induction, within 4 weeks, in 10% of the cells and the value of 8⇢, differently
from 9⇢ while similar to i⇢, i = 1, 2, ..., 7, is very informative (see Materials and
methods section).
We should keep in mind that a possible differential proliferation among
Foxp3+CD4+, Foxp3-CD4+ T cells and exTregs could be a confounding factor.
For instance, in experiments performed in lymphodeficient conditions, where
Foxp3+ T cells are transferred alone and a population of Foxp3- cells accumu-
lates over time, growing in frequency, we cannot conclude whether this popula-
tion is mainly due to Foxp3 loss, or to preferential proliferation of a small popula-
tion that has loss Foxp3 expression. The second possibility has been proposed
[Komatsu et al., 2009, Miyao et al., 2012]. Nevertheless, to confirm this possibil-
ity, a quantitative link between the CFSE proliferation and the respective change
in frequencies should be established.
3.3.5 A slow dynamics yet to be explained.
What still remains to be explained is the ”slow” dynamics through which
Foxp3+CD4+ T cells lose Foxp3 expression, when transferred alone in lym-
phodeficient host. Our analysis showed that the median time needed for
Foxp3 expression loss, by Foxp3+ cells in this condition, is in fact around four
weeks. Because the half-life of the Foxp3 protein has been estimated to be of
few hours [Morawski et al., 2013], the same being for RNA half-life (1.46 hrs)
[Bending et al., 2018], the observed dynamics cannot be explained in terms of
Foxp3 protein and RNA degradations, once the transcription is over. We instead
need to call for other processes, like epigenetics. In fact, epigenetic signatures of
the Foxp3 locus, which determine chromatin remodeling and accessibility of the
locus to the transcription factors and machinery, are inherited and maintained
across cell generations. For this reason their modifications and dynamics are
slow if compared with transcription and translation dynamics. This analysis is
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Figure 3.7: A new key to reading coherently the different experiments we
analysed. Left: According to our meta-analysis, the pool of CD4 T cells in a
lymphoreplete mouse can be divided into, at least, two compartments. One con-
stituted by cells that in no case can up-regulate Foxp3 (”committed Foxp3-”), a
second one of cells that, depending on the context, can express or not the gene
(”context-dependent”). A third compartment (constituted by ”committed Foxp3+”
cells) is also compatible with data, but it is not necessary to explain the data ob-
served. Intervals of admissible values for the fraction of each compartment (↵, 
and 1   ↵    ) are shown. Right: Illustrations of the compartment/s from which
cell cohorts are sampled for the tracking of Foxp3 expression, in different ex-
periments. Full colored mouse indicates lymphoreplete mouse, partially colored
mice indicate lymphodeficient hosts that have received lymphocytes by adoptive
transfer.
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3.4 Materials and methods
3.4.1 Stochastic model of Foxp3 expression in a CD4 T cell.
The model introduced in the main text describes the probability over time for a
CD4 T cell to be in any of the four states, given the following model parameters:
↵ is the frequency of Foxp3 committed CD4 T cells,   is the frequency of CD4
T cells that can be either positive or negative for Foxp3 and are able to change
their phenotype over time,  +,   are the rates of acquisition and loss of Foxp3
expression of the cells belonging to the fraction   of CD4 T cells.
We defined the probability vector:
z(t) = (z1(t), z2(t)), (3.15)
where z
k
(t), k 2 {1, 2}, is the probability, restricted to the cells in the fraction   of
CD4 T cells, of being in state Zk at time t. The time evolution of z(t), is described
by the following system of ordinary differential equations :
ż = z ⇤, (3.16)
where ż indicates the time derivative of the vector z(t) of probabilities and ⇤ is the







Given the rates of transitions and the initial probability distribution
z(0) = (1  p2, p2), (3.18)
where p2 is the probability of being Foxp3+ at time zero for a cell in the fraction  ,
the solution of the Markov chain model is unique and it is the following:
z(t) = z(0) · e⇤t, (3.19)
where e⇤t is the exponential matrix and · indicates the scalar product. The prob-
ability of the cell being Foxp3+ at time t, which is the second component of the
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By substituting in equation 3.20





 + = %#,    = (1  %)#, (3.22)
the solution for the probability of the cell in the fraction   being Foxp3+ at time t
simplifies as:
f(t, p2) = e
 #t
(p2   %) + %. (3.23)
Finally, remembering that the initial conditions p2 = 1 means that the probability
of a a cell in the fraction   to be Foxp3+, is equal to 1, we obtain the definitions
for m(t), a(t), aex(t), reported in the main text.
In particular, the probability over time for a general CD4 T cell to be Foxp3+















where eq is the frequency of Foxp3+ cells at equilibrium in lymphoreplete condi-
tion, restricted to the second compartment of CD4 T cells. The same probability,




f(t, p2 = 0)
 





1  (↵+ eq ) . (3.25)
The same probability, given that at time t = 0 the cell was Foxp3- and particularly
in state Z2, is:
aex(t) = f(t, p2 = 0) = %  e #t%. (3.26)
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As mentioned in the main text, we assumed that any CD4 T cell of the fraction
  in a given host, due to the immune cell population composition of the host, is
subjected to a mean field of pro-Foxp3 inputs per time units, as antigen presenta-
tion by cognate antigen presenting cells and cytokines stimulations by other CD4
T cells. The field of inputs over the time window of each experiment is reflected in
the model parameters. We also assumed that every time that a cell up-regulate
or down-regulate Foxp3 expression, it does not impact on the mean field: no
transition that happen over the time of any given experiment can change the av-
erage characteristics of the field of inputs in which the very cell is embedded.
This means that the model parameter values are constant over the time of any
experiments and reflect the average characteristic of the experimental setting.
Under these assumptions, the probability over time for a cell to be in any state of
the model can me compared with the frequencies of CD4 T cells that are in any
state of the model. For this reason, we can use the equations 3.24, 3.25, 3.26
as a measure of the frequency of Foxp3+ cells within, respectively, a cohort of
Foxp3+ cells from lymphodeficient condition, a cohort of Foxp3  cells from lym-
phodeficient condition and a cohort of exFoxp3+ cells.
3.4.2 Experimental data on Foxp3 stability in vivo collected from
literature.
Here we report the description of the experiments collected from literature and
whose data were included in our analysis. These experiments track over time
the frequency of cells expressing Foxp3 within cohorts of cells that were either
Foxp3+ or Foxp3- at time zero of the observation. When assembling the data
set, we adopted a necessary condition which would ensure a fair comparison
among experimental data in different contexts. We chose experiments in which
the cell cohorts were sorted (or labelled) as total peripheral CD4+ T cells, either
Foxp3+ or Foxp3-, from (or in) adult lymphoreplete Foxp3 reporter mice. Also,
we included experiments in which those same cohort were followed over time
upon a second transfer. Data from experiments performed under the same
experimental conditions and reported by different papers, were pooled together,
by averaging analogous time points, and were then marked with the same label.
Inducible labelling, upon tamoxifen administration, of Foxp3+ cells, in
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lymphoreplete mouse.
Foxp3eGFP-Cre-ERT2 ⇥ R26-YFP mice from 6 to 8 weeks of age received three
doses of tamoxifen (8 mg each) at days 0, 1, and 3, by oral gavage. Mice were
analysed at day 14 and at 5 months after treatment. Frequency and number of
Foxp3+ cells within CD4+YFP+ T cells recovered from spleen or lymph nodes,
were assessed (n=7). Foxp3eGFP-Cre-ERT2 ⇥ R26YFP mice were generated by
the authors of the paper by breeding knock in Foxp3eGFP-Cre-ERT2 mice with the
ROSA26YFP mice [Rubtsov et al., 2010]. In the knock in Foxp3eGFP-Cre-ERT2
mice the cassette containing an internal ribosome entry site (IRES), followed
by DNA sequence encoding a triple fusion protein eGFP-Cre-ERT2 (enhanced
green fluorescent protein, with Cre recombinase and mutated human estrogen
receptor ligand-binding domain) is inserted into the 3‘ untranslated region (UTR)
of the Foxp3 gene. Rosa26-YFP mice the harbour the loxP site-flanked STOP
cassette in the ubiquitously expressed ROSA26, followed by a DNA sequence
encoding the yellow fluorescent protein. In these mice, when the fusion protein
GFP-CreERT2 is expressed, it resides in the cytosol. Treatment with tamoxifen,
allows for the GFP-CreERT2 protein to enter the nucleus and to excide the floxed
STOP cassette. It causes therefore constitutive and heritable expression of YFP
in cells that were expressing Foxp3 at the time of tamoxifen administration.
Label: 1
Reference: [Rubtsov et al., 2010](Fig. 1B)
Adoptive cells transfer of peripheral Foxp3+ cells, into lymphoreplete
mouse.
Ly5.2/Thy1.1 mice received i.v. 1 ⇥ 105 CD4+eGFP+ T cells sorted from
Foxp3eGFP Ly5.1/Thy1.2. Mice (n=5,6) were analyzed at 4 and 8 weeks post
transfer, assessing the frequency of eGFP- cells in CD4+Ly5.1+Thy1.2+ donor T
cells, pooled from lymph nodes and spleen. Before staining for Ly5.1, Thy1.2,
and CD4, the recovered cells were enriched for donor T cells by depleting
Thy1.1+, Ig+, and adherent cells by panning. B6.Ly5.1 congenic mice were used
at 5-12 weeks of age.
Label: 3
Reference: [Komatsu et al., 2009](Fig. 1B)
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Adoptive cells transfer of peripheral Foxp3+ cells, into lymphodefi-
cient mouse + sustained IL-2 i.p. administration.
TCR -/- mice received i.v. 2.5 ⇥ 105 Thy1.1+ CD4+ Foxp3-GFP+ cells. Mice
were also injected daily with recombinant IL-2 i.p., during 3 weeks. Mice were
analyzed 3 weeks after transfer, assessing the frequency of Foxp3- cells in
CD4+CD3+ T cells recovered in spleen or pooled lymph node.(n=4)
Label: 5
Reference: [Duarte et al., 2009] (Fig 2D)
Adoptive cells transfer of peripheral Foxp3+ alone into lymphodefi-
cient mouse. (Data from two papers)
(First pool of data) Rag2-/- mice received i.v. 2.5⇥105 Thy1.1+ CD4+ Foxp3-GFP+
cells. Mice were analyzed at weeks 1, 2, 3, 4 and 10 after transfer, assessing
the frequency of Foxp3- cells in CD3+ Thy1.1+ cells, recovered from spleen or
lymph nodes.
Label: 7
Reference: [Duarte et al., 2009] (Fig 1E)
(Second pool of data) CD4+eGFP+ T cells were sorted from Foxp3eGFP Ly5.2
mice and adoptively transferred into Rag2-/- mice. Mice were analyzed 4 weeks
after transfer, assessing the frequency of GFP+ cells within the Foxp3+ (Ly5.1-)
donor-derived CD4+TCR + cells recovered from lymph nodes. Mice were used
at 5 to 12 weeks of age.
Label: 7
Reference: [Komatsu et al., 2009] (Fig. 1A)
Adoptive cells transfer of peripheral Foxp3+ together with Foxp3- cells at
Foxp3+: Foxp3- ratio, into lymphodeficient mouse. (Data from two papers)
(First pool of data) Rag2-/- mice received 2.5 ⇥ 105 Thy1.1+ CD4+ Foxp3-GFP+
cells together with the same number or 10 times less Thy1.2+ CD4+ Foxp3-GFP-
cells. Mice were analyzed 4 weeks after transfer, assessing the frequency of
Foxp3- cells gated in CD3+ Thy1.1+ cells in the spleen of mice host mice (n=4
for each group).
Labels: 4, 6
Reference: [Duarte et al., 2009] (Fig 2A)
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(Second pool of data) CD4+eGFP+ and eGFP- T cells were sorted from
Foxp3eGFP Ly5.2 and Foxp3eGFP Ly5.1 mice, respectively, and adoptively trans-
ferred into Rag2-/- mice, mixed at a 1:1 or 1:10 ratio (1⇥ 105 eGFP+ plus 1⇥ 105
or 1 ⇥ 106 eGFP-). Mice were analyzed 4 weeks after transfer. Lymph nodes
cells were stained for CD4, TCR  and Ly5.1. Frequency of GFP+ cells within the
Foxp3+ (Ly5.1-) or Foxp3- (Ly5.1+) donor-derived CD4+TCR + cells recovered
from each host mouse, was assessed. Mice were used at 5 to 12 weeks of age.
Labels: 2, 4
Reference: [Komatsu et al., 2009] (Fig. 1A)
Adoptive cells transfer of peripheral Foxp3- cells, recovered at 4 weeks
after a previous transfer of Foxp3+ cells (exFoxp3+), into a lymphodeficient
mouse.
CD3"-/- mice received i.v. 1 ⇥ 105 Foxp3  T cells from Foxp3eGFP (exFoxp3+)
recovered at 4 weeks after a previous transfer of Foxp3+ cells into CD3"-/-. Mice
were analyzed 4 weeks after the second transfer. Cells recovered from lymph
nodes were stained for CD4 and Ly5.1 and analyzed for eGFP expression,
assessing the frequency of re-induced Foxp3+ T cells in CD4+Ly5.1+ donor cells.
B6.CD3"-/-mice were used at 5 to 12 weeks of age.
Label: 8
Reference: [Komatsu et al., 2009] (Fig 3C)
Adoptive cells transfer of peripheral Foxp3- cells, into lymphodefi-
cient mouse (data from two papers)
(First pool of data) TCR -/- mice received i.v. 3 ⇥ 105 CD4+CD8-Foxp3- cells
purified from pooled lymph nodes isolated from Foxp3GFP reporter mice. Mice
were analyzed 4 weeks after transfer, assessing the frequency of Foxp3+ cells
within CD4+TCR+ lymphocytes recovered from pooled branchial, inguinal, and
axillary lymphnodes, or pooled mesenteric lymph nodes, or spleen(6 indepen-
dent experiments of n=6 each).
Label: 9
Reference: [Paiva et al., 2013] (Fig. S1)
(Second pool of data) Rag2-/- mice received i.v. 1 ⇥ 105 CD4+eGFP- T cells
sorted from Foxp3eGFP Ly5.1 mice. Mice were analyzed 4 weeks after transfer.
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Lymph nodes cells were stained for CD4, TCR  and Ly5.1. Frequency of GFP+
cells within the Foxp3+ (Ly5.1-) donor-derived CD4+TCR + cells recovered from
each host mouse, was assessed. Mice were used at 5 to 12 weeks of age.
Label: 9
Reference: [Komatsu et al., 2009] (Fig. 1A)
Adoptive cells transfer of peripheral Foxp3- cells, recovered at 4 weeks
after a previous transfer of Foxp3- cells (stillFoxp3-), into lymphodeficient
mouse
CD3"-/- mice received i.v. 1 ⇥ 105 Foxp3  T cells (stillFoxp3-) from
Foxp3eGFPLy5.1 mice recovered at 4 weeks after a previous transfer of
Foxp3- cells into CD3"-/-. Mice were analyzed 4 weeks after the second transfer.
Cells recovered from lymph nodes were stained for CD4 and Ly5.1, and analyzed
for eGFP expression. Frequency of induced Foxp3- T cells in CD4+Ly5.1+ donor
T cells was assessed. Mice were used at 5 to 12 weeks of age.
Label: 10





















Label Experimental setting Donor Host Initial proportion Initial cells number Cells Time points Reference
(Foxp3+: Foxp3-) (Foxp3+, Foxp3-) recovered from (days)
1 Inducible labelling of Foxp3+ cells, - Foxp3eGFP-Cre-ERT2
into lymphoreplete mouse ⇥ R26-YFP (1 : 7) (4.5⇥ 106, 3⇥ 107) LNs, Spleen T1 = {1, 126} [Rubtsov et al., 2010](Fig. 1B)
3 Adoptive cells transfer of peripheral Foxp3+ cells, Foxp3eGFPKI Foxp3eGFPKI
into lymphoreplete mouse (Ly5.1/Thy1.2) (Ly5.2/Thy1.1) (1 : 6.5) (4.9⇥ 106, 3⇥ 107) Lns,Spleen T3 = {0, 28, 56} [Komatsu et al., 2009](Fig. 1B)
Adoptive cells transfer of peripheral Foxp3+ cells,
into lymphoreplete mouse
5 + sustained IL-2 i.p. administration Foxp3eGFPKI Thy1.1 TCR -/- (1 : 0) (2.5⇥ 105, 0) LNs, Spleen T5 = {0, 21} [Duarte et al., 2009](Fig. 2D)
Adoptive cells transfer of peripheral Foxp3+ cells,
alone or together with Foxp3- cells, in portion
(Foxp3+:Foxp3-), into lymphodeficient mouse:
2 (1:10) Foxp3eGFPKI (Ly5.2, Ly5.1) Rag2-/- (1 : 10) (105, 106) LNs T2 = {0, 28} [Komatsu et al., 2009](Fig. 1A)
4 (1:1) Foxp3eGFPKI (Thy1.1, Thy1.2 ) Rag2-/- (1 : 1) (2.5⇥ 105, 2.5⇥ 105) Spleen T4 = {0, 28} [Duarte et al., 2009](Fig. 2A)
Foxp3eGFPKI (Ly5.2, Ly5.1) Rag2-/- (1 : 1) (105, 105) LNs [Komatsu et al., 2009](Fig. 1A)
6 (1:0.1) Foxp3eGFPKI (Thy1.1, Thy1.2) Rag2-/- (1 : 0.1) (2.5⇥ 105, 2.5⇥ 104) Spleen T6 = {0, 28} [Duarte et al., 2009](Fig. 2A)
7 (1:0) Foxp3eGFPKI (Thy1.1) Rag2-/- (1 : 0) (2.5⇥ 105, 0) LNs, Spleen T7 = {0, 7, 14, ... [Duarte et al., 2009](Figg. 1E, 2A)
Foxp3eGFPKI (Ly5.2) Rag2-/- (1 : 0) (105, 0) LNs 21, 28, 70} [Komatsu et al., 2009](Fig. 1A)
Adoptive cells transfer of peripheral Foxp3- cells,
9 into lymphodeficient mouse Foxp3eGFPKI (Ly5.1) Rag2-/- (0 : 1) (0, 105) LNs T11 = {0, 28} [Komatsu et al., 2009](Fig. 1A)
Foxp3eGFPKI TCR -/- (0 : 1) (0, 3⇥ 105) LNs, Spleen [Paiva et al., 2013] (Fig. S1)
Adoptive cells transfer of peripheral Foxp3- cells,
recovered at 4 weeks after a previous transfer of
Foxp3+ cells (exFoxp3+),
8 into a lymphodeficient mouse Foxp3eGFPKI CD3"-/- (0 : 1) (0, 105) LNs T9 = {0, 28} [Komatsu et al., 2009](Fig. 3C)
Adoptive cells transfer of peripheral Foxp3- cells,
recovered at 4 weeks after a previous transfer of
Foxp3- cells (stillFoxp3-),
10 into a lymphodeficient mouse Foxp3eGFPKI CD3"-/- (0 : 1) (0, 105) LNs T9 = {0, 28} [Komatsu et al., 2009](Fig. 3C)
Table 3.1: Summary of the 10 different experimental setting included in the analysis. Label attributed to each
experiment; experimental setting description; donor mice, in case of adoptive transfer; host mice in which the cohorts
of cells are followed; proportion Foxp3+ and Foxp3- CD4 T cells present in the host at time zero of experiment; ab-
solute number of Foxp3+ and Foxp3- CD4 T cells present in the host at time zero of experiment; organs from which
analysed cells were recovered; frequency and number of Foxp3+ and Foxp3- cells present in the host at time zero of




3. FOXP3 CELLULAR EXPRESSION
3.4.3 Fitting of the model to the experimental data
Let us indicate the model prediction for the frequency over time of Foxp3+ cells






%), i = 1, 2, ..., 10. (3.27)












given by the sum of the residuals between the model prediction if(t) and the i-th
experimental data set i ˆf(⌧), where T
i
for i = 1, ..., 10, is the set of the discrete
time points ⌧ of the i-th experiment.
To ensure a complete analysis of the values for the frequency of Foxp3 com-
mitted cells that are compatible with the ensemble of experimental data, we fixed
values for the parameter ↵, uniformly distributed within the interval
I
↵
= [0, 0.15]. (3.29)
For each of these fixed values, we minimized the score function S with respect
to the parameters  ,#, 1%, 2%, ..., 10%. The minimization was subjected to the
following constraint:
0.10  ↵+   1%  0.15, (3.30)
which translates the well known result that in physiologic condition 10-15% in
CD4 T cells are found to be Foxp3+. We explored the parameter space choosing
random initial values for the parameters ranging in specific intervals:
  2 I
 







= [0, 1], i = 1, 2, ..., 10. (3.31)
The ”Principal Axis” algorithm [Brent, 2013] was used to minimize the score func-
tion S. To avoid local minima, we fixed a threshold th = 0.01878 for the maximum
score value allowed, given that the square of the residuals in case of the experi-
ment 7 fitted alone was equal to 0.014784.
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The algorithm converged efficiently, finding global minimum for S in corre-
spondence of optimal distributions for the parameters. Optimum values for # and
for i%, i = 1, 2, ..., 8 were found regardless of their initial values, spanning in their
respective ranges, as shown in Figure 3.8. However, the score function S was
found to be not much sensitive to values of the ratios 9% and 10%, as distributions
of initial values and optimum values are very similar. We discuss this result in the
conclusion section. Finally, concerning the fractions ↵ and  , the algorithm con-
verged only for fixed values of ↵ below 0.042 and for initial values of   included
in the interval [0.06, 0.59] ⇢ I
 
. The cumulative distribution functions for the initial
and optimum values of the model parameters parameters showed in Figure 3.8,
concerns the distributions of 2483 different runs of the optimization algorithm.
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Figure 3.8: Convergence toward minimum for the score function S with re-
spect to model parameters. Cumulative distribution functions of the initial val-
ues (blue lines) of the model parameters provided to the algorithm in order to
minimize the score function S and of the optimum values (yellow lines) that min-












, i = 1, 2, ..., 10.
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Slow epigenetic dynamics of
Foxp3 locus can explain Foxp3
dynamics in murine CD4 T cells
in different contexts. A
quantitative approach.
Statement: All the work included in this chapter is my own, carried out under the
supervision of Jorge Carneiro and Jocelyne Demengeot.
Abstract
Foxp3 expression is necessary for Tregs development and regulatory function.
While in physiologic condition Tregs show stable Foxp3 expression, in several
other experimental conditions, Foxp3 expression can be lost over time, following
a slow dynamics. This dynamics cannot be explained as the result of transcrip-
tion, translation and protein degradation.
Here we propose that both stability and lability of Foxp3 expression is the re-
sult of the combination of the fast and context-dependent transcription activation
and repression dynamics together with a slow epigenetic dynamics, that depend
on the transcriptional state of the cell, rather than on the context in which the cell
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is.
We developed a stochastic model for Foxp3 expression in CD4 T cells that
accounts for transcriptional, translational and epigenetic dynamics and in which
Foxp3 expression can be reversible or irreversible. Model parameters that control
the dynamics of either transcription or epigenetic remodeling of the chromatin,
can be tuned in a context-dependent or -independent way. We fitted the model to
experimental data collected from the literature, describing the temporal evolution
of Foxp3+ cells frequency in Tregs cohort, in different experimental conditions.
We found that the different dynamics can be all coherently and quantitatively
reproduced, by tuning the ratio between fast Foxp3 transcriptional activation and
repression rates across the experiments, while epigenetic rates were kept slow
and constant across the experiments. Also, model predicts that in physiologic
condition, where Tregs are stable, the vast majority of Tregs has an active state
of chromatin in the Foxp3 locus. This characteristic ensures on the one hand,
the stability of Foxp3 expression in lymphopenic conditions, where the context
provides stimuli that enhance Foxp3 gene transcription, prevent its repression;
on the other hand it explains the slow dynamics of Foxp3 expression loss, ob-
served in those lymphopenic condition where Foxp3 transcription is prevented.
Indeed the dynamics of Foxp3 loss, observed in lymphopenia, coincides with the
epigenetic remodeling dynamics in Foxp3+ T cell predicted by our model.
4.1 Introduction
The forkhead box protein 3 (Foxp3) is a transcription factor, mainly expressed in
the subset of CD4 T cells, called Regulatory T cells (Tregs). Foxp3 gene expres-
sion is necessary for Tregs development and confers them suppression activity
[Fontenot et al., 2003, Hori, 2003, Khattri et al., 2003]. In physiologic condition
for mice, Foxp3 expression in CD4 T cells has been observed to be stably main-
tained in vivo over several rounds of cells divisions, persisting for several months
[Rubtsov et al., 2010]. In vivo Foxp3 stability over time has also been observed
in Foxp3+ cohort of CD4 T cells, upon adoptive transfer into normal lymphore-
plete mice [Komatsu et al., 2009]. Even in lymphodeficient mice in which normal
proportion of Foxp3+ and Foxp3- CD4 T cell have been reconstituted, by co-
transferring both populations, Foxp3 expression is maintained, at least for four
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weeks [Komatsu et al., 2009]. Yet, loss of Foxp3 expression by Foxp3+ CD4+ T
cells and consequent in vivo accumulation of the so called exTregs in the pe-
riphery of mice, has been experimentally observed in several contexts, such as
lymphopenia and under inflammation [Duarte et al., 2009, Komatsu et al., 2009,
Mellor and Munn, 2011, Yurchenko et al., 2012].
Through meta-analysis on experimental data that assessed Foxp3 dynamics
in vivo in different experimental conditions, we have already suggested that, at
least for a consistent fraction of Tregs, Foxp3 stability or lability is determined
by the context in which Tregs are embedded (see chapter 3). In particular Foxp3
stability in Tregs strongly positively correlates with the frequency of Foxp3- CD4 T
cells within the total CD4 T cells compartment, as well as with absolute number of
Foxp3- CD4 T cells within the host (see chapter 3). This result is in accordance
with the knowledge that Foxp3 expression needs, together with T cell receptor
stimulations [Levine et al., 2014], continuous IL-2 stimulation, mainly produced
by activated Foxp3- CD4 T cells [Malek, 2008], to be maintained.
When occurring, the process of loss of Foxp3 expression over time within
cohort of Foxp3+ T cells follows a rather slow dynamics. For instance, in the case
in which Foxp3+ T cells are purified from Foxp3-GFP reporter mouse and then
adoptively transferred into Rag2-/- mouse, we have estimated the average time a
Treg is able to maintain Foxp3 expression, in the periphery and in absence of pro-
Foxp3 stimuli, to be four weeks. On the other hand the half-life of Foxp3 protein
has been experimentally estimated to be of 2-3 hours [Morawski et al., 2013],
as well as the one of Foxp3 RNA [Bending et al., 2018]. For this reason, the
slow dynamics that characterizes Foxp3 loss in lymphopenic condition cannot be
explained by the time expected for Foxp3 transcripts and protein to be degraded,
after Foxp3 transcription is over.
The experimental observations of loss of Foxp3 expression, by cells in envi-
ronment that do not provide enough pro-Foxp3 stimuli, hould already rule out the
possibility that Foxp3 directly regulates itself through a positive feedback loop.
Beside that, there are not very convincing evidences of Foxp3 enhancing its own
expression.
Yet, it has been widely described that CD4 T cells use epigenetic and the
remodeling of the chromatin structure to imprint gene induction events that oc-
curred in the progenitor cells [Reiner, 2005]. Concerning Tregs, CD4+CD25+
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T cells have been shown to display full demethylation of a conserved CpG-
rich region within the Foxp3 locus in one of its enhancers, as well as histone
modifications [Floess et al., 2007]. In particular, it has been proposed that the
complete demethylation of this region, called the Tregs-specific demethylated re-
gion (TSDR), is the key mechanism through which stable Foxp3 expression is
achieved in CD4 T cells [Floess et al., 2007, Miyao et al., 2012].
Epigenetic signatures of the gene locus, which determine chromatin remod-
eling and accessibility of the locus to the transcription factors and machinery, are
inherited and maintained across cell generations. Epigenetic signatures dynam-
ics include the changes in epigenetic marks that make the locus more or less
competent for transcription and which then become inherited in the next genera-
tions. For this reason these dynamics can be considered slow, if compared with
transcription and translation activation and repression dynamics.
Here we want to put forward the idea that prolonged Foxp3 expression in
a CD4 T cell, due to a context that provides enough pro-Foxp3 stimuli, can in-
duce epigenetic remodeling of the locus that, in turns, ensures stable Foxp3
expression. In this view, the process occurs without epigenetic remodeling be-
ing directly induced by external inputs provided by the context. In particular, we
propose that both the stability of Foxp3 expression observed in lymphoreplete
conditions, as well as its lability, observed in limphopenia, and encompassing
all the intermediate cases of mice whose immune system populations of CD4 T
cells have been partially reconstituted by adoptive transfers, can be explained
as the result of a combination of two processes: a fast and context-dependent
transcription/translation activation and repression of the Foxp3 gene, combined
with a slow and context-independent epigenetic remodeling of the Foxp3 locus.
4.2 Results
4.2.1 A stochastic model for gene expression accounting for epige-
netic remodeling and transcription is able to describe Foxp3
dynamics in CD4 T cell cohorts.
We decided to explore whether the different dynamics of Foxp3 expression ob-
served in vivo in different experimental contexts can be explained by combin-
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ing fast and context-dependent transcription dynamics together with slow and
context-independent chromatin remodeling of the gene locus.
Model assumptions and description.
For this, we developed a stochastic model for gene expression at the Foxp3 locus
in a CD4 T cells, that accounts for transcriptional, translational and epigenetic
dynamics.
According to the model, which is an extension of the model developed in the
previous chapter, any CD4 T cell can be found in one out of a set of mutually
exclusive states. Each state is indicated by Zij. The subscript i refers to the
transcriptional/translational state of the cell and can acquire values in {0, 1, 2,
3}. If i 2 {0, 1} the cell is Foxp3-, if i 2 {2, 3}, the cell is Foxp3+. The subscript j
refers to the epigenetic status of the chromatin at the Foxp3 locus. In this regard,
states are distinguished by the collection of epigenetic marks that either prevent
accessibility of the locus from the transcription machinery, or that makes the
locus fully competent for transcription. Also, we assumed that the locus can be
found in an intermediate condition, in which either expression or repression of the
gene can occur. In nature there is an almost-continuum of different epigenetic
states, two of which (the extreme ones) are clearly identifiable It is our choice
to discretize the continuum into three states and we refer to those states by the
subscripts j=0 (for closed chromatin), j=1 (for the intermediate state), j=2 (for
open chromatin). A cartoon of the model is depicted in figure 4.1.
The model assumes that a fraction   of the entire pool of CD4 T cells can
change their status over time: these cells can acquire or lose Foxp3 expression
and undergo modification of their epigenetic marks. Any transition from one state
to another one happens stochastically, according to a characteristic constant rate
which is the expected value from a exponential distribution. We indicated these
rates by Greek letters. In particular we assumed that if the locus is not accessi-
ble by the transcription machinery, the gene is silenced and transcription is not
possible. Nevertheless, the locus undergoes stochastic remodeling, switching
from state with j=0 to j=1 and vice-versa, according to rates "01 and "10. In case
the locus is at least partially accessible (j=1), gene transcription is possible, as
well as its repression. Transition from Foxp3- to Foxp3+ includes transcription of
the gene and translation and occurs according to the rate ⌧+. Vice-versa, the
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Figure 4.1: A stochastic model for gene expression at the Foxp3 locus in a
CD4 T cells, accounting for epigenetic remodeling and transcription. Car-
toon of the stochastic model. Circles represent the mutually exclusive states
in which any CD4 T cell can be found. Arrows, where present, represent the
stochastic transitions between states, happening according to constant rates in-
dicated by Greek letters: "01, "10, "12, "12 are the epigenetic remodeling rates,
while ⌧+ and ⌧  are, respectively, transcription activation and repression rates.
Dashed lines separate three compartments, among which state transitions are
precluded. In parenthesis, the fraction of CD4 T cells belonging to each com-
partment.
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opposite transition, which occurs according to the rate ⌧ , includes repression
of the transcription and degradation of transcripts and proteins. Moreover, we
assumed that in case of ongoing transcription, the locus can undergo further
chromatin remodeling (according to the constant rate "12), becoming fully acti-
vated. For Foxp3+ cells whose chromatin at Foxp3 locus is fully activated (cells
in state Z22), the model assumes that repression of the gene is prevented. Then,
for the gene to be shut down, it is necessary first a transition to epigenetic state
characterized by j=1 (state Z21 of cell), which occurs with rate "21.
Finally, the model accounts for the existence of cells that do not change their
state over time. We called these cells committed and we considered two types
of them. We assumed that a portion ↵ of CD4 T cells are committed to Foxp3
expression, with a fully activated chromatin: their state was named Z32. The
remaining 1   ↵     fraction of CD4 T cells are committed to be Foxp3-, with a
locus that is fully incompetent for transcription. Their state was namedZ00.
We assumed that the rates ⌧+, ⌧  depend on the context in which the cell
is embedded. Indeed we expect the rates of Foxp3 transcription activation
and repression to depend on the immune cell populations composition in the
host and on the subsequent inputs the cell receives from the environment (in
terms of IL-2 and TGF-  availability, mainly). Instead, we assumed that the
rates "01, "10, "12, "21 of epigenetic remodeling, are context independent. In other
words, the value of the epigenetic remodeling rates is conserved across envi-
ronments, whether constituted by lymphodeficient or lymphoreplete mice, and
encompassing all the the lymphodeficient hosts in which the immune system
CD4 populations have been partially reconstituted by adoptive transfers.
The fractions ↵ and   are model parameters that we assumed to be context-
independent and that need to be quantified. However, we had previously esti-
mated ↵ to range from 0 to 4.2% of the total CD4 T cells compartment, and   to
range from 7.6% to 15.4% (see chapter 3).
Transient behavior and equilibrium.
The model is able to reproduce the frequency of cells m(t) that maintain Foxp3
expression over time, within a cohort of Foxp3+ CD4 T cells that belong to a
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f1 represents the frequency at equilibrium of Foxp3+ cells, in lymphore-
plete condition, within the uncommitted CD4 T cells, meaning within the CD4 T
cells that are assumed to up-regulate or down-regulate Foxp3 depending on the
context. Also, f(t) is the frequency of Foxp3 positive cells within the uncommit-
ted CD4 T cells at time t. The expression for f(t) is a linear combination of three
exponential functions plus a constant:










where the functions x
j
(j = 0, ..., 3) depend on the model rates and on the initial
distributions of the uncommitted cells within the states Z10, Z11, Z21, Z22; while
the decay rates r
j
(j = 1, ..., 3) are the three roots of a polynomial q(x) of degree
three, whose expression depends on the rates only. Both the expressions for
f(t), which is the solution of a continuous time Markov chain model, and the
one for q(x) are fully derived in Method section. Equation 4.1 can be used to
quantify the frequency of cells that maintain Foxp3 expression over time, in any
cohort of Foxp3+ cells, either followed in lymphoreplete condition or sorted from
lymphoreplete conditions and then adoptively transferred in another host.
The model predicts also that, once the rates are fixed, and irrespective of the
initial distributions across the four uncommitted states, waiting long enough, the
system shall reach a stable equilibrium, resulting in a fixed frequency of Foxp3+
cells within the uncommitted T cells, defined as following:
f1 =
"01("21 + "12)⇢
"01("21 + "12⇢) + "10"21(1  ⇢)
, (4.3)
where ⇢ is the ratio between Foxp3 transcriptional activation and repression,
characteristic of the environment in which the cells are followed, and defined
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The expression in 4.3, which represents the frequency of cells in either state
Z21 or Z22 within the uncommitted CD4 T cells, can be also used to quantify the
portion at equilibrium of uncommitted Foxp3+ cells that have a fully active state




Under the assumption that epigenetic remodeling rates of the Foxp3 locus do
not change across hosts, the fraction in equation 4.5 refers to the uncommitted
Tregs with fully open chromatin found in any mouse in physiologic condition (that
we assume being at equilibrium).
4.2.2 There is a family of solutions, that combine context-
independent epigenetic remodeling with context-dependent
transcription, able to explain Foxp3 in vivo dynamics.
We fitted the model to experimental data, available from the literature, describing
the temporal evolution of Foxp3+ cell frequency in cohort of cells that were Foxp3+
in physiologic condition, at a given time. In all these experiments, the cohorts of
cells were followed in vivo either in physiologic condition [Rubtsov et al., 2010]
or in lymphodeficient host (Rag2-/- or TCR- -/-) after being adoptively trans-
ferred, either alone or together with CD4+Foxp3- population in different propor-
tions [Duarte et al., 2009, Komatsu et al., 2009]. Depending on the experimental
context, the frequency measured of Foxp3+ within the followed cohort over time,
changes: in lymphoreplete condition, Foxp3 expression is kept in all the followed
cells during four months, while on the contrary in lymphodeficient condition, 40%
of cells lose Foxp3 expression within four weeks . All the experimental data and
the model fittings are shown in figure 4.9 of supplemental material section.
We used the model to check whether Foxp3 dynamics in vivo could be ex-
plained as the result of the combination of a slow context-independent epige-
netic remodeling of the Foxp3 locus, together with a much faster and context-
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Figure 4.2: Slow epigenetic rates and fast transcriptional rates. Values of the
rates that are compatible with the experimental data of Foxp3 dynamics in vivo.
Each column represents one parameter set (any of the set fits equally well all the
10 experiments considered in our analysis). Rates of transcription/translation
activation and repression are represented, respectively, by green and grey dots.
Black dots correspond to the fastest transcription rates (both activation and re-
pression). Epigenetic remodeling rates for Foxp3+ cells are represented by green
open circles (dark green for "12, light green for "21). Epigenetic remodeling rates
for Foxp3- cells are represented by gray open circles. Horizontal dashed grey
lines highlight the value of rate corresponding to, respectively, from bottom to
top, one event per year, one event per month, one event per day, twelve events
per day. Parameter sets are sorted according to decreasing value of the epige-
netic remodeling rate "12.
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dependent transcription and translation dynamics. To do that, while performing
the fitting, we imposed all the epigenetic rates to be constant across experiments,
while transcription/translation rates could change their value across experiments,
if needed. Also, the frequency of committed Tregs and the one of uncommitted
CD4 T cells (respectively ↵ and  ) were fixed as context-independent.
In each fitting, we also imposed the fastest epigenetic rate to be much slower
than both the fastest transcription activation and repression rates. This constraint
on the one hand, forces transcription activation and repression to be faster than
epigenetic remodeling. On the other hand it allowed the search for parameters
to include the possibility that, in some hosts, the context fully prevents either the
gene transcription (in which case ⌧+ ⌧ 1) or, on the contrary, the shut down of
the transcription (in which case ⌧  ⌧ 1).
Under these assumptions, we looked for optimum values for the rates, able to
quantitatively reproduce the data. We found an entire family of possible solutions
(figure 4.2) that can explain equally well all the experimental data.
The highest values for transcription rates (either activation of repression) were
found in the two extreme contexts, namely in lymphoreplete condition and in the
case of Tregs transferred alone in lymphodeficient host. In fact, respectively, the
median value of activation rates ⌧1+ in lymphoreplete condition was 26.6 day 1,
and the median value of repression rate in lymphodeficient condition, ⌧7 , was
equal to 29.86 day 1 (see transcription rates in figure 4.3).
Conversely, the rate ⌧7+ of activation of Foxp3 transcription in lymphodeficient
host was found with much slower median value of 0.25 day 1 (and a minimum
value close to zero). Also, the rate ⌧1  of Foxp3 transcription repression in lym-
phoreplete condition, was found much slower if compared with the correspondent
rate of activation ⌧1+, yet the median value was 8.43 day 1, with minimum values
found close to zero (see figure 4.3).1 We found slow and context-independent
epigenetic remodeling rates able to reproduce all the experimental data. We ob-
serve that the distributions of the remodeling rates for Foxp3- CD4 T cells ("01
and "10) were much spread, if compared with the ones of Foxp3+ CD4 T cells
(see figure 4.2 and epigenetic rates in figure 4.3). This result held particularly
for the rate "21, which distribution was found to be very narrow around the value
0.03 day 1. Finally although being both slow, the values for the rate "12 were
consistently found higher (with median value of 2.44 day 1) that the ones for the
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Figure 4.3: Cumulative distribution functions of fast transcription and slow
epigenetic rates. Cumulative distribution functions (CDF) of the transition rates
found by fitting the data to the ensemble of experimental data on Foxp3 dynamics
in vivo, in ten different experimental settings. (Top) Slow epigenetic remodeling
rates, assumed to be constant across all the experiments (context-independent
rates). (Bottom) Fast transcription/translation activation and repression rates in
two different and extreme contexts: lymphoreplete host and lymphodeficient host
(Tregs adoptively transferred alone into lymphodeficient host mice).
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rate "21.
To summarize, we found a family of solutions that, combining a slow and
context-independent epigenetic remodeling of the Foxp3 locus together with
much faster context-dependent transcription and translation dynamics, are able
to reproduce coherently all the experimental data here gathered on Foxp3 dy-
namic in vivo in mice, in different experimental contexts.
4.2.3 Slow context-independent epigenetic explains the dynamics
of loss of Foxp3, while being compatible with Foxp3 stability
in physiologic condition.
In all the sets of model parameters compatible with experimental data, we found
the value of the fraction in equation 4.5, equal to 99%. This result means that the
vast majority of uncommitted cells whithin a cohort of Foxp3+ T cells sorted from
physiologic condition is characterised by fully active state of the chromatin.
Also previous results, found in the simpler version of the stochastic model
analyzed in chapter 3, regarding the fraction of CD4 T cells committed to Foxp3
expression (↵) and the fraction of cells to which Foxp3 expression is precluded
(1  ↵    ), still held in the results of the current model fittings. In particular, the
possible values, compatible with the data, for the fraction ↵ of Foxp3 committed
cells within the CD4 T cells compartment ranged between 0.0% and 4.2%, which
correspond to a maximum of 28% of Foxp3 committed cells within Tregs (see
figure 4.4). Also, the frequency   of CD4 T cells, that can acquire or lose Foxp3
expression in a context-dependent way, was found to range between 7.9% and
15.4% (see figure 4.5).
It can readily be imagined that each combination of ↵ and   of a particular
parameter set, results in a specific portion of Foxp3 committed cells, within the
total Foxp3 expressing cells. We looked at the kinetics of the sub-population of
Foxp3+ cells across the three states defined by the model (namely Z32, Z22, Z21),
in the model solutions that reproduce experimental data, in lymphoreplete and
lymphodeficient condition. No matter the portion of committed cells within Tregs
(cells in state Z32) and the one of uncommitted with fully active state of chro-
matin (cells in state Z22), we always observed the same temporal behavior, as
shown in figure 4.6. Particularly, in lymphodeficient conditions, when indeed a
dynamics of Foxp3 loss is experimentally observed, we found that this very tem-
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Figure 4.4: Frequency of committed Tregs. Left: Cumulative distribution
functions (CDF) of the frequency ↵ of committed Tregs within the CD4 T cells
compartment. Rigth: CDF of the frequency of committed Tregs within the
CD4+Foxp3+ T cells.












Figure 4.5: Frequency of context-dependent CD4 T cells. Cumulative distribu-
tion functions (CDF) of the frequency   of context-dependent CD4 T cells within
CD4 T cells pool.
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poral dynamics is entirely explained by the population of uncommitted cells with
fully active Foxp3 locus. These cells, over time and according to the slow rate
"21, lose the epigenetic signature that confers them the active state of chromatin,
and then, quickly and because of the context, lose Foxp3 expression. Indeed,
the state Z22 characterized by intermediate state of the chromatin, always con-
stitutes a transitory state: accordingly, the corresponding sub-population never
accumulates.
As a matter of fact, it is interesting to note that the value of the rate "21, which
was found to be narrowly distributed around the value 0.03 day 1 (figure 4.3) and
which describes the transition from active to intermediate state of the chromatin,
is the characteristic rate of decay of a single exponential function that best fits the
experimental data in lymphodeficient condition (see in figure 4.6). In this regard,
it is worth noting that the mentioned experiment is the only one that, among the
ones included in our analysis, provides information on kinetics. By fitting the
data with linear combinations of exponential functions, we found that those data
cannot be distinguished from a single exponential decay of the form:
y(t) = a+ (1  a)e rt, (4.6)
with rate of decay r = 0.03, as we tested through the Aikake information criteria
[Akaike et al., 1973, Bozdogan, 1987].
In summary, we found that the dynamics of Foxp3 expression loss, when
observed, can be fully explained by a slow epigenetic remodeling of the chro-
matin at the Foxp3 locus that occurs in uncommitted Foxp3+ cells in a context-
independent way. This phenomenon, also occurs in contexts in which Foxp3
expression is stable, and it is compatible with Foxp3 expression stability. In this
case, the system is at equilibrium, and the context-dependent frequent activation
of transcription counterbalances the context-independent epigenetic remodeling.
4.2.4 Foxp3 mean residence time relates to frequency of committed
Tregs
As we shown, the experimental data used in our analysis, support an infinite fam-
ilies of solutions, in which the frequency of committed Tregs can range from 0 to
28% of the total peripheral Tregs. Unfortunately (see figure 4.6), given the exper-
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Figure 4.6: Dynamics of loss of Foxp3 expression observed in lymphod-
eficiend host is well explained by context-independent epigenetic remod-
elling of Foxp3 locus over time. Frequency of Foxp3+ T cells within cohort
of CD4 T cells that were 100% Foxp3+ at time zero and where then followed
in vivo, in two extreme experimental conditions, namely in lymphoreplete mice
and in lymphodeficient mice, upon adoptive transfer. Experimental data (dots),
model predictions (lines). Model predictions are shown for the frequency of total
Foxp3+ cells (black), committed Foxp3+ cells (cells in state Z32), uncommitted
Foxp3+ cells with fully active chromatin in Foxp3 locus (cells in Z22), uncommit-
ted Foxp3+ cells with intermediate state of chromatin at the Foxp3 locus (cells
in state Z21). Two extreme conditions in parameter space are shown. A: pa-
rameter set corresponding to 0.0% of committed cells within Tregs (↵ = 0.0%):









⌧  = 36.60. Also   = 15.36% and %98.4 of context-dependent Tregs are
with fully activated state of chromatin.; B: parameter set corresponding to 28% of





⌧  = 2.12 ⇤ 10 5, 7⌧+ = 1.79 ⇤ 10 12, 7⌧  = 29.86. Also
  = 10.8% and 98.8% of context-dependent Tregs are with fully activated state of
chromatin.
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iments in our possess, there is no way to distinguish among these possibilities,
which one is indeed occuring. In an attempt to overcome this issue, and in par-
ticular with the aim of finding predictions for an observable, whose value would
strongly vary, depending on the frequency of committed Tregs, allowing us to
distinguish between different scenarios, we computed the Foxp3 mean resident
time, ⌧
foxp3.
The Foxp3 mean resident time is defined as the time that any uncommitted
Treg (no matter whether in state Z21 or Z22) would spend in the cluster of states
{Z21,Z22}, before losing Foxp3 expression (see figure 4.7).
This time is computed as the expected value of the density probability distri-
bution f(t), describing the probability that the cell will leave the cluster at time t,








The derivation of the formula is described in detail in supplemental methods sec-
tion 4.4.3.
In absence of committed Tregs (same parameter regime showed in figure 4.6
A) the model predicts that the average time ⌧
foxp3 that any Tregs would express
Foxp3, before losing it, is 42 days in lymphodeficient host, and 45 days in physi-
ologic condition (see the dot labelled with b in figure 4.8 A). Then, for increasing
values of frequency of committed Tregs, we found that, in lymphodeficient condi-
tion, Foxp3 mean residence time decreases (figure 4.8 A, in yellow). Neverthe-
less, in lymphoreplete condition, the relations was not as clear as compared to
lymphopenia, due to an increasing spread in the values found for ⌧
foxp3 (figure
4.8 A, in blue), as committed Tregs frequency increases. In fact, as it can be ap-
preciated in figure 4.8 A, for the extreme case of 28% of committed Tregs within
Foxp3+ cells, we found the maximum and the minimum value of ⌧
foxp3 among all
the values (respectively dots c and d in 4.8 A). For the parameter regime showed
in figure 4.6 B, the mean residence Foxp3 was found to be infinite, while we
found another parameter regime whose corresponding mean residence Foxp3
time was 32.8 days. Nevertheless, in both cases the Foxp3 mean residence time
in lymphopenic condition, was 30 days. Results are summarized in table 4.1.
We have just said that, for some values of frequency of committed Tregs,
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Figure 4.7: Foxp3 mean residence time. Cluster of states of uncommitted
Tregs, and possible transitions. The Foxp3 mean resident time is defined as the
time that any uncommitted Treg (no matter whether in state Z21 or Z22) would
spend in the cluster of states {Z21,Z22}, before losing Foxp3 expression.
no committed Tregs
committed Tregs
(28% of Foxp3+ cells)
(I) (II)
Lymphoreplete 45.5 32.8 forever
Lymphodeficient 42.4 30.4 30.2
Table 4.1: Foxp3 mean residence time. Foxp3 mean residence time, in days, of
the uncommitted Tregs, in physiologic condition and in lymphopenia, in case of no
committed Tregs and for two different parameter regimes (I and II), corresponding
to maximum amount of committed Tregs: 28% of Foxp3+ CD4 T cells. Regime II
corresponds to the solution represented in figure figure 4.6 B.
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(7) Tregs into Rag2-/-
freq. commit ed re
Figure 4.8: Foxp3 mean residence time versus frequency of committed
Tregs. A: Foxp3 mean residence time of the uncommitted Tregs (⌧
foxp3) plot-
ted against the frequency of committed Tregs within Foxp3+ cells (↵/(↵+ 
 
f1)),
in lymphoreplete conditions (blue) and lymphodeficient condition (yellow). Note
the change in scales in the y axis. Letter b in the plot indicates the case of no
committed Tregs, letters c and d indicate, respectively, the maximum and the min-
imum value found for ⌧
foxp3 in lymphoreplete condition. They both correspond to
the maximum predicted frequency of committed Tregs (28%), as highlighted by
the vertical grey dashed line. B, C, D: in dark blue is plotted the frequency of
Foxp3+ cells, within a cohort of followed Foxp3+ CD4 T cells, over time, in lym-
phoreplete condition. Dots are the experimental data from [Rubtsov et al., 2010],
solid lines are the model predictions, dashed lines are the predicted value of
equilibrium. In light blue is plotted the frequency over time of cells that, within the
same cohort, are Foxp3+ and have never lost Foxp3 expression, not even tran-
siently. Solid lines are the model predictions, dashed lines the predicted value of
equilibrium, which is the corresponding frequency of committed Tregs. Dashed
black line represents the straight line y(t) = 1   ⌧ 1
foxp3 t. Plot B corresponds to
parameter set b in A, C correspond to c and D corresponds to c.
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there are several and spread values of ⌧
foxp3 compatible with the experimental
data in lymphoreplete condition, as can be appreciated by the spread of the blue
dots in Figure 4.8 A. Nevertheless, any of this blue dot is associated to a unique
function, whose analytical expression is known.
In fact, for any predicted couple of values for the frequency of Foxp3 commit-
ted Tregs (↵/(↵+ 
 
f1)) and Foxp3 mean resident time (⌧foxp3) of the lymphore-
plete condition, there is a unique function that describes the time evolution of the
frequency of cells that, within the cohort of Foxp3+ T cells followed in lymphore-
plete condition, are Foxp3+ and have never lost Foxp3 expression. Its analytical











This function, plotted in light blue in figure 4.8 B,C,D, has the tangent in t = 0
whose derivative is ⌧ 1
foxp3 and a plateau whose value is the frequency of pre-




In this chapter we proposed an interpretation in terms of cellular mechanism, that
quantitatively explains the dynamics observed in vivo in cohorts of Foxp3+ and
Foxp3- cells, in different experimental conditions. We proposed that both stability
and lability of Foxp3 expression could be the result of a fast (in terms of hours)
end context-dependent transcription translation dynamics combined with a slow
(in terms of weeks) and, in principle, context-independent epigenetic dynamics
that happen in any peripheral CD4 T cell. We assumed, in particular, that epige-
netic dynamics depends on the transcriptional state of the cells and not explicitly
on the input the cell receive from the environment.
We used a stochastic model for Foxp3 expression in CD4 T cells, in which
both transcription activation and repression and epigenetic remodelling are
stochastic process. In our model the model parameters that control the dynamics
of either transcription or epigenetic remodeling of the chromatin, can be tuned in
a context-dependent or -independent way. We used the model to fit the model to
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experimental data.
We found that the different dynamics can be all coherently and quantitatively
reproduced, by tuning the ratio between fast Foxp3 transcriptional activation and
repression rates across the experiments, while epigenetic rates were kept slow
and constant across the experiments.
Also, model predicts that in physiologic condition, where Tregs are stable,
the vast majority of Tregs has an active state of chromatin in the Foxp3 locus.
This characteristic ensures on the one hand, the stability of Foxp3 expression in
lymphoreplete condition, where the context provides stimuli that enhance Foxp3
gene transcription, prevent its repression; on the other hand it explains the slow
dynamics of Foxp3 expression loss, observed in those lymphopenic condition
where Foxp3 transcription is prevented. Indeed the dynamics of Foxp3 loss,
observed in lymphopenia, coincides with the epigenetic remodeling dynamics in
Foxp3+ T cell predicted by our model.
4.3.1 Epigenetics as a slow stochastic process
We assumed that the epigenetic state of the Foxp3 locus and its re-
modelling over time could be modelled as a step-wise process with
stochastic transitions. Before us, others have used this approach
[Christogianni et al., 2017, Calado et al., 2006, Josefowicz et al., 2012,
Berry et al., 2017, Bintu et al., 2016].
We also assumed that the transitions between epigenetic states could be
linked with the transcriptional state of the gene. In fact, on the one hand, we
assumed that the epigenetic rates would not depend on the particular context.
Therefore, while fitting the model to the data, we looked for the optimum value
for epigenetic rates that are conserved across all the experimental environment.
Nevertheless, from the other hand, we left the possibility for any epigenetic rate
to assume a different and characteristic value. This would tell us whether or not
chromatin remodelling depends on the transcriptional state of the cells. Indeed,
we found different distributions for the different epigenetic rates. In particular
we found that, when Foxp3 is being transcribed, it is much more likely for the
chromatin to become more active than the opposite transition.
Also we found that remodelling of the locus that makes it less accessible
takes weeks, in case the gene is transcribed, and that this dynamics is the one
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that explains the kinetic observed in lymphodeficient host [Duarte et al., 2009].
4.3.2 Peripheral Foxp3 induction
We have observed that, differently from the distributions of the epigenetic remod-
elling rates in Foxp3+ cells, which were narrowly distributed around the respective
expected value, the rates of epigenetic remodelling in Foxp3- cells were spread
(see figure 4.2). This spread is probably due to characteristic of the data concern-
ing Foxp3- T cell cohort dynamics in vivo, that we included in our analysis. These
data, differently from the ones on Foxp3+ T cell cohort, do not display variety of
behaviors, which indicates much less sensibility to changes of experimental con-
text. Also, none of them show kinetics. In all the cohorts of naive CD4+Foxp3-
T taken in consideration, very small percentage, if not zero, up-regulate Foxp3
in the periphery, no matter whether they are followed in lymphodeficient condi-
tion, which is poor in pro-Foxp3 stimuli, or in conditions that provide plenty of
pro-Foxp3 stimuli (like natural or ”reconstituted” lymphoreplete conditions).
It is known that within CD4SP Foxp3- thymocytes that have been adoptively
transferred into TCR -/- mice, 5 to 10 % up-regulate Foxp3 in the periphery within
4 weeks [Paiva et al., 2013]. Furthermore, within peripheral CD4+Foxp3- T cells
enriched for Qa-2lo recent thymic emigrants, Foxp3 conversion is observed in
around 5% of cells within 4 weeks upon adoptive transferred into TCR -/- mice
[Paiva et al., 2013]. We chose not to include these experiments in our analysis,
because we consider thymocytes and recent thymic emigrants as different from
mature naive T cells in circulation, mainly due to their developmental stage. All
the cohorts of cells included in our meta-analysis are in fact constituted by total
peripheral naive CD4 T cells, which are mostly mature cells. Nevertheless, Qa-
2lo recent thymic emigrants constitute around 5% of the CD4+ Foxp3- peripheral
T cells [Paiva et al., 2013]. Also, within their complementary population of CD4+
Foxp3- Qa-2hi no up-regulation of Foxp3 expression is observed within 4 weeks
upon adoptive transferred into TCR -/- mice [Paiva et al., 2013]. Therefore the
observation on the recent thymic emigrant as preferential precursors of Tregs
differentiated in the periphery, performed in lymphodeficient host, is quantitatively
compatible with the observations on total peripheral cells included in our analysis,
where less than 2% of total peripheral CD4+ Foxp3- up-regulate Foxp3, upon
adoptive transfer into lymphodeficient host [Komatsu et al., 2009].
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Acquisition in Foxp3 expression in the periphery by naive CD4+Foxp3- has
been observed in experiments conduced in DEREG mice. The DEREG mice
(DEpletion of REGulatory T cells), are bacterial artificial chromosome (BAC)
transgenic mice, whose Foxp3 expressing cells also express the diphtheria toxin
(DT) receptors on their surface, allowing for specific depletion of Tregs, upon
DT treatment [Lahl and Sparwasser, 2011]. In these mice, it is observed a re-
bound of Tregs within 6 days: following DT treatment, there is a transient deple-
tion of Tregs, after which the frequency of Foxp3+ Tregs is restored to the level
of WT mice. Nevertheless if, shortly after depleting Tregs, CD4+Foxp3- naive
T cells are adoptively transferred, then 30 to 40% within the transferred cells,
up-regulate Foxp3 [Pratama et al., 2020, Almeida-Santos et al., 2020]. Never-
theless, our current model is not able to reproduce this dynamics. In order to
do this, in fact, together with the context dependency of Foxp3 expression, a
model is needed that accounts for the population dynamics.
The cross regulation model has already predicted that Tregs mainly compete
with Tregs and Teffs mainly compete with Teffs [Carneiro et al., 2007]. Indeed,
when Tregs are transferred into lymphoreplete mice, most of them die. Yet, in
this case, the ones that to not die remain Tregs [Komatsu et al., 2009]. We in-
corporated this experiment in our analysis, which lacks the population dynamics,
and we interpreted the stability observed as the result of the context which pro-
vides enough pro-Foxp3 stimuli. In the same line, when Tregs are simply followed
in lymphoreplete environment, Foxp3 expression is stable [Rubtsov et al., 2010].
We also included this experiment in our analysis. Also in this case population
dynamics can be neglected, because we expect that in physiologic condition the
system is at equilibrium.
When lymphodeficient animals are reconstituted by co-transferring Tregs and
Teffs, in proportions that resemble physiologic conditions, Tregs are stable, as a
consequence of the richness of pro-Foxp3 stimuli characteristic of the context,
yet the up-regulation of Foxp3 in the periphery is almost negligible. The transfer
experiment in DEREG mice, seems to suggest that, beside an environment that
provides inputs for stable maintenance of Foxp3 expression, it is necessary to
”create space for Tregs” to observe Foxp3 up-regulation in naive CD4 T cells. In
fact, when CD4+Foxp3- cells are transferred after Tregs depletion, 30 to 40% up-
regulate Foxp3. While donor Teffs would be outcompeted by endogenous Teffs,
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not only the environment favours Foxp3 up-regulation (the host is replete with en-
dogenous Teff cells) but also the newly converted Tregs do not have endogenous
Tregs to compete with, and can freely proliferate.
We did not include this experiment in this chapter, given that our current
model do not account for cells proliferation. Yet it would be interesting to fur-
ther investigate on this, using a model that integrates population dynamics and
cellular dynamics.
4.3.3 Preferential stability of Foxp3 expression in subpopulation of
peripheral Foxp3+ is compatible with our analysis
When we assembled the data from literature to perform the meta-analysis, we
adopted a criteria of homogeneity among the cell cohorts in which Foxp3 ex-
pression is tracked over time. The aim was to ensure a fair comparison among
experimental data in different contexts. For this reason, in all the experiment cho-
sen, the cohorts are constituted by total peripheral CD4 T cells, either Foxp3+ or
Foxp3-, belonging to adult lymphoreplete mice at steady state. Therefore, we
could not include in our analysis experimental data in which the frequency of
Foxp3+ cells was assessed in cell cohorts sorted following different criteria, for
instance sorting subpopulation within the total peripheral Foxp3+ or Foxp3- CD4
T cells.
Yet, the tracking of Foxp3 expression in specific CD4 T cell subpopulations
has shown the existence of subpopulations of Foxp3- CD4 T cells which pref-
erentially up-regulate Foxp3 in the periphery, such as the already mentioned
case of the recent thymic emigrants [Paiva et al., 2013]. Similarly, among pe-
ripheral Foxp3+ T cells, there are subpopulations that exhibit more stable Foxp3
expression, if compared with others. For instance, using genetic fate mapping,
which allows to sort Foxp3+ T cells that have recently initiated Foxp3 transcrip-
tion and to distinguish them from the ones that have expressed Foxp3 for some
time, it has been shown that these two subpopulations are different in terms
of stability of Foxp3 expression [Miyao et al., 2012]. When peripheral newly de-
veloped Foxp3+, sorted as GFP+RFP-/lo from Foxp3GFP-Cre⇥ROSA26RFP mice,
are adoptively transferred into Rag1-/- mice, together with naive Foxp3- CD4
T cells (in proportion of 1:4), half of them lose Foxp3 expression within 5
weeks [Miyao et al., 2012]. Yet, if the same experiment is performed with their
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complementary subpopulation of peripheral resident Foxp3+ cells, sorted as
GFP+RFPhi, 97% of them keep Foxp3 expression.
We used this data to cross-validate our analysis. When total peripheral CD4+
cells are sorted from steady state Foxp3GFP-Cre⇥ROSA26RFP mice, 90% of them
are GFP+RFPhi and 10% of them are GFP+RFP-/lo [Miyao et al., 2012]. So in a
hypothetical experiment in which total peripheral Foxp3+ and Foxp3- CD4 T cells
are co-transferred in lymphodeficient host in proportion of 1:4, we can imagine
the Foxp3+ T cell cohort being constituted by 90% of resident Foxp3+ cells and
the remaining by newly generated Foxp3+ cells. In this case, the frequency of
cells maintaining Foxp3 expression within the total Foxp3+ cohort is expected to
be 93%. This frequency is compatible with the correspondent frequencies found
in analogous co-transfer experiment and with the model predictions. In fact, al-
though the data set used in our analysis does not include co-transfer in proportion
1:4, it includes co-transfer performed with proportions 1:10 and 1:1. We expect,
in accordance with our model prediction, the case 1:4 to be an intermediate case
between the case 1:10 and 1:1 in which the frequency of cells maintaining Foxp3
expression is 97% at 4 weeks with a plateau of 97% and 92% at 4 weeks with a
plateau of 91%, respectively. Finally, the loss of Foxp3 observed along 5 weeks
within the subpopulation of newly generated Foxp3+ is compatible with the pre-
diction of Foxp3 mean residence time.
4.3.4 Foxp3 mean residence time
The Foxp3 mean residence time describes the average time during which any
uncommitted Tregs would maintain Foxp3 expression, before losing it. As the
definition suggests and the formula in equation 4.7 confirms, its value is func-
tion of the epigenetic remodelling rates of a Foxp3 transcribing/translating cell
(in our model, rates "12, "21), together with the rate of transcription/ translation
repression (⌧ ).
We expected its value also to vary together with the frequency of committed
Tregs, which in no case can lose Foxp3 expression. In fact, the bigger the frac-
tion of committed Tregs within a cohort of Foxp3+ T cells, the smaller the fraction
of cells than, within the same cohort, can lose Foxp3 expression over time. Con-
sequently, the smaller the fraction of cells able to loose Foxp3 expression, the
faster the dynamics of these cells, at least in lymphodeficient conditions where
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loss of Foxp3 expression is observed over time. When looking at the Foxp3 res-
ident time in lymphopoenia (figure 4.8), we actually found a negative correlation
between ⌧
foxp3 and the frequency of committed Tregs.
In physiologic condition, we found something slightly different. As expected,
the Foxp3 mean residence time in lymphoreplete condition, is always longer than
the one in case Tregs are transferred into lymphodeficient host. Apart from that,
first of all, for any given frequency of committed Tregs, we found more than one
possible value, for ⌧
foxp3, compatible with Foxp3 stability. Moreover, we found
that the spread of these values increases as the frequency of committed Tregs
increases (see figure 4.8). Finally, while we found some parameter regimes char-
acterized by values of ⌧
foxp3 very different between physiology and lymphopenia,
in other parameter regimes, the Foxp3 residence time was very similar in the two
different and extreme contexts.
Let us remember that, because we assumed conserved epigenetic remod-
elling rates across experimental contexts, what determines the different values of
⌧
foxp3 between physiology and lymphopenia, is the rate ⌧  of transcription/ trans-
lation repression. This implies that in those parameter regimes that share similar
Foxp3 residence time in both physiology and lymphopenia, uncommitted Tregs
lose Foxp3 expression over time, even in lymphoreplete hosts. In those cases,
values of ⌧
foxp3 range from 32 to 45 days. The model therefore predicts that,
due the context, the loss is transient. In particular, the reacquisition of Foxp3 ex-
pression by those uncommitted exTregs is so fast that, within a cohort of Foxp3+
T cells followed over time, as in the experiment (1) in lymphoreplete condition
[Rubtsov et al., 2010], at any moment almost all the cells are found Foxp3+.
On the other hand we have also found parameter regimes in which the mean
resident time of Foxp3 is very different between physiologic and lymphopenic
conditions. If this was the case, it would mean that, in lymphoreplete condition
there are no Treg that lose Foxp3 expression, not even transiently. Therefore, in
case we were able to label and quantify in vivo transient Foxp3 expression within
cohort of originally Foxp3+ T cells, we would not find any of them.
4.3.5 Distinguishing between scenarios
Our analysis suggests that data support the possibility of Tregs being a hetero-
geneous population of cells.
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An heterogeneity model has already been proposed, according to which
Foxp3+CD4+ T cells are constituted by committed Tregs and by a minor popula-
tion of plastic cells with the potentiality to convert into Teffs [Komatsu et al., 2009,
Miyao et al., 2012]. According to the heterogeneity model, the distinction be-
tween committed Tregs and the cells that exhibit promiscuous Foxp3 expression,
without being Tregs, resides in the demethylated status of the TSDR which en-
sures the commitment, irrespective of Foxp3 expression.
In a slightly different way, our analysis focuses on Foxp3 expression. When
we talk about heterogeneity within cells, we refer to the property of the cell to
committed to Foxp3 expression. In fact, our model account for cells that are
committed to Foxp3 expression and others in which Foxp3 expression is context-
dependent. While the first subpopulation of cells, committed to Foxp3 expression,
are characterized by fully active Foxp3 locus, the cells that belong to the second
population can be found in different phenotypic state. More specifically, each cell
can switch stochastically among the phenotypic states in response to external
cues, by remodelling the Foxp3 locus and by changing its transcriptional activity.
The confrontation of the model with experimental data, suggests the compati-
bility of the data with Tregs heterogeneity. Nevertheless, in this case, the analysis
suggests that only a minor fraction of Tregs would be committed (up to 28% of
them), while the majority would express Foxp3 either stably or transiently, in a
context-dependent way. Also, the model prediction accounts for the possibility of
Tregs being a homogeneous pool of CD4 T cells in which Foxp3 expression is
stable or labile depending on the context. Between these two extreme scenario,
there are all the intermediate case in which cells committed to Foxp3 expres-
sion represent anything between 0 and 28% of Tregs. All these scenarios are
compatible with data.
As already mentioned, we do not have experimental evidences that could
allow us to distinguish among these scenarios. Nevertheless, the predictions on
Foxp3 residence time can shed some light in this regard. In case we were able
to asses the frequency of cells within Foxp3+ T cell cohort that, at any time, have
stopped expressing Foxp3, even transiently, we could compare its dynamics with
the model prediction (cfr. Figure 4.8B). This would allow to quantify the Foxp3
mean residence time whose value characterizes each different scenario.
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4.4 Methods
4.4.1 Stochastic model for the uncommitted CD4 T cells.
The model for the compartment of uncommitted CD4 T cells, introduced in sec-
tion 4.2.1, is described by a continuous time Markov chain with four states: Z10,
Z11, Z21, Z22. Its solution gives the probability over time for a cell in this compart-
ment to be in any of the four states. Let us define the probability vector:
z(t) = (z10, z11, z21, z22)(t) = (z10(t), z11(t), z21(t), z22(t)), (4.9)
where z
ij
(t), for i 2 {1, 2}, j 2 {0, 1, 2}, is the probability for a cell to be in state Zij
at time t. Note that we used roman capital letters to indicate the states, whereas
the probabilities of being in the respective states are indicated by small italic
letters. The model is described by the following system of ordinary differential
equation:
ż = z ⇤, (4.10)
where ż indicates the time derivative of the vector z(t) and ⇤ is the infinitesimal
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Given the rates of state transitions and the initial probability distributions,
defined as z(0) = (z001, z010, z012, z021), the solution of the Markov chain model is
unique and it is the following:
z(t) = z(0) · e⇤t, (4.12)
where e⇤t is the matrix exponential and · indicates the scalar product.
Finally, the probability of an uncommitted CD4 T cell to be Foxp3 + is defined
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as:
f(t) = z21(t) + z22(t). (4.13)
The complete expression for f(t) can be written as:












, for k = 1, 2, 3 are the three root of the following polynomial of degree
three:
q(x) = "10"21#+ "01"21#  "10"21#⇢+ "01"12#⇢+ ...
("10"21 + "01"21 + "10"12 + "01"12 + "10#+ "01#+ ... (4.15)
"21#  "10#⇢+ "12#⇢)x+ ("10 + "01 + "21 + "12 + #)x2 + x3.
In case the initial conditions are (0, 0, 1 z021, z021) the expression for the constants
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, j = 0, 1, 2, 3, are:
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x1 =
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where:









1"01 + 2r1⌧ "01 + 2r1⌧+"01 + 3r
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1"10 + 2r1⌧ "10 + ...
+3r
2
1"12 + 2r1⌧+"12 + 2r1"01"12 + ⌧+"01"12 + 2r1"10"12 + 3r
2
1"21 + 2r1⌧ "21 + ...









2"01 + 2r2⌧ "01 + 2r2⌧+"01 + 3r
2
2"10 + 2r2⌧ "10 + ...
+3r
2
2"12 + 2r2⌧+"12 + 2r2"01"12 + ⌧+"01"12 + 2r2"10"12 + 3r
2
2"21 + 2r2⌧ "21 + ...









3"01 + 2r3⌧ "01 + 2r3⌧+"01 + 3r
2
3"10 + 2r3⌧ "10 + ...
+3r
2
3"12 + 2r3⌧+"12 + 2r3"01"12 + ⌧+"01"12 + 2r3"10"12 + 3r
2
3"21 + 2r3⌧ "21 + ...
+2r3⌧+"21 + 2r3"01"21 + ⌧ "01"21 + ⌧+"01"21 + 2r3"10"21 + ⌧ "10"21.
4.4.2 Fitting the model to the experimental data.
To fit the model solution defined in section 4.2.1 to the experimental data we min-
imized the score function S which is given by the residuals between the model
prediction and the experimental data set across ten different experimental condi-
tions.
Under the assumption that the epigenetic remodeling rates "01, "10, "12, "12
are context-independent, while the transcription activation and repression rates,





⌧  i = 1, 2, ..., 10, (4.16)
where i refers to the i-th experimental setting. Accordingly, we defined the ratio
i









i = 1, 2, ..., 10. (4.17)
Finally, for convenience, we defined also the following context-independent
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%), i = 1, 2, ..., 10. (4.19)
the model prediction for the frequency over time of Foxp3+ cells within the cell co-













with i ˆf(⌧) being the i-th experimental data set, where T
i
for i = 1, ..., 10, is the
set of the discrete time points ⌧ of the i-th experiment.




= [0, 0.15], (4.21)
and for each fixed value, we minimized the score function S with respect to the
parameters  , "01, "10, "12, "12,#, 1%, 2%, ..., 10%.
The minimization was subjected to the following constraints:
1. 0  ↵+    1;
2. 0  ↵+   f1  0.15;
3. max{i=1,...,10}{✓ i⇢} > 8max {"01, "10, "12, "12};
4. max{i=1,...,10}{✓ (1  i⇢)} > 8max {"01, "10, "12, "12}.
The symbol f1 in constraint 2 represents the frequency of equilibrium in
physiologic condition, of the uncommitted Foxp3+. The constraints, therefore,
translates the well known result that in physiologic condition 10-15% of CD4 T
cells are found to be Foxp3+. Constraints 2 and 3 ensure the transcription We
explored the parameter space choosing random initial values for the parameters
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= [0, 1], i = 1, 2, ..., 10;
We used the ”Principal Axis” algorithm [Brent, 2013] to minimize the score
function S. To avoid local minima, we fixed a threshold for the maximum score
value allowed, which was equal to th = 0.01878.
4.4.3 Foxp3 mean residence time, derivation of the formula
In this section we derive the formula of the Foxp3 mean residence time. Let us
recall that, because according to our model a cell is Foxp3+ provided it is either is
state Z21 or in state Z22, the Foxp3 mean residence time, ⌧foxp3, is the expected




once it gets there. We will here derive a general formula, assuming that the cell
can leave the cluster (therefore becoming Foxp3-) through any of the two states
of the cluster, respectively with rate ⌧ 1 (if it leaves through the state Z21), or ⌧ 2
(in case it leaves through the state Z22). The formula used in the main text can
then be derived by setting ⌧ 1 = ⌧  and ⌧ 2 = 0.





t f+(t) dt (4.24)
where f(t) is the density probability function, of the continuous time random vari-
able X+ = X+(t), describing the probability the cell leaves the cluster F+ at time
t, given that the cell was in the cluster at time t = 0, no matter in which of the two
states.
At any given time t, the cell can leave the cluster through one out of an infi-
nite number of paths. Each path has an associated probability, that decreases
together with the number of transitions involved. We can group those density
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(t) i, j 2 {1, 2} (4.25)
each of which defined as the density probability that the cell leaves the cluster
at time t from the state Z2j, given that at time t = 0 the cell was in state Z2i,
times the probability p
i
that the cell was in the state Z2i at time t = 0. Now, each
f
ij
(t) is the sum of a serie of function, given that there are infinite paths that start
from state Z2i and leave the cluster from state Z2j. Then the density probability







In order to define the f
ij
(t), for i, j 2 {1, 2} let us first define  
i
(for i = 1, 2)
as the sum of the rates that go out from the state Z2i :
 1 = ⌧1  + "12 (4.27)
 2 = ⌧2  + "21. (4.28)
Then we can define the density function f
i
(t) (for i = 1, 2) describing the











Also we define the operator F as following:
F : C[0,1) ! C[0,1)
g 7! F(g) = (f1 ⇤ f2) ⇤ g
(4.30)
where ⇤ is the product of convolution.
The operator F can be applied to the identity function i. In that case we write:
F(i) = F = f1 ⇤ f2. (4.31)
Also, the operator F can be repeatedly applied, in the sense that it can be com-
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posed with itself:
Fn(g) = (F   · · ·   F| {z }
n times
)(g) = F(. . . (F))| {z }
n times
(g) n=0,1,2,. . . (4.32)
where
F0(g) = I(g) = g. (4.33)
This said, we define the four aforementioned density probability functions f
ij
for














































4.4.3.1 Sum of the serie in the Laplace s-Space
To compute the sum of the four series of functions that define f
ij
, we take advan-





is a linear operator;
- L
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(s+  1)(s+  2)  "12"21
;
(4.35)
Where the equality (*) holds because the serie is a geometric one, with ratio
0 < q < 1.





p1( 1⌧1  + "12⌧2 ) + p2( 2⌧2  + ⌧1 "21)
(s+  1)(s+  2)  "12"21
. (4.36)
4.4.3.2 Back to the real t-Space

















⇤t   1)(⌧1  2 + "12⌧2 )(p1 + p2)
(4.37)
where
  = ⌧1  + "12 + ⌧2  + "21;
⇤ =
p
( 1    2)2 + 4"12"21.
(4.38)
Let’s stress the fact that:
Z 1
0
f+(t) dt = p1 + p2 (4.39)
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which, under the hypothesis of starting in the F+ cluster, is equal to 1.
The mean residence time of the Foxp3+ cluster, computed using the (4.24) is
therefore the following:
⌧+ =
p1⌧2  + p2⌧1  + ("12 + "21)
⌧1 ⌧2  + ⌧1 "21 + ⌧2 "12
. (4.40)
Finally, to get the formula 4.7 used in the main text for the Foxp3 mean resi-
dence time, we substitute ⌧ 1 = ⌧ , ⌧ 2 = 0 and p2 = "12/("12 + "21) in equation
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4.5 Supplemental material







































































































Figure 4.9: Model predictions reproducing the experimental data on Foxp3
in vivo dynamics. Frequency of Foxp3+ cells within cohort of cells followed in
vivo over time, in different experimental conditions. Dots represent experimental
data (experiments have been described in details, in materials and methods sec-
tion of the previous chapter), lines are the model predictions from one represen-
tative parameter set out of the equally good found sets. Solid lines are the tempo-
ral solutions of the stochastic model, dashed lines represent the predicted value
of equilibrium. In blue, the experimental data in which maintenance of Foxp3
expression over time, is assessed, in yellow, the experimental data in which ac-
quisition of Foxp3 expression assessed over time. In each experiment is reported
the value of the ratio i⇢ obtained through the fitting. Other parameter values are:
↵ = 0.02,  = 0.13,# = 28.56, "01 = 0.28, "10 = 1.28, "12 = 2.83, "21 = 0.03.
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4.5.2 Distribution of rates without constraints

















































































































































































































Figure 4.10: Convergence of optimization algorithm (I). Cumulative distribu-
tion function (CDF) of the model parameters ↵, ,#, "01, "10, "12, "21 optimized to
fit the experimental data under constraints 1 and 2 (see materials and method
section 4.4.2). In blue the distribution of the initial values provided as initial val-
ues to the algorithm, in order to minimize sum of residuals between experimental
data and model solution. In yellow the distribution of the optimum values.
155
4. EPIGENETIC CONTROL OF FOXP3 CELLULAR EXPRESSION

















































































































































































































Figure 4.11: Convergence of optimization algorithm (II). Cumulative distribu-
tion function (CDF) of the model parameters i⇢, i = 1, ..., 10 optimized to fit the
experimental data under constraints 1 and 2 (see materials and method section
4.4.2). In blue the distribution of the initial values provided as initial values to the
algorithm, in order to minimize sum of residuals between experimental data and
model solution. In yellow the distribution of the optimum values.
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4.5.3 Foxp3 mean residence time versus frequency of committed
Tregs.




























































(7) Tregs into Rag2-/-
(2) Co-transfer (1:10) into Rag2-/-
(4) Co-transfer (1:1) into Rag2-/-
freq. com itted reg
Figure 4.12: Foxp3 mean residence time versus frequency of committed
Tregs in different experimental conditions. Foxp3 mean residence time of
the uncommitted Tregs (⌧
foxp3) plotted against the frequency of committed Tregs
within Foxp3+ cells (↵/(↵ +  
 
f1)), in four experimental conditions: lymphore-
plete conditions, experiment 1 from [Rubtsov et al., 2010] (blue); co-transfer of
Tregs and CD4+Foxp3- T cells in proportion (1:10) into Rag2-/-, experiment
2 from [Komatsu et al., 2009] (red); co-transfer of Tregs and CD4+Foxp3- T
cells in proportion (1:1) into Rag2-/-, experiment 4 from [Komatsu et al., 2009,
Duarte et al., 2009] (violet); transfer of Tregs into Rag2-/-, experiment 7 from
[Duarte et al., 2009] (yellow). Note the change in scales in the y axis.
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Immunological tolerance is a robust process that relies on the development and
maintenance of population of functional Tregs, able to prevent the clonal expan-
sion of auto-reactive Teffs that circulate in the periphery. Maintenance of a func-
tional population of Tregs, in balance with the population of Teffs they control,
requires sustained Foxp3 expression at the cellular level and the stable coexis-
tence of Teff and Treg populations with shared specificities.
This thesis aimed at theoretically investigating the sub-cellular and super-
cellular mechanisms that preside over tolerance and its robustness.
We started with the very fundamental and general question of whether it is
possible to maintain Treg and Teff populations in dynamic balance under the
assumption of Foxp3 lability. To do that, in chapter 2, we built upon the cross
regulation model for APCs-mediated CD4 T cells interactions [León et al., 2000,
Carneiro et al., 2007], introducing context-dependent Foxp3 loss. We considered
the worst case scenario of no peripheral Foxp3 up-regulation that could counter-
balance Foxp3 loss. In this extended model, tolerance is maintained provided
that Foxp3 loss is slower than a critical value. Furthermore, the introduction of
Foxp3 lability determines a qualitative change in the so called tolerance equi-
librium, particularly in the trajectories of the system when subjected to a per-
turbation. As a result, robustness of tolerance increases. It was shown that
robust tolerance can be guaranteed by the non-linear and density-dependent
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population dynamics of a Foxp3 committed Tregs population, together with cog-
nate Teffs and APCs populations [Carneiro et al., 2007]. Our result implies that
a population of uncommitted Tregs, in which Foxp3 expression is determined by
the context, could better cope with perturbations.
The requirement for a critical slow Foxp3 loss was a non trivial theoretical
result that raised the question of estimating the characteristic time of Foxp3 loss
in vivo. To this end, in chapters 3 and 4 we moved to the cellular level. We
focused on Foxp3 expression dynamics in CD4 T cells, by the implementation
and analysis of stochastic models of gene expression. These models allowed
us to investigate, first, the characteristic time scale of Foxp3 loss in vivo and,
secondly, the commitment and plasticity of Tregs.
Specifically, in chapter 3 we investigated whether postulating commitment to
Foxp3 expression is necessary for the observed Foxp3 stability and what can
control stability and lability of Foxp3 expression. We investigated also whether
we could make quantitative predictions on heterogeneity of Tregs, regarding their
ability to maintain stable Foxp3 expression. We fitted the stochastic model of
Foxp3 expression to the experimental data on Foxp3 stability in vivo in different
experimental contexts. Our analysis showed that experimental data are com-
patible with Tregs being a homogeneous pool of CD4 T cells in which Foxp3
expression is stable or labile depending on the context. We found positive corre-
lation between stability of Foxp3 expression and number and frequency of Teffs
in the host. We quantified the average time needed for the loss of Foxp3 expres-
sion in peripheral Tregs in absence of pro-Foxp3 stimuli as four weeks. Data also
suggest that the majority of CD4 T cells cannot be induced in vivo to express
Foxp3 regardless of the context.
In chapter 4 we asked whether the Foxp3 loss rate, estimated in chapter 3,
can be the consequence of slow epigenetic dynamics. Fitting of an extended
model, combining fast transcriptional activation with slow epigenetic dynamics,
suggested that this could be the case.
In each chapter, we have discussed the respective results. Here, we would
like to make some considerations of a more general character, integrating cross-
cutting aspects of our results. Also, we try to propose some experimental ap-
proaches that could be useful to validate our predictions.
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5.2 Three subpopulations of CD4 T cell
Navigating through the Treg literature can be challenging. As more exper-
imental evidences have been collected regarding Foxp3 expression in CD4
T cells, more definitions for Tregs have been introduced [Abbas et al., 2013,
Shevach and Thornton, 2014, Koizumi and Ishikawa, 2019]. These definitions
reflect the idea that many subpopulations of Foxp3+ Tregs with distinct identi-
ties exist. Accordingly, several interpretations and models for these populations
have been proposed.
Some Foxp3+ cell subpopulations were defined according to the location
of their differentiation: tTreg differentiate in the thymus [Fontenot et al., 2005a,
Hsieh et al., 2012, Klein et al., 2019], pTreg in the periphery [Chen et al., 2003],
iTreg are generated in vitro [Curotto de Lafaille and Lafaille, 2009]. Helios and
Neuropilin-1 (Nrp1) have been used to distinguish between tTreg (Helios+
Nrp1+) and pTreg (Helios- Nrp1-) [Thornton et al., 2010, Yadav et al., 2012,
Weiss et al., 2012]. However the ambiguity between tTregs and pTregs arises
since high versus low expression of Nrp1 and Helios have been shown not to un-
equivocally identify tTreg and pTregs [Szurek et al., 2015]. Furthermore, by using
the Foxp3-Tocky (Timer of cell kinetics and activity) reporter mice, it has been
shown that both Nrp1 and Helios are dynamically regulated in vivo, according to
Foxp3 transcription dynamics [Bending et al., 2018b]. These observations have
led to question the significance of these two markers [Bending and Ono, 2019].
Other Foxp3+CD4+ T cell subpopulations were defined depending on the ac-
tivation status of the cells. In particular, tTregs have been divided into two dis-
tinct subpopulations. Naive tTregs are defined as central Treg (cTreg) cells, also
called resting Tregs; while tTregs that have been activated upon TCR stimula-
tion are called effector Treg (eTreg) cells, or activated Tregs or effector memory
Tregs [Levine et al., 2014, Liston and Gray, 2014, Li and Rudensky, 2016]. Mark-
ers for cTregs are generally CD62LhiCD44lo while eTregs are characterised as
CD62LloCD44hi.
Many other definitions reflect rather the interpretations of the dynamics
of Foxp3 expression in these cells. Often some of these definitions for
CD4 T cells different populations are not associated with distinctive markers.
The debate has been wide [Bailey-Bucktrout and Bluestone, 2011, Hori, 2011a,
Sakaguchi et al., 2013, Hori, 2014, Qiu et al., 2020]. Some authors mention
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Treg lineage stability when Tregs differentiation appears to be stable, regard-
less of the different perturbations in the extracellular environment they are sub-
jected to [Hori, 2011b, Josefowicz et al., 2012]. Phenotypic plasticity of Tregs,
on the other hand, refers to Tregs ability to change their gene expression in
response to external inputs [Josefowicz et al., 2012, Campbell and Koch, 2011,
Burzyn et al., 2013]. Finally, the context-dependent change in gene expres-
sion and the ability of Tregs to acquire gene signatures and functions char-
acteristics of various Teff cell types has also been interpreted as reprogram-
ming. According to this interpretation, these cells are susceptible to lin-
eage or developmental plasticity being referred to as reprogrammed exTregs
[Zhou et al., 2009, Mellor and Munn, 2011, Liston and Piccirillo, 2013]. However,
the cellular markers of reprogramming are unclear. Observing loss of Foxp3 ex-
pression is not a sufficient indication for reprogramming to functional Teffs be-
cause these exTregs may re-express Foxp3 stably and display suppressive func-
tion [Miyao et al., 2012]. Also, the expression of pro-inflammatory cytokines by T
cells does not allow to conclude that one is in the presence of functional Teffs.
For instance, in the contest of bone marrow adoptive transfer, donor Foxp3+
T cells protect the host from graft-versus-host disease [Hoffmann et al., 2002].
However, in this highly inflammatory model, more than 50% of donor Foxp3+
T cells produce INF-  while displaying fully demethylated TSDR and stably ex-
pressing Foxp3. Also, the protection is INF- -dependent, given that blocking
INF-  with specific mAb abolishes the beneficial effect of donor Foxp3+ T cells
[Koenecke et al., 2012]. Also, Foxp3+ cells isolated from INF-  deficient mice fail
to protect the host from graft-versus-host disease [Sawitzki et al., 2005]. Finally,
Foxp3+ T cells have been reported to acquire Teffs-like features without losing
Foxp3 expression in vivo and in vitro. Foxp3+ cells expressing ROR- t and IL-17
[Zhou et al., 2008] or T-bet and INF-  [Oldenhove et al., 2009] have been found
in normal or Toxoplasma gondii infected mice, respectively. The latter phenotype
was also induced in Foxp3+ cells stimulated in vitro in Th1-promoting conditions
[Wei et al., 2009, Koch et al., 2012, Zhao et al., 2012].
Genetic fate mapping allowed to sort Foxp3+ T cells that have recently ini-
tiated Foxp3 transcription and to distinguish them from the ones that have ex-
pressed Foxp3 for some time [Miyao et al., 2012, Zhou et al., 2009]. Newly de-
veloped Foxp3+ T cells exhibit transient Foxp3 expression [Miyao et al., 2012].
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This observation have led to wonder whether these cells are developmental in-
termediates on the way to become stable Tregs [Hori, 2010] or activated Teffs
that transiently and promiscuously express Foxp3, regardless of Treg differenti-
ation [Miyao et al., 2012, Hori, 2014]. In this line it has also been proposed that
Tregs represent a ”meta-stable” activation state, rather than a distinct lineage of
suppressive cells [Hori, 2014, Bending and Ono, 2019].
A heterogeneity model was proposed [Komatsu et al., 2009, Hori, 2010,
Miyao et al., 2012] that overcomes the reprogramming of committed Tregs def-
inition by calling into play conversion and selection. These authors proposed that
there are two distinct populations of Foxp3+ CD4 T cells: the majority are com-
mitted Tregs, whereas a minor subpopulation are uncommitted, plastic and have
the potentiality to convert into Teffs. This minor population does not proliferate
in lymphoreplete conditions while it preferentially proliferates in lymphopenia and
under inflammation.
The heterogeneity model was extended to the population of former Foxp3+
[Miyao et al., 2012, Hori, 2014]. This population was portrayed as a mixture of a
population of Teffs that transiently expressed Foxp3 after activation, and a popu-
lation of Tregs that have lost Foxp3 expression but retain epigenetic memory of
Foxp3 expression and suppressive function. The latter population was defined as
latent Tregs. This model was introduced to accommodate the observations that
the population of former Foxp3+ cells displayed partially demethylated TSDR.
Upon transfer into Rag1-/-, some cells reacquired Foxp3 expression, becoming
fully suppressive and showing fully demethylated TSDR. Other cells remained
negative to Foxp3 expression, were not suppressive and had fully methylated
TSDR [Komatsu et al., 2009, Miyao et al., 2012, Hori, 2014].
It was proposed that the level of CD25 expression could be a distinctive
marker to deal with the heterogeneity. Committed or latent Tregs would be
CD25high whereas non-Tregs would be CD25low, regardless of Foxp3 expres-
sion. Yet, within CD25lowFoxp3+ cells there are some bona fide Tregs with stable
Foxp3 expression, and CD25highFoxp3+ cells contain some cells that exhibit un-
stable Foxp3 expression [Komatsu et al., 2009]. In addition, CD25 expression in
Foxp3+ cells is dynamically regulated, depending on IL-2 availability and prolifer-
ation status [Fontenot et al., 2005b, Zelenay et al., 2005, Almeida et al., 2006a].
Finally it was proposed that the distinction between committed Tregs and cells
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that exhibit promiscuous Foxp3 expression, without being Tregs, is based on the
differential methylation status of the Foxp3 locus [Miyao et al., 2012]. In fact,
the demethylated status of TSDR, identifies both Tregs expressing Foxp3 and
the Foxp3- latent Tregs that retain epigenetic memory. Therefore, according to
the heterogeneity model, Tregs are a stable cell lineage, whose commitment is
provided by the demethylation of the Foxp3 locus, regardless of ongoing Foxp3
expression [Miyao et al., 2012].
In the face of such multiplicity of definitions, we proposed here a model that
divides the pool of CD4 T cells into three populations: committed Foxp3- cells,
committed Foxp3+ cells, and cells with context-dependent Foxp3 expression. The
confrontation of this model with the data indicated that there is no absolute re-
quirement to postulate the existence of the committed Foxp3+ cell population.
In this simplified view, the majority of Treg populations defined in literature, be-
come a single population of context-dependent cells. More specifically, instead
of distinguishing subpopulations of CD4 T cells, we consider different phenotypic
states that some CD4 T cells can assume. Each cell can switch stochastically
among these phenotypic states in response to external cues, by remodelling of
the Foxp3 locus and by changing its transcriptional activity. For a cell of this
context-dependent population, being regarded as exTreg, latent Treg, committed
Treg or newly developed Treg, depends on the recent history of the cell before
the sorting, but it does not necessarily mirror its function nor predicts its fate.
As we have discussed in chapters 3 and 4, our stochastic model can
reconcile the experimental observations on stability and lability of Foxp3 ex-
pression in vivo [Rubtsov et al., 2010, Duarte et al., 2009, Komatsu et al., 2009,
Paiva et al., 2013]. Moreover, the model predictions are compatible with ob-
servations that were not included in the analysis. For instance, the apparent
heterogeneity of former Foxp3+ cells mentioned above [Komatsu et al., 2009,
Miyao et al., 2012, Hori, 2014] can be alternatively explained by the slow and
stochastic epigenetic remodelling of the Foxp3 locus over time, which depends
on the transcriptional state of the cell. According to our stochastic model, for-
mer Foxp3+ cells that are found with partially demethylated TSDR are cells in
state Z11. Also, the model explains how only a fraction of these cells re-acquire
Foxp3 expression and become fully demethylated at the TSDR. This fraction is
interpreted as those cells that make the transition from state Z11 to Z21 and sub-
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sequently to Z22. Likewise, the model explains the fraction of exTregs that are
pathogenic [Miyao et al., 2012, Duarte et al., 2009], as those that happen not to
require Foxp3 remaining in states Z11 or Z10.
Although many heterogeneous behaviours and promiscuous profiles of Tregs
can be quantitatively interpreted through our model, some cannot. For instance,
given that our model does not account for CD25 expression, it cannot explain
CD25 dynamics. Nevertheless, based on the result (chapter 4) that the vast ma-
jority of stable Tregs are in state Z22, we expect cells in state Z21 to be enriched
in CD25low, while cells in state Z22 to be enriched in CD25high. For simplicity, we
made the choice of introducing only three epigenetic states and we assumed that
cells with fully active chromatin do not lose Foxp3 expression, unless they first
undergo chromatin remodelling. The last assumption corresponds to saying that
Foxp3 loss is negligible in state Z22. Observed CD25highFoxp3+ T cells with par-
tial demethyletad TSDR but exhibiting stable Foxp3 expression and suppressive
function [Hori, 2014] could be perhaps better explained in case we introduced
some more intermediate epigenetic states.
It is not straightforward, with our model, to reproduce the observation that
most immature CD25highFoxp3+ thymocytes stably express Foxp3, while hav-
ing largely methylated TSDR [Toker et al., 2013]. This observation has been
interpreted as CpG demethylation in TSDR occurs after Foxp3 stable expres-
sion has been achieved, in the sense that TSDR demethylation maintains
Foxp3 stability, rather than inducing it. Consistently, demethylation at the
TSDR is not required for initiation of Foxp3 expression, but it is needed for its
long-term maintenance according to [Polansky et al., 2008, Huehn et al., 2009,
Zheng et al., 2010]. More recently, Bending et al. have investigated the in vivo
dynamics of demethylation of the Foxp3 gene, by using the Foxp3-Tocky re-
porter mice [Bending et al., 2018a]. In this mice the transcriptional activity of
the Foxp3 gene is reported by Fluorescent Timer protein, which spontaneously
shifts its emission spectrum from blue to red after translation. Using the Foxp3-
Tocky reporter mice, Bending et al. have shown that in Foxp3+ thymocytes,
Foxp3 expression occurs before TSDR demethylation, while the most active
demethylation process happens when Foxp3 expression is already sustained
[Bending et al., 2018a]. Also for these cases, the data could be potentially better
explained by a model featuring more epigenetic states, particularly if the balance
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between of transcriptional activation and repression increases as the locus be-
come more accessible. This kind of stochastic model of gene expression has
been described for the IL-10 gene [Paixão et al., 2007].
Our modelling results suggest that exTregs and newly generated Tregs
can be observed in lymphoreplete conditions, thus reconciling the apparent
contrasting observations made by fate mapping strategies [Miyao et al., 2012,
Zhou et al., 2009, Rubtsov et al., 2010], as further discussed in section 5.5.
Several experimental observations indicate that Foxp3 expression, per se, is
not sufficient to ensure its continued and stable expression. Therefore, Foxp3
transcription and translation does not work as a molecular switch, as it was origi-
nally described for the transcription of other master transcription factors of CD4 T
cell differentiation such as T-bet or GATA-3 for Th1 and Th2 lineages, respectively
[Szabo et al., 2000, Zheng and Flavell, 1997]. Already for Th1 and Th2 differen-
tiation, it appeared soon clear that lineage specification is more plastic than it
was originally thought [Evans and Jenner, 2013]. That said, our analysis sug-
gests that what makes a CD4 T cell be a Treg, expressing Foxp3 in a sustained
and prolonged manner, are sustained environmental cues. Likewise, inhibition of
suppressive activity and ”reprogramming” toward Teff function occur in scenarios
in which the environmental context ensures that Foxp3 expression is prevented
for a sufficiently long period.
We found a positive correlation between the number of Foxp3- CD4 T cells
in the host and stability of Foxp3 expression. This result, reported in chap-
ter 3, holds also in the analysis described in chapter 4. This correlation is in
agreement with the indexation of Treg cells to the number of activated IL-2-
producing cells [Almeida et al., 2006b], which was posited to be a mechanism
for maintaining homeostasis and preventing autoimmune or lymphoproliferative
diseases. This correlation is also a straightforward prediction of the original
cross regulation model [Carneiro et al., 2007] which still holds in the presence
of context-dependent Foxp3 expression, as for the model presented and stud-
ied in this work in chapter 2. Finally, it is in agreement with the result that the
number of Teffs, producing IL-2, is controlled via a quorum sensing?like feed-
back loop where the IL-2 is sensed by both the activated Teffs and by Tregs
[Amado et al., 2013, Reynolds et al., 2014]
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5.3 Consequences of neglecting population dynamics
while addressing Foxp3 cellular expression
In chapters 3 and 4, that focus on Foxp3 expression at cellular level, we put aside
the population dynamics. In fact, while focusing on the frequency of Foxp3+ cells
within cell cohorts, we did not consider cell proliferation nor death.
To clarify the implications of this choice, let us recall that we assumed that the
temporal evolution of the observed frequency depended on the context in which
the cohort of cells was followed. Beyond antigens presentation, that we assume
not to vary across the different experimental contexts examined, in some exper-
iments the context is mainly constituted by the followed cohort itself. This is the
case for the experiments in which Foxp3+ cells are transferred alone into lym-
phodeficient host mice. In the remaining experiments the context is constituted
by the followed cohort together with other lymphocytes populations, either co-
transferred into, or endogenous to, the host. In each experiment considered in
our analysis, there were portions of cells, within the cohort, whose Foxp3 expres-
sion state would change over time: they either up-regulated or down-regulated
the gene. Neglecting cell proliferation and death mainly implied that, within each
followed cohort, we neglected any preferential proliferation of Foxp3- cells over
Foxp3+ cells or vice-versa, regardless of the context.
When transferring 2.5 ⇥ 105 Foxp3+ T cells alone into lymphodeficient host,
Duarte et al. ”spiked” the Treg cells preparation with 2% of CD4+Foxp3- Teffs
cells (as few as 5 ⇥ 103 cells). These contaminants could be distinguished by
the others T cells thanks to genetic marker. After 4 weeks the contaminants
accounted for 15% of the total CD4+Foxp3- recovered.
Cells that have up-regulated Foxp3 expression in the periphery, lose Foxp3
expression in lymphodeficient condition [Miyao et al., 2012]. Also, they preferen-
tially proliferate in lymphodeficient condition, if compared with the total pool of ex-
Foxp3 cells that have lost Foxp3 expression in lymphodeficient condition. While
the latter cohort of cells do not undergo major proliferation, the former cohort of
cells exhibits a variety of behaviors: within 4 weeks they can either increase up to
50 folds or be halved [Miyao et al., 2012]. Starting from a small amount of cells
as 2⇥ 104, which constitute the 0.5% of the total cohort of the Foxp3+ cells trans-
ferred into lymphopenic host, after 4 weeks they can constitute, on average, from
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less than 1% up to 20% of the Foxp3- cells accumulated. Based on this obser-
vation, researchers have been proposed that the accumulation of cells that have
lost Foxp3 expression, observed in lymphopenic condition and under inflamma-
tion, is mainly the result of preferential proliferation of a minor population of Teffs
that transiently express Foxp3, rather than the pure conversion of Foxp3+ cells
into Foxp3- [Miyao et al., 2012]. Although this might be the case, the link between
the proliferation and the change in frequency was not quantitatively established,
leaving the door open to alternative interpretation. Also, the high non linearity
that affects Tregs and Teffs dynamics when out of their equilibrium, makes the
interpretation of these observations anything but trivial.
Conventional CD4+ T cells poorly expand when adoptively transferred into
lymphoreplete, presumably being outcompeted by endogenous cells. In con-
trast, when conventional CD4+ T cells are adoptively transferred into lym-
phodeficient hosts, they undergo massive proliferation [Annacker et al., 2000,
Annacker et al., 2001, Almeida et al., 2002]. Likewise, in case of adoptive trans-
fer of Tregs into lymphodeficient mice, we expect that the cells that first lose
Foxp3 expression will, at least transiently, proliferate more than the cells that re-
main Foxp3+. These expectations are in line with the original cross regulation
model predictions [León et al., 2001, Carneiro et al., 2007] and still hold in the
model presented in chapter 2. According to the cross regulation model, the T
cell per capita net growth rate, dT
Tdt
, increases as the cell density decreases, thus
being larger in lymphodeficient as compared to lymphoreplete hosts. This rate
is zero in lymphoreplete condition which corresponds to the equilibrium of the
system. Moreover, at low T cells density the co-conjugation of Tregs and Teffs on
APCs is diluted by the excess of APCs, since T cells likely conjugate alone with
APCs. Under these conditions, Teffs are activated and proliferate, whereas Tregs
do not. The preferential Teffs proliferation is expected to be transient. As soon as
Teffs density grows, the chance for Tregs to form a multicellular conjugate with
Teffs increases, and Teffs start ”fuelling” Tregs proliferation, while they are inhib-
ited by activated Tregs. This dynamics is evident in the trajectories of Teffs and
Tregs populations toward the equilibrium (see figures 2.4 and 2.5): any trajectory
that starts within the basin of attraction of the tolerance equilibrium with minute
Teff densities, displays initially a Teffs population growth, before the equilibrium,
dominated by Tregs, is reached.
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In our models, introduced in chapters 3 and 4, we focused on cellular fre-
quencies which is analogous to a scenario of equal proliferation and death of
Foxp3- and Foxp3+ CD4 T cells. This was the simplest approach in our first ap-
proximation to the problem. We are aware that we are neglecting the transient
preferential proliferation of Teffs that occurs at low T cells densities. We expect
this process not to happen in the lymphoreplete condition and to be mitigated in
co-transfers experiments. Concerning lymphodeficient condition, we are assum-
ing that the preferential proliferation of Teffs during a the initial transient period,
can be neglected in comparison with the longer time window of weeks, during
which most of the dynamics is observed. Nevertheless, we cannot rule out the
possibility that neglecting this preferential proliferation has led us to overestimate
the frequency of cells that express Foxp3 in a context dependent way. For this
reason, including the population dynamics in this analysis is a desirable path for
future research.
In the study of Foxp3 cellular expression (chapters 3 and 4), we assumed
that each host provides a particular environment for the CD4 T cells. That is to
say, we assumed that any CD4 T cell in a specific host, given the host particular
composition of immune cells populations, is subjected to certain interactions with
other CD4 T cells, mediated by APCs. This average host-specific context, to
which each CD4 T cell is subjected during the time window of any experiment, is
reflected in the context-dependent model parameters values. We also assumed
that the change in Foxp3 transcriptional state occurring in any CD4 T cell, does
not impact the average characteristics of the field of inputs in which all the cell are
embedded. It means that the model parameter values do not change over the
time of the experiments, but reflect the average characteristics of the experiment.
Also, in this sense, the population dynamics is neglected in these two chapters.
With such an approximation, we regarded any mouse as if it was a well-
stirred system, in which, each cell being sampled is representative of any CD4
T cell: given that the time window of the experimental observation is long
enough, any sampled cell would receive, on average and throughout the ex-
periment, the same input as any other. We are, therefore, using a mean field
approximation to analyse the interactions among T cells mediated by APCs.
The idea of the mean field approximation, in case of stochastic model in-
volving high-number of interacting particles, is to focus on one average par-
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ticle. In our case the ”particles” are cells. The approximation assumes that
the effect of the neighbouring cells on any given cell is approximated by a
single averaged effect of what is called mean field. This approximation re-
duces a many-body problem to a one body problem. The approach of mean
field approximation in modelling the adaptive immune system is not new. It
has been used to study the maintenance of diversity in T cells repertoire
[Stirk et al., 2008, Stirk et al., 2010], the mechanism of T cell receptor triggering
and down-regulation [Milutinovic et al., 2003, Sousa and Carneiro, 2000] and the
dynamics of the TCR expression level distribution [Milutinović et al., 2007].
5.4 Can sub-cellular and super-cellular dynamics be
reconciled?
The population dynamics analysis in chapter 2 suggested that loss of Foxp3 ex-
pression needs to be a slow process such that tolerance is maintained. The
analysis of the cellular dynamics of Foxp3 expression in CD4 T cells, conducted
in chapter 3 with the use of experimental data, gave us an estimation for Foxp3
rate loss. Irrespective of the fractions of committed Tregs and plastic Tregs, the
rate at which un-stimulated Tregs convert into Teffs is of the order of weeks. Fi-
nally, the analysis in chapter 4 showed that the slow rate of Foxp3 loss can be
explained by epigenetic remodelling of the Foxp3 locus that controls the accessi-
bility for the transcription machinery. Let us recall that, because epigenetic marks
are inherited traits, epigenetic dynamics needs to be, by definition, slow. At least,
it cannot be faster than cell proliferation, otherwise epigenetic marks, rather than
being inherited, would be stochastic.
In the interaction between Tregs and Teffs that we have studied here, the cel-
lular and population levels are actually intertwined and interdependent. In fact
population dynamics, which controls proliferation and death of the two popula-
tions, and Foxp3 expression dynamics, which defines the identity of the cells,
depend on the densities of Tregs, Teffs and APCs. On the one hand, T cell
populations interact through multicellular conjugates and the kind of inhibitory
or activatory interactions depends on the conjugate stoichiometry that in turn is
determined by the densities of the populations. On the other hand, the cellular
dynamics, which determines the change in identity between Tregs and Teffs, de-
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pends on what we have called the environment of the cells. In chapter 3 we also
showed that the environment can be likely explained by density of Teffs. Cellular
dynamics, therefore, depends on the densities of the cell populations.
Therefore, population dynamics and cellular Foxp3 dynamics depend on cells
density and eventually determine the densities themselves. While the global
equilibrium, at cellular and population level can be studied (and, in a way, is
the assumption behind the analysis in chapters 3 and 4), investigating the global
dynamics can be tricky. In fact the two levels determine one another. If their
respective time scales were different, one could simply address their joint dy-
namics, by quasi-steady-state approximation, for instance. However this is not
the case: in addition to determining one another, the dynamics at sub-cellular
and super-cellular level share the same time-scale.
We incorporated the epigenetic dynamics into the population dynamics model
and did some preliminary analysis. We introduced two sub-populations of Tregs,
distinguished by their epigenetic state of the Foxp3 locus. In the model, cells
belonging to the first Tregs subpopulation can lose Foxp3 expression in a context-
dependent way, as the Tregs in the model introduced in chapter 2. The other
subpopulation of Tregs cannot lose Foxp3 expression, unless they first convert
into the other population. Transition between the two populations happens in a
context-independent way.
We used this model to reproduce the experiments showing stability of
Foxp3 expression in physiologic condition [Rubtsov et al., 2010] and the ex-
periments where Tregs are adoptively transferred into lymphodeficient host
[Duarte et al., 2009, Komatsu et al., 2009]. We managed to fit the experimental
data, using a rate of Foxp3 loss, for un-stimulated Tregs, equal to the one deter-
mined by the analysis in chapter 3. Nevertheless, in the regime we found, the
dynamics of loss of Foxp3 in the lymphodeficient condition displayed damped os-
cillations. This means that, according to the model interpretation, the frequency
of Foxp3+ cells would converge to the equilibrium in the new environment through
transient oscilllations of progressively low amplitude. For this reason, further in-
vestigation should be carried to know the bifurcation diagram of the integrated




5.5 Dynamical interpretation of Foxp3 expression and
stability
The two stochastic models for cellular Foxp3 expression (chapters 3 and 4) al-
lowed us to interpret the different temporal dynamics of Foxp3 expression, ob-
served in vivo in different hosts, under a single framework. Our analysis included
experiments performed in lymphoreplete as well as lymphodeficient conditions,
encompassing several intermediate cases. Moreover, the data were produced
by experiments assessing the frequency of cells that maintained or that acquired
Foxp3 expression.
Prior to performing this analysis, we fitted the same data sets, using simpler
stochastic models for just down-regulation of Foxp3, in case the experiments
addressed maintenance, or for just up-regulation of Foxp3, in case the data ad-
dressed acquisition (see Figure 5.1). We used single-step models, which repre-
sent the most parsimonious choice, as well as multi-step models, which consider
several epigenetic remodelling steps of the locus or, alternatively, account for
other molecular mechanisms that influence gene transcription and translation. In
short, within several possible linear combinations of exponential functions, we
choose the most reasonable model, based on the Akaike information criterion
(AIC) [Akaike et al., 1973, Bozdogan, 1987], which makes a trade-off between
the likelihood of the fit and the parsimony of the model. This is a way to quantify
the characteristic rate of Foxp3 loss within the cohort, in case the cohort was of
Foxp3+ cells. More specifically, it is a way to quantify the ”net rate of decay”. Like-
wise, in case the cohort was of Foxp3- cells, the ”net rate of acquisition” would be
quantified. Obviously this analysis was only performed on time series with three
or more points. Each data on Foxp3 maintenance was then associated to a net
rate decay (function of the model rates), and each data on Foxp3 acquisition to a
net rate of acquisition. The drawback of this approach was that, by construction,
the two rates were independent of each other, even in case maintenance and ac-
quisition of Foxp3 expression were assessed in the same host, by simultaneously
following two cell cohorts (one positive and one negative for Foxp3 expression, at
time zero). This approach regards Foxp3 maintenance and up-regulation as they
were independent from each other, rather than the result of the same context that
provides the inputs which regulate gene activation and repression.
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Figure 5.1: Comparison among different multi-step stochastic models for
Foxp3 expression and consequences on dynamical interpretation of Foxp3
expression. Not any multi-step stochastic model for gene expression allow for
dynamical of Foxp3 expression. Left: models for Foxp3 down-regulation only,
can be used to perform fitting of experimental data assessing the maintenance
of Foxp3 expression over time in cohorts of Foxp3+ cells and to quantify the net
rate of Foxp3 expression decay within the cell cohort. Center: models for Foxp3
up-regulation only can be used to perform fitting of experimental data assessing
the acquisition of Foxp3 expression over time in cohorts of Foxp3 Foxp3- cells
and to quantify the net rate of Foxp3 expression acquisition within the cohort.
Right: models accounting for both Foxp3 up- and down- regulation, as the ones
used in chapters 3 and 4, allow for dynamical interpretation of Foxp3 expression
and stability. They can be used to fit experimental data assessing maintenance
as well as acquisition of Foxp3 expression in cohorts of Foxp3+ and Foxp3- cells,
respectively, even when the assessment is performed in the same host. When
using these models to reproduce experimental data, each host is characterised
by net rates of Foxp3 decay as well as acquisition and the two rates are interde-
pendent by construction. As a consequence, these models permit to disentangle
the net behaviour of the cohort of cells from the dynamics of its individual cells.
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On the other hand, models in chapters 3 and 4 assume that, in each host,
both up- and down- regulation of Foxp3 are allowed. And yet to any of the activa-
tion or repression rates, it can be attributed a value so small as to be practically
zero relative to the life of a mouse. With these models, therefore, each host
(meaning each context in which CD4 T cells are embedded) is characterised by
two rates: the rate at which a CD4 T cell switches from Foxp3+ to Foxp3- and the
rate of reverse transition. This assumption means that the empirically observed
frequencies of Foxp3+ cells within any cohort of cells is seen as the net result of
both transitions. And in fact, the prediction of a large fraction of Teffs that never
up-regulates Foxp3 in lymphoreplete conditions was a result of fitting the mod-
els to the data from Tregs and Teffs co-transfers, where both maintenance as
well as up-regulation were assessed. In these experiments, the cohort of Foxp3+
cells showed stable Foxp3 expression whereas almost no up-regulation of Foxp3
was observed in the Foxp3- cohort. The discrepancy observed in the frequency
of equilibrium of Foxp3+ cells within the two cohorts together with the fact that
those frequencies are the net result of the shared up- and down- regulation rates
support the existence of a subpopulation of Teff cells that, no matter the rate of
Foxp3 up-regulation, do not make the transition. Also, the constraint on the ob-
served fraction of Foxp3+ cells within CD4 T cells compartment, came into play
in the quantification of this subset of CD4 T cells. If we had dissociated up- and
down- regulation in the analysis, we would not have obtained this quantitative
insight into Teff heterogeneity.
Furthermore, using these models, we could compute the net decay rate as-
sociated with the dynamics of the frequency of Foxp3+ cells in a selected cohort
of Foxp3-expressing cells but also the rate at which any of these cells lost Foxp3
expression for the first time. In this way the models permitted to disentangle the
net behaviour of the cohort of cells from the dynamics of its individual cells. In
particular, this allowed to account for possible loss of Foxp3 expression occurring
in physiologic conditions that, nevertheless, does not impact on the apparent rate
of decay, because it is transient.
The analysis opened the door to a dynamical interpretation of the stability
of Foxp3 expression, observed in lymphoreplete condition, that so far has been
often overlooked. As already mentioned, our analysis puts forward the possibil-
ity that stable Foxp3 expression can be the result of the context, which provides
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sustained pro-Foxp3 stimuli to a subset of CD4 T cells, without a necessary com-
mitment to Foxp3 expression. Furthermore, our analysis suggests that stability
of Foxp3 expression can be the apparent outcome of a slow loss of Foxp3 ex-
pression in Tregs counterbalanced by a fast Foxp3 up-regulation. Also, according
to our analysis, the majority of Tregs (at least the 72%) if not all, would be sub-
jected to the slow Foxp3 loss. This results, as we have shown in chapter 4, is
compatible with the high level of CpG demethylation in Foxp3 locus, observed in
vast majority of stable Tregs [Miyao et al., 2012, Ohkura et al., 2012]. Recently,
Bending et al. have investigated the Foxp3 transcriptional dynamics, using the
Foxp3-tocky reporter mice. These transgenic mice allow to distinguish among
cells that have just initiated Foxp3 transcription, cells with sustained transcrip-
tion and cells that have recently down-regulated Foxp3 expression and are not
transcribing the gene any longer [Bending et al., 2018a, Bending et al., 2018b].
They proposed a dynamical perspective on Foxp3, regarded as a dynamically
expressed gene [Bending and Ono, 2019]. In their perspective the activation of
the Foxp3 transcription is regulated by temporally persistent TCR signalling and
enhanced by IL-2, TGF-  and retinoic acid signalling. Furthermore, the mainte-
nance of Foxp3 transcription requires the demethylation of the Foxp3 locus which
allows the Foxp3-RUNX1/CBF- -mediated auto-regulatory transcriptional loop to
occur and that can be affected by IL-2 signalling. Finally they suggest a mutual
relation between what they called ”the dynamic Foxp3 auto-regulatory loop” and
the chromatin remodelling of the Foxp3 gene.This view is fully compatible with
our results and interpretations.
Transient Foxp3 expression has been observed in physiologic condition by
genetic lineage tracking of Foxp3+ cells [Zhou et al., 2009, Miyao et al., 2012]. In
these studies, 10 to 20 % of the Foxp3+ cells lost the expression of this marker
in physiologic conditions. This result was interpreted as a proof of the dynamical
regulation of Foxp3 expression. Nevertheless, continuous labelling was criticised
as leading to overestimate the amount of Tregs that would lose Foxp3 expres-
sion in physiologic conditions. The rationale behind the criticism was that, in
presence of continuous labelling, cells that had just transiently expressed Foxp3,
without ever having acquired suppressive function would be regarded as exTregs
[Rubtsov et al., 2010]. As a matter of fact, in case of inducible labelling upon ta-
moxifen administration in adult mice, as we discussed at length in this work, no
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accumulation of exFoxp3 population is observed [Rubtsov et al., 2010].
Rather than being interested in cells that transiently express Foxp3, we sug-
gest to focus on cells that transiently lose Foxp3 expression. The analytic expres-
sions of the Foxp3 mean residence time, that we derived, allows for quantitative
prediction of the frequency of cells that have never lost Foxp3 expression (see
equation 4.8) and, therefore, allows for experimental testing. The major issue
then becomes the fact that available experimental data, so far, measure only the
net rate of Foxp3 loss in a population, which overlooks transient loss.
5.6 An experimental approach to reveal Foxp3 commit-
ment
The analysis carried out in chapters 3 and 4 suggests the possibility of Tregs
being heterogeneous and constituted by two populations. A population of cells
committed to Foxp3 expression and another population of plastic cells, as pre-
viously suggested [Miyao et al., 2012]. Nevertheless, our model predicts that, in
case of Tregs heterogeneity, only a minor fraction of Tregs would be committed
(at maximum 28%), while the majority would be plastic, expressing Foxp3 stably
or transiently depending on the context. The model fitting also supports the pos-
sibility that all the Tregs belong to this plastic pool of CD4 T cells and there are
no committed Tregs.
It is still unclear whether an animal in normal physiologic conditions pos-
sesses a core of CD4 T cells that, once have acquired Foxp3, cannot lose it.
This question could be addressed by performing successive transfers of Foxp3+
cells isolated from lymphodeficient recipients. However, these experiments have
major technical hurdles. The number of Tregs that are recovered after two con-
secutive adoptive transfers in lymphodeficient mice (either Rag2-/-, TCR -/- or
CD3"-/-) is very small and does not allow for robust assessment (as reported by
Demengeot laboratory, unpublished data).
The theoretical results on Foxp3 residence time suggested that the existence
of plastic Tregs in adult mice in lymphoreplete condition could be revealed by
experiments that do not involve adoptive transfer of cells. If plastic Tregs ex-
ist, they should be identified in physiologic conditions and in an experimentally
manageable time span (30 and 45 days) (see figure 4.8).
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Such an experimental observation would be possible, for instance, in case
we could engineer the Foxp3GFP-Cre-ERT2 ⇥ ROSA26YFP transgenic mouse
[Rubtsov et al., 2010], to allow for permanent and inducible labelling of cells
that lose Foxp3 expression, within a cohort of already labelled Foxp3+ cells.
This mouse model would allow to quantify a putative fraction of cells that tran-
siently lost and subsequently re-acquired Foxp3 expression, within the cohort of
YFP+ cells that was found to stably express Foxp3 in the Foxp3GFP-Cre-ERT2 ⇥
ROSA26YFP transgenic mouse [Rubtsov et al., 2010] (see Figure 5.2).
The design of such a transgenic mouse model presents technical hurdles.
It would require, along with the tamoxifen-induced Cre-Loxp recombination sys-
tem, a second system of inducible and permanent labelling, upon a different drug
administration. Furthermore, it is not trivial to induce permanent labelling in cells
that do not express a gene (in this case the Foxp3 gene). The molecular descrip-
tion of such a mouse model goes beyond the scope of this work. Here we would
like to describe the experiment that the model would allow, in case it was viable
(Figure 5.2). We assume that in this mouse, Foxp3 expression in CD4 T cells is
reported by GFP. Upon drug 1 administration, cells that express Foxp3 at the time
of treatment are permanently labelled as YFP+. Drug 1 administration, therefore,
establishes the cohort of Foxp3+ cells in which Foxp3 dynamics will be assessed.
Starting from time t = 0 of the experiment, few days after drug 1 administration,
mice are provided with food containing drug 2, which induces the RFP perma-
nent labelling of CD4 T cells that, from time t = 0 on, do not express Foxp3. At
any later time point, the cells belonging to the followed cohort, that have never
lost Foxp3 expression since time t = 0, are labelled as GFP+YFP+RFP-, the cells
that have transiently lost Foxp3 expression are labelled as GFP+YFP+RFP+. Fi-
nally, the cells that have lost Foxp3 expression without re-acquiring it are labelled
as GFP-YFP+RFP+. The frequency of GFP+YFP+RFP- cells within the YFP+ cell
cohort over time can be used to infer the Foxp3 residence time and the frequency
of committed Tregs, as described in section 4.2.4 and Figure 4.8.
This transgenic mouse model would uncover putative transient loss and re-
acquisition of Foxp3 expression. Nevertheless, as predicted by our analysis,
it would not be resolutive in case of permanent yet context-dependent Foxp3
expression. Let us explain it in more details.
Our model fitting analysis showed that experimental data are compatible with
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Figure 5.2: Experimental design to assess dynamical Foxp3 expression in
physiologic condition. Mice are the transgenic mice model proposed in the
main text. In them, Foxp3 expression is reported by GFP. Upon drug 1 admin-
istration Foxp3+ cells are permanently labelled as YFP+. These cells constitute
the cell cohort in which Foxp3 dynamics will be assessed. Continuous drug 2
administration via food permanently labels as RFP+ the cells that, from t = 0
on, are Foxp3-. At any later time point t = t⇤, GFP+YFP+RFP- cells are the
ones that have never lost Foxp3 expression since t = 0; GFP+YFP+RFP+ ones
are cells that have transiently lost Foxp3 expression, GFP-YFP+RFP+ ones are
cells that have lost Foxp3 expression without re-acquiring it. The frequency of
GFP+YFP+RFP- cells within the YFP+ cell cohort over time can be used to infer
the Foxp3 residence time ⌧
foxp3 and the frequency of committed Tregs.
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an infinite Foxp3 mean residence time in lymphoreplete conditions (see blue dots
in figure 4.8 A for ⌧
foxp3 > 100). For this extreme case, the prediction is that
there is something in lymphoreplete context that prevents the down-regulation of
Foxp3, irrespective of the slow and stochastic epigenetic remodelling that takes
place. Yet, for this case, the model also predicts that the fraction of commit-
ted Tregs would be revealed by performing an adoptive transfer experiment into
lymphodeficient host.
In this scenario there is no longer need for two systems of inducible and
permanent labelling. It is enough that cells can be sorted based on Foxp3 ex-
pression (due to GFP reporter, for instance) and that permanent RFP labelling
can be induced in the CD4 T cells that lose Foxp3 expression. Furthermore, in
case of co-transfer of Tregs, together with Teffs, the experiment requires the two
cell cohorts to be distinguishable, based on genetic marker, for instance. This is
necessary in order to label the cohort of Foxp3+ cells in which Foxp3 dynamics
will be assessed.
The experiment consists in co-transferring, into lymphodeficient host, Tregs,
sorted from the transgenic mouse, together with Teffs, sorted from a different and
distinguishable donor (see Figure 5.3). The co-transfer is performed in propor-
tion than ensures stability of Tregs (e.g. 1 Tregs : 10 Teffs [Komatsu et al., 2009]).
Right after the transfer, at time t = 0 of the experiment, the host mice are pro-
vided with food containing drug 2. Drug 2 continuous administration induces the
permanent labelling of cells that do not express Foxp3, from time t = 0 on. At
any later time point t⇤, cells that have never lost Foxp3 expression since time
t = 0 are labelled as GFP+Thy1.1+RFP-, cells that have transiently lost Foxp3
expression in the time window [0, t⇤] are labelled as GFP+Thy1.1+RFP+, cells
that have lost Foxp3 expression after time t = 0 without reacquiring it, are are
labelled as GFP-Thy1.1+RFP-. The frequency of GFP+Thy1.1+RFP- cells within
the Thy1.1+ cell cohort over time can be used to infer the Foxp3 residence time
and the frequency of committed Tregs, as described in section 4.2.4 and Figures
4.12 and 4.12.
The model predicts that, even in case Foxp3 expression in lymphoreplete
condition context-dependent yet permanent (as the blue dots in 4.12), the fraction
of committed Tregs would be revealed in this experiment in a reasonable amount
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Figure 5.3: Experimental design to quantify dynamical Foxp3 expression
upon adoptive transfer. Thy1.1 donor mice are the transgenic mice model pro-
posed, in which Foxp3 expression is reported by GFP; Thy1.2 donor mice are
Foxp3GFP mice. GFP+Thy1.1+ CD4 T cells are sorted from Thy1.1 donor mice,
while GFP+Thy1.1- naive CD4 T cells are sorted from Thy1.2 donor mice. The
two cohorts are transferred into lymphodeficient host mice in proportion (1:10),
which ensures stable expression of Foxp3 in Foxp3+ cells [Komatsu et al., 2009].
Thy1.1 genetic marker labels cell cohort in which Foxp3 dynamics will be as-
sessed. Continuous drug 2 administration, via food, permanently labels as RFP+
the cells that, from t = 0 on, are Foxp3-. At any later time point t = t⇤,
GFP+Thy1.1+RFP- cells are the ones that have never lost Foxp3 expression since
t = 0; GFP+Thy1.1+RFP+ ones are cells that have transiently lost Foxp3 expres-
sion, GFP-Thy1.1+RFP+ ones are cells that have lost Foxp3 expression without
re-acquiring it. The frequency of GFP+Thy1.1+RFP- cells within the Thy1.1+ cell
cohort over time can be used to infer the Foxp3 residence time ⌧
foxp3 and the
frequency of committed Tregs.
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5.7 Relationship between the repertoires of Tregs and
Teffs
The analysis of populations dynamics carried out in chapter 2 motivates some
considerations about Tregs repertoire. The model predicts that, in absence of
thymic output, Teffs that are under the control of cognate Tregs, get progressively
outcompeted by former Tregs that have lost Foxp3 expression. In other words,
in thymectomised animals, the population of potential autoimmune Teffs cells
eventually becomes constituted exclusively by exTregs. This means that, if one
waits long enough after thymectomy, the sequence repertoire of Tregs would be
included in that of Teffs.
This prediction depends on two model assumptions adopted in chapter 2.
The first is that unstimulated Tregs lose Foxp3 expression with a constant rate,
which means that all Tregs are plastic and there are no committed Tregs. The
second assumption is that there is no up-regulation of Foxp3 in the periphery . As
already mentioned, these assumptions are simplifications that we adopted with
the aim of exploring, in the worst case scenario, what is the impact of Foxp3 la-
bility in the maintenance of tolerance. The absence of committed Tregs is in part
supported by the experimental data, according to the analysis of chapters 3 and
4, yet it remains an assumption which still lacks a definite empirical support. Un-
der these two assumptions, as seen in chapter 2, as long the Foxp3 loss is slow,
tolerance is not broken and Tregs coexist with Teffs populations they control. In
the presence of thymic output, the Teffs that are controlled by Tregs, are of two
kinds: the ones that come from the thymus, escaping the negative selection, and
the ones that derive from Tregs that lost Foxp3 expression. Thymectomy would
eliminate the source of thymic derived Teffs, which would be then gradually sub-
stituted by ex Tregs. This result could be experimentally tested, by sequencing
TCR of Teff and Treg cells in adult thymectomised animals.
This prediction is compatible with previous claims. In the context of fate
mapping (using the Foxp3GFP-Cre⇥ROSA26YFP transgenic mouse) Zhou et al.
have shown that there is some overlap in the repertoire of exTregs and tTregs
[Zhou et al., 2009]. Moreover, Sepulveda et al. suggested that Teffs thymocytes
are more diverse than Tregs [Sepúlveda, 2011]. Yet their analysis did not rule




What if any of the two assumptions is not fulfilled? The analysis of cellu-
lar Foxp3 dynamics (chapter 4) suggested the possibility that the net frequency
of Tregs is dynamically maintained, with Foxp3 down- and up- regulation over
time. If this is the case, in lymphoreplete animals, the slow Foxp3 loss to which
un-stimulated Tregs are subjected is counter balanced by a context-dependent
up-regulation of Foxp3. Furthermore, in line with the results of chapter 3, the
possible up-regulation over time of Foxp3 would only affect the subset of CD4 T
cells that we called context-dependent. Yet, we cannot rule out the possibility that
even in case Foxp3 expression was dynamical, thymectomy would determine that
the compartment of auto-reactive Teffs will be constituted by cells that at some
point had expressed or will express Foxp3. Going back to the figure 3.7, this
eventuality corresponds to an expansion, upon thymectomy, of the compartment
depicted in light grey at the expenses of the dark one.
Also, there is another factor that could determine progressive substitution of
the auto-reactive T cells by exTregs upon thymectomy, even under dynamical
maintenance of the Foxp3+ population. For this, it is worth to remember that,
according to the population dynamics, in case the Tregs and cognate Teffs are
in tolerance equilibrium, Tregs are characterised by a higher density than the
Teffs they control. This result was first found in the original cross regulation
model [Carneiro et al., 2007] and still holds in case of context-dependent Foxp3
expression (see chapter 2), where Tregs are subjected to continuous Foxp3 loss.
High density of Tregs could favour the exTregs, whose source are the Tregs, in
the competition against thymic derived auto-rective Teffs.
Further analysis of the population dynamics could shed some light on con-
ditions required for competitive exclusion of auto-reactive Teffs by exTregs upon
thymectomy.
Finally, in case there was a core of Tregs that is not subjected to any Foxp3
loss and in case their difference with respect to the context-dependent Tregs
rely on TCR repertoire, then the sequence diversity in TCR of committed Tregs,




5.8 Foxp3- committed CD4 T cells and peripheral Foxp3
induction
As already mentioned, in chapter 2, we did not assume peripheral Tregs differ-
entiation, mainly as a first approximation. On the other hand, one of the main
results of chapters 3 is that the large majority of CD4 T cells are prevented from
up-regulating Foxp3 in the periphery, and a main result from chapter 4 is that sta-
ble Foxp3 expression in lymphoreplete condition is likely achieved in a dynamical
way that includes transient down-regulation of Foxp3 expression.
Modigliani et al. have proposed that when naive cells exit the thymus there
is a limited period of time during which they can be ”educated” to become Tregs,
after which the cells lose this ability [Modigliani et al., 1996]. This proposal is in
line with the finding that Recent Thymic Emigrants are the preferential precur-
sors of Tregs which differentiate in the periphery [Paiva et al., 2013]. Also, Tregs
that have lost Foxp3 expression can reacquire it in vivo if opportunely stimulated
[Komatsu et al., 2009, Hori, 2014]. However, it is unclear whether this ability is
confined to a limited time window after the Foxp3 loss.
More generally, it is known that CD4 T cells differentiate in the periphery
in response to environmental cues such as TCR ligands stimuli and cytokines.
Accordingly, naive T cells can differentiate in vitro into Th1 or Th2 type, if the ap-
propriate cytokines are provided in the culture media, together with anti-CD3 and
anti-CD28 antibodies. Cells that have differentiated in vitro into Th1 type and
are subsequently switched into pro-Th2 medium, reprogram toward Th2 type,
provided the change of medium is done early enough, but not later. The same
happens for Th2 induced cells that can be reprogrammed to become Th1. These
evidences fit with the more general idea that changing gene profiles and repro-
gramming in response to environmental cue is an ability that decreases with cell
maturation and as cells differentiate along alternative pathways.
Also in case of Tregs, Foxp3+ T cells stimulated in vitro together with anti-
CD3 and CD28 antibodies and Th cell polarising cytokines, have shown how
cytokines signals determine exFoxp3 fate. Several Th canonical like phenotypes
have been observed, together with promiscuous phenotypes. Anti-TGF-  leads
to IL-2 producing exFoxp3 cells [Komatsu et al., 2009]; IL-4 stimulations leads
to IL-4 producing Th2-like exFoxp3 T cells, IL-6 stimulation leads to IL-17 se-
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creting Th17-like exFoxp3 T cells; finally IL-2 stimulation does not affect Foxp3
expression, but induces the promiscous phenotype of INF- + Foxp3+ T cells
[Wei et al., 2009, Koch et al., 2012, Zhao et al., 2012].
A different view, arises from the modelling of the gene regulatory net-
work underlying the CD4 T cells differentiation program in response to dis-
tinct micro-environments by Naldi et al.. They found hybrid phenotypes as
transient states of the network, in a context-dependent way [Naldi et al., 2010,
Abou-Jaoudé et al., 2015]. This result might contrast with the previous view, in
the sense that it admits the possibility of transitioning from one phenotype to an-
other one regardless the maturation state of the cells, as long as the external
cues are available. Yet, it is worth to remember that gebe regulatory networks do
not model cell maturation, nor time evolution.
Going back to the cells that we called committed Foxp3- as they cannot up-
regulate Foxp3. The inability to express Foxp3 could be seen as a cell intrinsic
property, either in terms of maturation and limited time window for plasticity, or
in terms of up-regulation of other master genes that inhibit the up-regulation of
Foxp3. Another possibility is that the incapacity of these cells to up-regulate
Foxp3 is a cell extrinsic property, in the sense that depend on the context. This
would imply that, although the cells could be induced to express the Foxp3 even
later, the context is not able to provide enough pro-Foxp3 stimuli to the major-
ity them, that continue their differentiation toward other phenotypes. This could
reconcile the results of the gene regulatory network with the evidences of promis-
cuous phenotypes observed in vivo in pathologic conditions and the one that can
be induced in vitro, where the conditions can be forced to resemble the pathologic
ones. In any way, our modelling cannot discriminate between the two possibili-
ties.
5.9 Concluding remarks
Robustness of tolerance can be explained as a result of non-linear and den-
sity dependent dynamics among populations of Teffs and Tregs of similar speci-
ficities, mediated by populations of cognate APCs ([Carneiro et al., 2007], here
chapter 2). The CRM predicted two main subsets of clones in which CD4+ T
cells repertoire in the periphery is divided. A first set of highly diverse clones
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that barely react to self-antigens and most likely are responsible for mounting
immune responses against pathogens: their clonal expansion is limited and gov-
erned by the APCs availability; and a second set of less diverse clones that are
auto-reactive. The set of auto-reactive clones contain both Tregs and Teffs: Teffs
are the ones that can potentially cause autoimmunity by orchestrating the im-
mune response against the bodies organs and tissues, whereas Tregs control
their expansion, supported by high density of APCs presenting auto-antigens.
The main contribute of the present work is to propose that, within the entire
pool of CD4 T cells, not all the cells are committed to be either Teffs, thus able to
determine the cascade of events that give rise to immune responses, or Tregs,
thus able to suppress the activation and clonal expansion of other immune cells.
A large fraction of CD4 T cells is committed to be Foxp3- and in no case can up-
regulate Foxp3 and become suppressive. Within this compartment, we expect
the majority of cells to be barely auto-reactive (therefore to belong to the first set
of clones described) and only a minority to be the auto-reactive clones whose
expansion is controlled by Tregs.
The remaining CD4 T cells, except at most a minor fraction of cells that are
committed to Foxp3 expression, are auto-reactive cells whose phenotype and
function is strongly determined by the context. Namely, for these cells, the inputs
they receive from the density-dependent interactions ultimately determine their
phenotype.
This means that for the majority of Tregs, that in lymphoreplete condition are
observed to stably maintain Foxp3 expression and suppressive function, their
stability is context-dependent. Also we have shown that stability of Foxp3 ex-
pression, is to be understood in a dynamical way, in the sense that within a stable
cohort of Tregs, actually the cells transiently lose Foxp3 expression in a stochas-
tic way, and quickly revert to the Foxp3+ state. In case the pro-Foxp3 stimuli are
not adequately provided by the interactions, Tregs stop being suppressive and
become pathogenic.
In this sense Treg identity, exemplified by stable Foxp3 expression which en-
ables the suppressive function, is determined by the context, namely depends on
the interactions Tregs make with the other cells of similar specificity. Treg identity
ultimately depends on the population densities themselves.
The fact that Foxp3 expression depends on the context for large part of Tregs,
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plays an important role in the robustness of tolerance: as long as the rate of
Foxp3 loss is slow, plasticity of Tregs determines a smoother restoration of home-
ostasis after perturbation as compared to a scenario of purely committed Tregs.
Furthermore, the slow time scale characteristic of Foxp3 expression loss, in Tregs
that do not receive enough pro-Foxp3 stimuli, can be explained by the epigenetic
remodelling of the Foxp3 locus. Data are compatible with epigenetic mecha-
nisms being consequences of the transcriptional state of the cells, without being
necessarily and directly determined by the inputs the cells receive.
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